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8 Chapter 1
RATIONALE
Subfertility
Worldwide 70-80 million couples experience difficulties in conceiving [1]. In about 10-15% 
of these couples subfertility is present defined as; “A disease of the reproductive system 
characterized by the failure to achieve a clinical pregnancy within 12 months or more of regular 
unprotected sexual intercourse” [2]. A routine fertility investigation has to be performed to 
investigate whether causes can be attributed to a female factor, a male factor or a combination 
of both and to design an individual treatment plan [3]. Several techniques can improve 
pregnancy rates such as artificial insemination, ovulation induction, or in-vitro fertilization 
(IVF), and new insights and enhanced techniques arise. Unfortunately, a substantial part of 
the subfertile couples will experience mild to severe physical complications and psychological 
and emotional constrains (such as medicalization on the relationship, sexual well-being) due 
to the fertility treatment [4]. Since major health care and societal costs are involved in fertility 
treatment, subfertility has economic and societal consequences as well. For example the mean 
costs per live birth with IVF treatment are 87,748 euro [5]. 
Diet and medication
The chances of a successful fertility treatment are mediated by complex interactions between 
non-modifiable risk factors, for example age and ethnicity, and modifiable factors, such as 
obesity, smoking or an inadequate diet. When improving in particular these modifiable risk 
factors, patients can contribute to their own health and thereby chances of pregnancy for 
example by changing inadequate lifestyles [6]. 
Our group has shown before that a healthy diet in women improves the ovarian response, 
embryo morphology and pregnancy chances [6-8]. Moreover, in men an adequate diet is 
associated with a better semen quality by decreasing the sperm DNA fragmentation index 
and increasing the semen concentration [9]. The absorption of nutrients can be inhibited 
by specific types of medication, resulting in a drug-induced malabsorption which leads to 
nutritional deficiencies especially during chronic medication use. Gastric acid secretion 
is necessary for the absorption of nutrients and the acid-suppressant drugs histamine H2 
receptor antagonists (H2RA) and proton pump inhibitors (PPI) are associated with zinc and 
B12 vitamin deficiencies [10-12]. For example B vitamin deficiencies are not only observed in 
users of acid-suppressant drugs, but also in users of antiepileptic drugs, metformin, colchicine, 
antibiotics, methotrexate and cholestyramine [13-19]. Thus, we hypothesize that chronic use 
of specific medication might impact on male as well as on female fertility as a consequence of 
secondary nutrient deficiencies.
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One-carbon metabolism
The involvement of micro- and macronutrients in metabolic pathways is complex and 
numerous, however the one-carbon pathway (1-C) is of interest in human reproduction 
and in particular during the periconception period [20]. Subfertility and most reproductive 
failures originate in the periconception period and can arise as a partial consequence of a 
derangement in 1-C metabolism. A healthy diet provides substrates (folate, methionine) and 
cofactors (cobalamin, vitamin B6 and B2) that are necessary for a proper functioning of the 1-C 
metabolism (Figure 1). Therefore, a low serum folate and cobalamin and an elevated plasma 
tHcy are indicators of a deranged 1-C metabolism [20]. 
Nutrigenomics is a new field of research with a focus on gene-nutrient interactions of which 1-C 
metabolism is a nice example [21]. This metabolism is essential for the development of oocytes 
and spermatocytes, since it is involved in protein and DNA synthesis and DNA methylation. 
Methylation is essential for the regulation of gene expression, the supply of methyl groups 
through 1-C metabolism is essential for the programming of gene transcription through the 
binding of methyl groups to CpG islands. Therefore, deficiencies of methyl groups easily lead 
to hypomethylation and as such can result in derangements in the programming of genes 
involved in disease (Figure 1). 
Methionine
Homocysteine
(Hcy)
Cysteine Folate
DHF
THF
5-mTHF
Cobalamin
mCobalamin
Folate cycleMethionine cycle
CpG Island Gene
Silencing of genes
One carbon metabolism
Methyl groups
CpG Island Gene
Expression of genes involved in disease
DNA methylation
Diet
Vitamin B6
Methyl groups
Epigenetic programming
Figure 1 | Summary of the 1-C metabolism and the role in epigenetic programming.
Abbreviations; 5-mTHF = 5-methyl-tetrahydrofolate, THF = tetrahydrofolate, DHF = dihydrofolate. Adapted from Twigt et al. 
(2010)
An optimal 1-C metabolism is necessary for the most active phase of ovarian follicular 
development which starts 14 weeks before conception and therefore in women we have 
defined this moment as the start of the periconception period. During this window it is 
important to have an optimal health status and to use an adequate diet for epigenetic 
programming. The complete spermatogenic cycle in men covers a time span of 10 weeks, 
which means that the preconception period in men is only slightly shorter than in women [20]. 
From this background it is important to emphasize that preconception care and interventions 
should start at least three months before conception.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 10
10 Chapter 1
FEMALE SUBFERTILITY; POLYCYSTIC OVARY SYNDROME
PCOS
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory subfertility 
with an estimated prevalence of 5-15% [22,23]. This syndrome is characterized by ovarian 
dysfunction (OD), hyperandrogenism (HA) and/or polycystic ovarian morphology (PCOM) [24]. 
The pathogenesis of PCOS is not yet fully understood but considered a complex disorder, in 
which genetic variants together with environmental factors contribute to the diversity of the 
clinical spectrum of PCOS.
Patients can be categorized into four phenotypes according to the presence of the following 
features; (1) HA, OD and PCOM, (2) HA and OD, (3) HA and PCOM, (4) OD and PCOM. The 
first three phenotypes comprise the hyperandrogenic PCOS patients, which might have 
a higher prevalence of cardiovascular and metabolic riskfactors in comparison to the non 
hyperandrogenic PCOS phenotypes [25, 26].
In PCOS an elevated LH secretion is one of the findings which occurs due to abnormal 
gonadotropin dynamics (Figure 2) [27]. Although the aetiology is unknown, it is reported that 
an increased GnRH pulse frequency is induced by an impaired sensitivity of the hypothalamic 
GnRH pulse generator to feedback inhibition of progesterone [28]. Elevated levels of LH 
result in hyperandrogenism, due to the stimulation of theca cells in the ovary. A relative FSH 
deficiency together with the elevated levels of androgens might result in the arrest of follicular 
maturation [28]. Without the maturation of follicles and the selection of one dominant follicle 
anovulation occurs. The accumulated small antral follicles produce elevated levels of AMH, 
often used as marker for ovarian function [29]. Recently, an interesting new theory emerged 
due to the fact that AMH type II Receptors were detected in the hypothalamus. Subsequent 
research suggest that AMH, which is elevated in most PCOS patients, might reach through the 
blood-brain barrier GnRH neurons and might in this way alter GnRH pulsatility leading to LH 
hypersecretion and relative FSH shortage [30].
The role of homocysteine as marker of 1-C metabolism has been extensively investigated in 
PCOS [31]. Moreover it has been shown that a healthy diet improves the clinical course of PCOS 
[32, 33]. Because overweight and obesity are features of a poor diet and sedentary lifestyle 
and often present in PCOS, it is not surprising that dietary interventions promoting weight 
loss are important in the treatment of PCOS [34]. Diet can influence hyperandrogenism, cycle 
regularity, metabolic and psychiatric outcome and therefore the general recommendation is 
to achieve weight loss using an adequate diet [32,33,35-40]. Furthermore in subfertile women, 
it was shown that biomarkers of 1-C metabolism in blood reflected the concentration in 
follicular fluid and are associated with the number of oocytes, the follicle diameter and with 
embryo quality [41-43]. In the same study population it was also observed that the adherence 
to an adequate dietary pattern reduced the estradiol concentration and improved the chance 
of pregnancy after conventional ovarian hyperstimulation treatment [44]. 
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MALE SUBFERTILITY
Male factor subfertility can be caused by several factors, such as testicular insufficiency, 
genetic abnormalities, endocrine disturbances, obstructive diseases, infections or due to 
stress, medication use or sexual disturbances. Previous research demonstrated the important 
contribution of 1-C metabolism in spermatogenesis (Figure 3) [45,46]. Therefore, the further 
investigation of determinants affecting the substrates and cofactors of 1-C metabolism as well 
as the determination of its biomarkers (cobalamin, folate, homocysteine) can be of interest.
AIMS OF THE THESIS
Worldwide, subfertility is still a rather common and complex problem. Since the pathogenesis 
is in most cases unknown, we aimed to investigate periconceptional modifiable determinants 
of 1-C metabolism in association with human subfertility. The main aims are to investigate;
(1) the Preconception Dietary Risk score (PDR score) and the mHealth coaching program 
Smarter Pregnancy (www.slimmerzwanger.nl) as tool to assess and change diet adequacy 
and empower health care professionals and patients. (Part 1)
(2) the impact of the diet in the development and treatment of the clinical spectrum of PCOS. 
(Part 2)
(3) the influence of medication use on semen parameters. (Part 3) 
METHODOLOGY
For this study we used data of the ‘Achieving a healthy pregnancy’ study, the ‘COLA database‘ 
(screeningsprogram for patients with irregular menstrual cycles; cycle disturbances, oligo- 
or amenorrhea), the Dutch Integrated Primary Care Information (IPCI) database, and of the 
Slimmer Zwanger survey.
Achieving a healthy pregnancy study
Between 2007 and 2012 all couples planning a pregnancy and visiting the outpatient clinic 
of the division of Reproductive Medicine of the department of Obstetrics and Gynaecology 
of the Erasmus Medical Center in Rotterdam, received preconception counselling at the 
‘Achieving a Healthy Pregnancy’ clinic. Both women and men completed a questionnaire 
to obtain information on general characteristics and six additional questions comprising 
habitual diet inadequacy, which were based on the Dutch food based dietary guidelines and 
from which a summary PDR score was calculated. Venous blood samples were obtained for 
the determination of the biomarkers of 1-C metabolism: serum and red blood cell (RBC) folate, 
serum cobalamin and plasma total homocysteine concentrations (tHcy). Anthropometrics 
were performed by trained counsellors. Semen parameters were extracted from medical 
records. Additionally, the couples were invited to participate in the Rotterdam Periconception 
cohort (Predict study), a periconception cohort study with follow up until one year after 
pregnancy for which they received a Food Frequency Questionnaire to be completed at home 
and returned by mail for the detailed assessment of the habitual dietary patterns.
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The COLA database
The women with oligo- or anovulation were also screened for PCOS at the outpatient clinic 
for cycle disturbances (‘COLA’; cycle disturbances, oligo- or amenorrhea) during which a 
standardized physical examination and an extensive endocrine evaluation were performed by 
trained professionals. PCOS was diagnosed according to the Rotterdam criteria [24] and two 
of the following symptoms needed to be present: oligo- or anovulation, hyperandrogenism, 
and/ or polycystic ovaries. 
The Dutch Integrated Primary Care Information 
The IPCI database consists of medical records of 1.5 million patients from 720 general 
practitioners spread across the Netherlands. We selected a cohort of men planning pregnancy 
and with available semen analysis data from all patients visiting the general practitioner 
between 1996 and 2013. Additional information on general characteristics was extracted 
automatically for the period of 12 months preceding the semen analysis using search codes 
and text strings.
Smarter Pregnancy survey
www.slimmerzwanger.nl is a Dutch personal web based lifestyle coaching program on the 
smartphone, identifying inadequate diet and lifestyle in couples contemplating pregnancy 
or being pregnant. After a baseline online identification of risk factors, a 6 months coaching 
program is generated. The content of the individual coaching consists of the baseline screening 
and follow up screening at 6, 12, 18 and 24 weeks of the program as well as a maximum of 
3 interventions per week comprising of SMS and push-messages, as well as e-mail messages 
containing tips, recommendations, additional questions addressing behavior, pregnancy 
status, Body Mass Index (BMI), adequacy of the diet, and seasonal recipes and vouchers. A 
personal page of the website represents a couples results and provides access to additional 
modules supporting physical activity, an agenda improving the compliance of hospital 
appointments and intake of medication, and a module to monitor the safety of prescribed 
medication. For the participation in the survey women and men visiting the outpatient clinic 
of the Department of Obstetrics and Gynaecology of the Erasmus Medical Center were offered 
a free subscription of this coaching program between January 2012 and December 2013.
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OUTLINE OF THE THESIS
In Part 1, chapter 2, we describe the validity of the use of the PDR score as a tool to assess the 
inadequacy of the habitual diet in clinical practice. 
In chapter 3 the first results of the personal online lifestyle coaching program Smarter 
Pregnancy are presented.
In Part 2, chapter 4, we report on associations between the PDR score and PCOS severity.
In chapter 5 we identify dietary patterns in association with PCOS severity of phenotypes and 
the chance of an ongoing pregnancy.
In Part 3, chapter 6, we present the investigations of the use of medication for gastric acid-
related symptoms and the impact on pH dependent B vitamins and semen parameters in men 
visiting our tertiary hospital. 
In chapter 7 we describe the associations between the use of proton pump inhibitors and 
semen quality in a population based cohort of men visiting the general practitioner as a 
validation of the previous study.
Chapter 8 covers the general discussion of the methodological considerations, the main 
findings and the suggestions for future research. In chapter 9 the summary is provided. 
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The Preconception Dietary Risk score;  
a simple tool to assess an inadequate 
habitual diet for clinical practice
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ABSTRACT 
Background and aims 
Worldwide unhealthy dietary behaviors in women and men in reproductive age are an 
increasing problem with adverse effects on reproduction. This emphasizes the need for a 
simple tool to assess the habitual diet in clinical practice. The aim of this study was to evaluate 
the use of the Preconception Dietary Risk score as a tool to determine the inadequacy of the 
habitual diet.
Methods 
We investigated 139 patients (68 women, 71 men) planning pregnancy at the outpatient clinic.
A summary Preconception Dietary Risk score was calculated from seven questions to assess 
the inadequacy of the diet using the six Dutch guidelines for the consumption of bread, oils/
fats, vegetables, fruit, meat and fish. The Preconception Dietary Risk score was used to predict 
the nutrient intakes derived from the Food Frequency Questionnaire and validated with the 
biomarkers of one-carbon metabolism in blood.
Results 
The Preconception Dietary Risk score assessed an inadequate habitual diet in 55.4% of women 
and 54.2% in men and revealed a sensitivity of more than 80% for an inadequate intake of 
bread, vegetables, fruit, meat and fish. ANOVA revealed significantly positive linear trends of 
the Preconception Dietary Risk score for saturated fat intake, and significantly negative trends 
for the intake of protein, EPA, DHA, fiber, folate and vitamin B6, B12 and C intake. Furthermore, 
a significant inverse correlation was observed between the Preconception Dietary Risk score 
and serum vitamin B12 (Spearman’s ρ= -0.172, p= 0.046).
Conclusions
The Preconception Dietary Risk score is a sensitive, quick and simple tool to assess an 
inadequate habitual diet in clinical practice.
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INTRODUCTION
Worldwide healthy dietary behaviors are deteriorating [6,47,48]. Dutch men and women 
in reproductive age, showed an insufficient consumption of more than 90% for fruit and 
vegetables, more than 70% for fish and 100% for fiber [49]. In addition, excessive intakes of 
saturated fats, animal proteins and carbohydrates are observed [49]. These qualitative poor 
diets result in relative deficiencies of essential vitamins and minerals, and as such contribute 
not only to the epidemic of obesity and ageing diseases, but also to reproductive failures 
[50,51].
The composition of the diet of women and men during the preconception period is considered 
increasingly important, because during this time frame of 14 weeks before conception female 
and male germ cells develop in order to be fertilized [20]. During this period, reproductive 
tissues of especially women also have to be replenished with essential micronutrients to cover 
the nutritional needs of the embryo as well as the placenta during the first trimester of mainly 
histiotrophic nourishment. The amount of evidence addressing the detrimental influences 
of a qualitative poor diet on reproduction with long-term consequences for parental- and 
offspring health is overwhelming [52-54]. Moreover, maternal but also paternal obesity, a 
resulting phenotype of a poorly composed diet and a more sedentary lifestyle, is in a similar 
manner associated with increased risks of reproductive failures and adverse pregnancy 
outcome [55-57]. Furthermore, it has been observed that poor maternal adherence to a 
healthy Mediterranean dietary pattern deteriorates chances of pregnancy and increases the 
risk of spina bifida and fetal growth restriction in offspring [8,52,58].
A change towards a healthier lifestyle can be achieved in a relatively short time and the 
preconception and pregnancy period is considered as ‘the window of opportunity’ to 
change poor dietary habits and to achieve lifestyle changes [59]. Therefore, all couples 
planning pregnancy should be personally counselled on the inadequacy of the diet during a 
preconception visit.
Previous research has shown that a self-administered questionnaire prior to the preconception 
visit is a valid method to identify risk factors [60]. To determine the inadequacy of the habitual 
diet, we created the Preconception Dietary Risk score (PDR), as summary score to assess the 
inadequate intake of six food groups, derived from a self-administered questionnaire and 
based on the six dietary guidelines of the Netherlands Nutrition Center [61].
The current study aims to evaluate the PDR score as a clinical screening tool to assess the 
inadequacy of the habitual diet in couples planning pregnancy. We compared the PDR score 
with nutrient intakes from a validated semi-quantitative Food Frequency Questionnaire (FFQ) 
[62] and biomarkers of one-carbon metabolism, important in reproduction and significantly 
influenced by the diet [49,62].
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MATERIALS AND METHODS
Study population 
Between November 2010 and October 2011, couples visiting the preconception outpatient 
clinic “Achieving a Healthy Pregnancy” [59] of the department of Obstetrics and Gynaecology 
of the Erasmus MC, University Medical Center in Rotterdam, the Netherlands were invited to 
participate in the Rotterdam Predict study [63], a preconception cohort study with follow up 
during pregnancy. Couples were eligible when they were living near Rotterdam and had an 
adequate understanding of the Dutch language in reading and writing. In the preparation of 
the preconception visit, all couples completed a Preconception Questionnaire (PQ) at home 
to obtain data on age, ethnicity, education, indication for referral, the use of medication, folic 
acid supplement, tobacco, drugs, beverages containing caffeine or alcohol, physical exercise, 
and diet inadequacy. The questions about habitual diet inadequacy were based on the Dutch 
food based dietary guidelines on average consumptions of bread, oils/fats, vegetables, fruit, 
meat and fish from which a summary PDR score was calculated (Table 1) [61]. Ethnicity and 
education level were classified according to the definition of Statistics Netherlands [47]. 
During the study period a total of 860 patients (women and men) received preconception 
counselling of which 428 patients were eligible because of an adequate understanding of the 
Dutch language in speaking and reading and living in the Rotterdam area. A subgroup of 139 
patients participating in the Predict study were available for analysis (68 women and 71 men) 
after exclusion of patients not responding the FFQ [62] (n= 173; 40%), patients completing the 
FFQ [62] r >1 month after the PQ (n= 89; 21%) and when patients reported substantial changes 
in diet between the moment of completing the PQ and the FFQ [62] (n= 27; 6%) (vegetarian, 
energy-restricted diet). During the preconception visit, a trained counsellor screened and 
advised couples by using the PDR score from the PQ. Anthropometric measurements were 
performed during the visit, i.e. height, weight, waist- and hip circumference, systolic and 
diastolic blood pressure and body mass index (BMI) was calculated. Non-fasting blood 
samples were obtained by venipuncture for the determination of biomarkers of one-carbon 
metabolism i.e. serum and red blood cell (RBC) folate, serum total vitamin B12 and plasma 
total homocysteine concentrations (tHcy). The participating patients received a FFQ [62] to be 
completed at home and returned by mail. All questionnaires and materials were anonymously 
processed. This study was conducted according to the guidelines laid down in the Declaration 
of Helsinki and all procedures involving patients were approved by the Medical Ethical and 
Institutional Review Board of the Erasmus University Medical Center in the Netherlands. 
Written informed consent was obtained from all participants. 
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Dietary assessment 
Based on the dietary guidelines of The Netherlands Nutrition Center regarding six food 
groups, the PDR score was calculated using seven questions from the PQ which reflects the 
habitual diet without a specific time frame (Table 1) [61]. When patients did not meet one of 
the dietary guidelines, one point was administered, resulting in a summary PDR score. Since 
six guidelines were evaluated, the PDR score had a maximum of 6 points and a minimum 
of 0 points. The higher the score, the more inadequate the food intake. In addition, couples 
completed a validated, semi-quantitative FFQ [62], developed by the division of Human 
Nutrition, Wageningen University, The Netherlands to estimate habitual food intake over the 
previous four weeks [62,64]. The FFQ [62] consists of 196 food items and comprises questions 
on consumption frequency, preparation methods and portion sizes according to Dutch 
household measures [62]. The intake of an individual nutrient was calculated by multiplying 
nutrient density with the consumed amounts of the food products containing the nutrient 
of interest. Nutrient densities as reported in the Dutch Food Composition Database of 2006 
were used for all calculations and standard portion sizes were verified by use of the portion 
size table [65].
Laboratory analyses 
For the determination of serum folate and vitamin B12, venous blood samples were drawn 
into dry vacutainer tubes and allowed to clot. After centrifugation at 2,000 xg, serum was 
collected and the samples were analyzed during routine laboratory procedures using an 
immune electro chemo luminescence assay (E170; Roche Diagnostics GmbH, Mannheim, 
Germany). For the determination of RBC folate and plasma tHcy, venous blood samples 
were drawn into ethylenediamine tetraacetate (EDTA)-containing vacutainer tubes. The 
EDTA-blood samples were kept on ice and plasma was separated by centrifugation within 
one hour for determination of tHcy. Directly after blood sampling, 0.1 ml EDTA tube was 
hemolysed with 0.9 ml of freshly prepared 1.0% ascorbic acid. Subsequently the hematocrit of 
the EDTA blood was determined on an ADVIA 120 Hematology Analyzer (Bayer Diagnostics, 
Leverkusen, Germany). The hemolysate was centrifuged for 5 minutes at 1000 xg after 
which the folate concentration was measured in the hemolysate. RBC folate was calculated 
using the following formula: nM RBC folate = (nM hemolysate folate x 10/hematrocit) – 
(nM serum folate x [1 – hematocrit] /hematocrit). tHcy in EDTA plasma was determined using 
high-performance liquid chromatography with reversed phase separation and fluorescence 
detection [66]. Inter-assay coefficients of variation for serum folate were 4.5% at 13 nmol/L and 
5.7% at 23 nmol/L, for serum cobalamine 3.6% at 258 pmol/L and 2.2% at 832 pmol/L and for 
plasma tHcy were 4.8% at 14.6 μmol/L and 3.3% at 34.2 μmol/L. The detection limit for serum 
folate was 1.36 nmol/L, for serum cobalamine 22 pmol/L and for plasma tHcy 4 μmol/L. 
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Statistical analyses
In order to classify individuals according to meeting the six Dutch dietary guidelines, data 
of the PQ and FFQ [62] were compared and the sensitivity and specificity of the PQ was 
calculated using FFQ [62] as reference. Considering that there is no general agreement 
about the acceptable level of sensitivity for this assessment, values of more than 80% were 
considered acceptable. Because portion sizes are not assessed with the PQ, standard portion 
sizes as reported in the portion size table were used [65]. We considered several potential 
confounders; gender, ethnicity, educational level, medication and folic acid use, smoking, 
alcohol or drug use and BMI. Chi-Square and Mann Whitney U tests were performed to test 
differences between women and men in the study group. Chi square tests and Kruskal Wallis 
tests were performed in women and men separately between the study group, the excluded 
group and the non-eligible group. Significant differences were subsequently tested pairwise 
between groups. Spearman’s correlation coefficients were calculated between the PDR score 
and biomarkers. Multivariable linear regression analysis was used to predict with the PQ the 
consumption per food group in grams per day derived from the FFQ [62]. The nutrient intakes 
derived from the FFQ [62] were energy-adjusted using the nutrient density method according 
to Willett and were normalized after log-transformation. ANOVA was used to assess differences 
in nutrient intake according to the PDR scores (p value for linear trend) and ANCOVA was used 
to adjust for gender, ethnicity, education level and energy intake. All statistical analyses were 
performed using SPSS for Windows (version 17.0.2, SPSS, Inc., Chicago, IL, USA). The level of 
significance was set to p <0.05 for all analyses.
RESULTS
The general characteristics of the 139 participants (68 women and 71 men) are shown in 
table 2. Women were younger and less likely to use drugs, caffeine and alcohol than men. 
Furthermore, women showed higher levels of folate (RBC and serum) and lower levels of tHcy 
than men, in line with their frequent use of folic acid containing supplements. The dietary 
inadequacies assessed with the PDR score were comparable between men and women 
(Table 2). The maximum PDR score of six, did not occur in our study group. In both women 
and men, we observed some differences in general characteristics between the excluded 
group, the non eligible group and the study group. In women and men the proportion of 
Dutch participants was significantly higher in the study group (women 76.5%, men 78.9%) 
than in the non-eligible group (women 47.2%, men 53.3%; both p <0.01). In men the study 
group showed a higher frequency of intermediate educational level compared to the non-
eligible group (46.5% vs. 32.7%; p <0.05). In women, the study group used more often alcohol 
(51.5% vs. 35.8%; p <0.05) and folic acid supplements (66.2% vs. 51.2%; p <0.05) than the non-
eligible group. 
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Table 2 | Characteristics of the study group.
Women (n= 68) Men (n= 71)
Age (y) 31(21-42) ** 35 (21-60)
Ethnicity 
Dutch 52 (76.5%) 56 (78.9%)
Non-Dutch 16 (23.5%) 15 (21.1%)
Educational level
Low 9 (13.2%) 11 (15.5%)
Intermediate 30 (44.1%) 33 (46.5%)
High 28 (41.2%) 26 (36.6%)
Indication for referral
Subfertility 62 (91.2%) –
Recurrent miscarriages 3 (4.4%) –
BMI (kg/m2) 25.4 (16.7-45.9) 26.1 (19.2-40.5)
25-30(kg/m2); 20 (29.4%) 31 (43.7%)
≥30 (kg/m2); 14 (20.6%) 12 (16.9%)
Waist-hip ratio (cm) 0.78 (0.63-1.34)** 0.87 (0.74-1.05)
Systolic blood pressure (mmHg) 110 (62-170)** 124 (90-160)
Diastolic blood pressure (mmHg) 72 (40-120)** 80 (58-110)
Exposure
Medication use ‘yes’ 32 (47.1%) 23 (32.4%)
Folic acid use ‘no’ 23 (33.8%) ** 68 (95.8%)
Supplement use ‘no’ 40 (58.8%) ** 58 (81.7%)
Lifestyle
No physical exercise 32 (47.1%) 30 (42.3%)
Smoking 18 (26.5%) 24 (33.8%)
Drugs 1 (1.5%) ** 10 (14.1%)
Caffeine a 2 (2.9%) * 9 (12.7%)
Alcohol 35 (51.5%) * 49 (69.0%)
Biomarkers
Folate, RBC(nmol/L) 1255 (713-1928)** 1054 (640-1999)
Folate, serum(nmol/L) 31.6 (10-45) ** 18.3 (9-40)
Vit B12, serum(pmol/L) 309.5 (145-1218) 301 (138-839)
tHcy, plasma(µmol/L) 8.5 (5-44)** 11.3 (7-60)
PDR score b
Mean 55.4% 54.2%
Median 3 (0-5) 3 (0-4)
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 27
27The Preconception Dietary Risk score
2
Table 2 | (Continued)
Women (n= 68) Men (n= 71)
PDR per item
Bread 47 (69.1%) 40 (56.3%)
Oils/fats 34 (50%) 31 (43.7%)
Vegetables 44 (64.7%) 48 (67.6%)
Fruit 45 (66.2%) 55 (77.5%)
Meat 8 (11.8%) 7 (9.9%)
Fish 48 (70.6%) 50 (70.4%)
Data are either presented as median (range) or as number of subjects (%). Pearson Chi-Square test or Mann-Whitney U test 
between women and men (* P value <0.05,** P value <0.01). a Caffeine use was defined as 6 or more cups/day. b Number 
(percentage) of individuals with inadequate dietary intake according to cut-off points used for calculating the PDR score.
When we compared the PDR score items, both women and men from the study group showed 
less inadequacy in consuming meat than the non-eligible group (women 11.8% vs. 29.8%; 
p <0.01 and in men 9.9% vs. 22.9% p <0.05). Table 3 shows the sensitivity and specificity of 
the PDR score to classify the inadequate intakes per food group in the total study group and 
stratified by gender using the FFQ [62] as reference. In the total study group the sensitivity 
was lowest for oils/fats (63.1%) and highest for fruit (99.0%) and the specificity was lowest for 
fish (36.6%) and highest for meat (83.9%). In women compared with men, we observed higher 
sensitivities for almost all food groups, except for meat and fish. The specificity in women was 
also higher for fish and vegetable consumption. 
Table 3 | Differences in the sensitivity and specificity of the PDR score for all subjects and stratified for 
gender. 
Study group (n= 139) Women (n= 68) Men (n= 71)
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
Bread a 95.4% 39.2% 100% 9.5% 90.0% 60.0%
Oils/fats b 63.1% 76.7% 70.6% 76.5% 54.8% 76.9%
Vegetables 81.5% 55.3% 84.1% 62.5% 79.2% 47.8%
Fruit 99.0% 30.8% 100% 26.0% 98.2% 37.5%
Meat 93.3% 83.9% 87.5% 83.3% 100% 84.4%
Fish 93.9% 36.6% 93.8% 50.0% 94% 23.8%
a One missing in the bread PDR item (n= 70 men). b One missing in the oils/fats PDR item (n= 70 men).
In women and men the lowest sensitivity was shown for oils/fats and the highest for bread 
in women and meat in men. The specificity was lowest for bread in women and fish in men 
and highest for meat in both women and men. The multivariable linear regression analyses 
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Eligible patients
428 women and men 
Preconception outpatient clinic
‘Achieving a healthy pregnancy’
860 women and men
received preconception counseling
 
 
  
 
 
Non eligible patients
432 women and men
Non responders
173 women and men
Exclusion
- FFQ response >31 days
- Reported changes in diet
116 women and men
Responders
255 women and men 
Study population
139 women and men 
Figure 1 | Flow diagram of the study population selection
Table 4 | Prediction of the consumption per food group (g/day) of the FFQ by the preconception 
questionnaire (n= 139).
Unadjusted Model Adjusted Model a Equal consumption 
in PQ and FFQ  
(g/day) b
Constant β R2 P value β a R2 P value
Bread c 11.6 0.853* 0.426 <0.001 0.657* 0.578 <0.001 78.9
Vegetables 18.1 0.908 * 0.126 <0.001 0.764 * 0.250 <0.001 196.7
Fruit 26.8 0.776 * 0.434 <0.001 0.752 * 0.518 <0.001 119.6
Meat 36.1 0.775* 0.142 <0.001 0.424* 0.384 0.008 160.0
Fish 2.8 0.664* 0.381 <0.001 0.571* 0.365 <0.001 8.3
a Multivariable linear regression analysis adjusted for gender, ethnicity, education level, folic acid supplement use, BMI, 
smoking, alcohol and energy intake. b The level of equal consumption according to the PQ and the FFQ was calculated by 
substituting y with x in the regression formula (y = βx + constant) derived from the unadjusted model. c One missing in the 
bread PDR item (n= 138).
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for the consumption of each food group in grams per day from the PQ and FFQ [62] and 
adjusted for gender, ethnicity and educational level and energy intake revealed significantly 
positive associations (Table 4). The analysis of the prediction of the energy-adjusted nutrient 
intakes of the FFQ [62] by the PDR score, using ANOVA, showed significant linear trends for 
the intake of protein, saturated fats, EPA, DHA, fiber, vitamin B6, B12, folate and vitamin C 
(Figure 2, Supplement Table 1). After adjustment for gender, ethnicity, educational level and 
BMI, significances remained except for total fat (p= 0.36, data not shown). The correlation 
between the PDR score and the biomarkers of the one-carbon metabolism showed an inverse 
correlation with vitamin B12 only (Spearman’s ρ= -0.172, p= 0.046, data not shown).
DISCUSSION 
In couples visiting a preconception outpatient clinic, the prevalence of an inadequate habitual 
diet defined by the PDR score and based on the Dutch guidelines, was 55%. The PDR score 
demonstrated a more than 80% sensitivity for inadequate intake of bread, vegetables, 
fruit, meat and fish. The PDR score specificity varied from 30.8% to 83.9%. From these data 
we conclude that the PDR score is a sensitive and simple tool for clinical practice to assess 
especially inadequacies of the habitual diet.
An important finding was that on nutrient level a higher PDR score was independent for 
gender significantly associated with a higher consumption of saturated fats and a lower 
consumption of protein, EPA, DHA, fiber, vitamin B6, vitamin B12, folate and vitamin C, 
suggesting adherence to a Western dietary pattern [67]. The importance for this validation 
study is emphasized by the rising figures of qualitative malnutrition and obesity in the 
reproductive population. The high frequency of overweight and obesity (40.2%) in the 
Dutch men and women in reproductive age [47] substantiate the 55% diet inadequacy in 
our subfertile study population. Furthermore, Hammiche et al. previously reported the high 
frequency of unhealthy dietary behavior in men and women attending this preconception 
clinic [59]. In addition, Inskip et al. showed similar high percentages of non-compliance to the 
nutrition- and lifestyle recommendations in women attempting to achieve pregnancy [48]. 
The further need of a valid dietary assessment tool is supported by the recent findings of Twigt 
et al. showing that in couples undergoing IVF/ICSI treatment, even one point improvement 
in the PDR score is associated with a 65% increased chance of ongoing pregnancy [6]. We 
observed a small but inverse significant correlation between the PDR score and serum vitamin 
B12. This is an interesting finding considering the associations between a poor vitamin B12 
status and fertility parameters [43,46]. It is very likely that due to folic acid supplement use 
in women and men, no significant correlations were observed with folate and tHcy. This is 
supported by Verkleij-Hagoort et al. showing significant correlations of folate and vitamin B12 
intake as estimated by the same FFQ [62] with serum and RBC folate and serum vitamin B12 
in a population of the same age not using vitamin supplements [64]. However, it must be 
mentioned that the correlation between biomarkers and diet is always hampered due to the 
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complexity of nutrition as composite determinant influenced by several conditions such as 
age, smoking, and alcohol consumption [68-70].
The strengths and limitations in the interpretation of the findings have to be addressed. The 
response rate of the eligible study group determined by the return of the FFQs [62] was 60%, 
which is an average response rate compared to others varying between 46% and 76% [71,72]. 
The sensitivity analysis showed general comparability of the study group, the excluded group 
and the non-eligible group, thereby excluding selection bias. With the exception of ethnicity, 
educational level, alcohol use, and folic acid use in the non-eligible group. Adjustment for 
ethnicity did not significantly affect the association between the PDR score and nutrient 
intake levels. We recommend for future research however that the generalizability of the PDR 
score in non-Dutch populations should be further evaluated. Strength of the PDR score is that 
it is a very simple and practical tool consisting of seven questions only, to be filled out by a 
couple in a matter of minutes, justifying an immediate individual result and conclusion on 
the inadequacy of the habitual diet. On the contrary, the FFQ [62] – is an extensive and time 
consuming list of 196 questions and is not used for giving advice on an individual level. Other 
dietary scores have been developed, however they are based on nutrient intake levels derived 
from a 24-hrs recall records and they are therefore time consuming in calculating a summary 
score [73,74]. Another strength of this study is that both questionnaires comprised the same 
time period and showed significant associations on nutrient intake levels. The estimation of 
the validity of the data of women and men separately and as a couple, is both interesting 
and important, because their dietary intake is often correlated. For all six food groups the 
multivariable linear regression models significantly predicted the nutrient intake in grams 
per day estimated with the FFQ [62]. Overestimation of meat, bread and fish intake, slightly 
occurred using the PDR score to predict the consumption in grams per day. However, it must 
be emphasized that the PDR score is designed to judge the inadequacy of the intake of the 
food groups and not to estimate consumption level. For the purpose of estimating the exact 
level of consumption the FFQ remains the Gold standard. A limitation of the study is that 
the PQ and FFQ [62] have correlated errors, since both questionnaires are retrospective and 
estimate usual consumption as opposed to recording actual consumed foods in detail [75]. 
Furthermore, it is known that individuals, with overweight or obesity, underreport food intake 
in the FFQ [62,75]. On the other hand, in the general population, the intake of healthy foods 
is often over reported in the FFQ [62,76]. For that reason we adjusted the analysis for BMI and 
total energy intake. The aim of the PDR sore is to estimate the inadequacy of the habitual diet 
and not to estimate unhealthy overconsumption. Therefore, the PDR score is not intended to 
classify the total diet as a more or less healthy diet. For example the patients with a PDR score 
of 1 reported the highest total daily energy intakes and showed the highest BMI. To improve 
the PDR score the addition of questions on fast-food, snacks and sweets can be considered 
to estimate unhealthy overconsumption as well. Another limitation of the PDR score is that 
vegetarians are classified as having an inadequate intake of meat, while it is possible to reach 
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an adequate nutrient intake when replacing meat with other foods. Therefore, such questions 
can be added for this subgroup in particular. 
In conclusion, diet is a composite determinant and increasingly associated with health 
and reproductive outcome. This study shows the validity of the PDR score in assessing the 
inadequacy of the habitual diet and quality of the nutrient composition in a simple and 
efficient manner.
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ABSTRACT
Background
Poor nutrition and lifestyle behaviors exert detrimental effects on reproduction and health 
during the life course. Therefore, lifestyle interventions during the periconceptional period 
can improve fertility, pregnancy outcome, and health of subsequent generations.
Objective 
This survey investigates the compliance, usability, and initial effectiveness of the Web-based 
mHealth platform, Smarter Pregnancy.
Methods 
A free subscription to the mHealth platform, Smarter Pregnancy, was provided to couples 
contemplating pregnancy (n= 1275) or already pregnant (n= 603). After baseline identification 
of inadequate nutrition and lifestyle behaviors, a personal online coaching program of 
6 months was generated. Using multiple imputation and the generalized estimating equation 
model with independent correlations, we estimated the changes from inadequate to 
adequate nutrition and lifestyle behaviors over time. Subgroup analyses were performed for 
(1) overweight and obese women (body mass index [BMI] ≥25 kg/m2), (2) pregnant women at 
the start of the program, and (3) couples.
Results 
A 64.86% (1218/1878) compliance rate was observed and 54.7% (range 39.2-73.4%) of 
participants rated the program usability as positive or very positive. Adequate nutrition and 
lifestyle behaviors at baseline were 21.57% (405/1878) for vegetable intake, 52.61% (988/1878) 
for fruit intake, 85.44% (1303/1525) for folic acid use, 86.79% (1630/1878) for no tobacco use, 
and 64.43% (1210/1878) for no alcohol consumption. After 6 months of coaching, these 
lifestyle behaviors improved by 26.3% (95% CI 23.0 to 29.9) for vegetable intake, 38.4% (95% 
CI 34.5 to 42.5) for fruit intake, 56.3% (95% CI 48.8 to 63.6) for folic acid use, 35.1% (95% CI 29.1 
to 41.6) for no tobacco use, and 41.9% (95% CI 35.2 to 48.9) for no alcohol consumption. The 
program showed the strongest effectiveness for participating couples.
Conclusions
This novel Web-based mHealth platform shows high compliance and usability, and users 
demonstrate improvements in nutrition and lifestyle behaviors. The next step will be further 
validation in randomized controlled trials and implementation.
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INTRODUCTION
Worldwide, more than 45 million couples are contemplating pregnancy, of which around 
22 million remain involuntarily childless. Moreover, of the more than 360 million pregnancies 
worldwide per year, at least 90 million end in miscarriage, 18 million result in congenital 
malformation, and 40 million result in children small for their gestational age. These 
reproductive and pregnancy failures largely originate in the periconceptional period, during 
which development and function of gametes, embryonic organs, and the placenta are 
programmed [20]. Poor periconceptional nutrition and lifestyle not only affect fertility and 
pregnancy outcome, but can also derange epigenetic programming with long-lasting health 
consequences [77]. Therefore, effective nutrition and lifestyle interventions in particular during 
this window of time will be an investment in healthy pregnancy and the health of current 
and future generations. Currently, the most effective preconceptional interventions comprise 
weight loss, improvement of nutrition, use of folic acid supplements, and lowering the use of 
tobacco [78,79]. 
Unfortunately, women and men contemplating pregnancy or pregnant couples, as well as 
health care professionals, are often not aware of the detrimental effects of poor lifestyle 
behaviors [59,80,81]. 
These behaviors often accumulate not only in an individual, but also in couples, in particular 
among those with a low socioeconomic status, increasing the risk of a poor pregnancy 
outcome [82,83]. 
Therefore, it should be the responsibility of both health care professionals and patients 
to improve inadequate nutrition and lifestyle. To this aim, we previously developed and 
implemented a specific preconception outpatient clinic tailored to improve nutrition and 
lifestyle, which showed a 30% reduction of inadequate nutrition and lifestyle and a 65% 
increased chance of ongoing pregnancy after in vitro fertilization (IVF) treatment [6,59]. 
Obstacles of lifestyle counseling as part of periconceptional (clinical) care, however, require 
special expertise and time without reimbursement of costs. Mobile health (mHealth) has the 
potential to transform health care delivery and to overcome obstacles by providing individual, 
tailored, and repeated information. Evidence is accumulating that mobile technology can 
effectively improve inadequate nutrition, lifestyle, and medication adherence [84]. Therefore, 
we developed the online, device-independent, Web-based coaching platform, Smarter 
Pregnancy [85]. This platform was based on scientific evidence of effective nutrition and lifestyle 
interventions, prevention and educational programs for noncommunicable diseases [86,87], 
and behavioral models, as well as our experience from the preconception outpatient clinic 
[59,88]. This mHealth platform aims to empower women, men, and health care professionals to 
improve inadequate nutrition and lifestyle. It also demonstrates the need for easily accessible, 
evidence-based interventions to improve the quality and effectiveness of periconceptional 
(clinical) care, the success of reproduction and pregnancy outcomes, as well as the prevention 
of disease during the life course [89,90].
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Here we investigate the compliance, usability, and initial effectiveness of the Dutch version of 
this Web-based mHealth platform on changing inadequate nutrition and lifestyle behaviors in 
prepregnant women and their partners.
METHODS
Study population
In 2012 and 2013, women and men contemplating pregnancy or pregnant couples living in 
Rotterdam, the Netherlands, visiting the Erasmus Medical Center (MC), University Medical 
Center, or midwifery practices in Rotterdam, were recruited to the study. Recruits were 
invited to sign up for a free subscription to the Web-based Smarter Pregnancy platform 
[85]. This included 6 months of coaching on the most prevalent inadequate nutrition and 
lifestyle behaviors (ie, vegetable, fruit, and alcohol intake) or the most strongly demonstrated 
associations of behaviors with fertility and pregnancy course and outcome (ie, tobacco and 
folic acid supplement use). 
Adequate daily intakes are defined as at least 200 grams of vegetables and at least two 
pieces of fruit, a folic acid supplement of 400 µg, and no tobacco or alcohol use [91]. Men 
were screened on the same behaviors, except for folic acid supplement use. Evaluation of 
the results of the baseline survey and the four follow-up screening surveys are shown on 
each participant’s personal page as lifestyle risk scores in graphs and text, accompanied by 
personal advice according to preconceptional recommendations and Dutch guidelines [91]. If 
a participant completes the final screening survey at 6 months, we consider this as maximum 
compliance. More details are described in the next paragraph.
Smarter Pregnancy
The coaching model developed for the Smarter Pregnancy platform is based on our research 
and expertise from the last 25 years on the impact of nutrition and lifestyle on reproduction 
as well as on pregnancy course and outcome [6,48,59,88,92]. In addition, we incorporated 
the following into the platform: results from the literature, Prochaska and Diclemente’s 
transtheoretical model with a focus on the readiness for behavioral change, Bandura’s social 
cognitive theory for self-efficacy, and Fogg’s behavior model to include triggers to motivate 
and increase the ability to change [93-95]. Features of the attitude, social influence, and self-
efficacy (ASE) model for coaching are applied; the ASE model has been frequently used for 
developing health education and prevention. Elements of this model comprise individual 
attitude, social influence, and self-efficacy aimed at the understanding and motives of people 
to engage in specific behavior [96].
The content of the individual coaching consisted of the baseline screening and follow-up 
screening at 6, 12, 18, and 24 weeks of the program. Coaching also included a maximum of 
three interventions per week comprised of short message service (SMS) text messaging and 
email messages containing tips, recommendations, vouchers, seasonal recipes, and additional 
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questions addressing behavior, pregnancy status, body mass index (BMI), and adequacy of the 
diet. Every 6 weeks, participants were invited to complete a short, online, follow-up screening 
survey to monitor the change in their inadequate nutrition and lifestyle behaviors. Results 
from the screening session compared to the previous screening sessions were shown on 
their personal page (see Figure 1). This page also provided access to additional modules (ie, 
applications) to support physical activity, an agenda to improve the compliance of hospital 
appointments and intake of medication, and a module to monitor the safety of prescribed 
medication. A summary of all individual results were available to be obtained at any point 
by the participant, and to be handed over or sent by email to the health care professional for 
further evaluation and support of preconceptional and antenatal care.
This mHealth platform complied with the highest rules of legislation for medical devices in 
Europe; therefore, it received the Conformité Européenne, classe 1 (CE-1), classification (2013) 
and can be used to improve the quality of medical care.
 
Erasmus Medical Center Midwifery practices
Smarter Pregnancy website
http://www.slimmerzwanger.nl 
Registration:
Online baseline screening
Coaching:
start (t= 0)
1-5 behaviors  
SMS, e-mail and incentives:
Until 26th week
Inadequate
behaviors
Adequate
behaviors
No coaching Additional screening on
identied behaviours:
t= 6, 12, 18 and 24
Personal page
Results per screening
Figure 1 | Overview of the web-based Smarter Pregnancy program: registration, identification of 
inadequate nutrition and lifestyle behaviors and coaching. SMS: short message service.
Statistical analysis
We analyzed all participants who completed or prematurely resigned from the platform. 
Compliance was defined by the percentage of participants who completed the 6-month 
program. Usability was assessed using a digital evaluation form containing 26 questions 
whose answers were scored using a 4-point Likert scale; the ratings were negative, neutral, 
positive, and very positive. This was used to report on participants’ satisfaction with the 
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platform, which was subdivided into three categories: (1) design and interface, (2) content 
and coaching, and (3) perception and personal benefit. General characteristics and lifestyle 
behaviors were compared using chi-square tests for proportions, and t tests and Mann Whitney 
U tests for continuous variables. Using a generalized estimating equation (GEE) model with 
an independent working correlation matrix, we modeled the fraction that scored adequate 
at each of the follow-up time points. In order to minimize selection bias, we used multiple 
imputation models to handle missing data of the participants who prematurely resigned. 
Therefore, a separate model was built for each of the five lifestyle behaviors of interest using all 
available information on each of the time points, as well as the subgroup indicators to impute 
the missing values. For each nutrition and lifestyle behavior, we examined those individuals 
that scored inadequate at baseline.
Subgroup analyses were performed between (1) normal weight and overweight or obese 
women defined as having a BMI of <25.0 and ≥25.0 kg/m2, respectively, (2) nonpregnant and 
pregnant women at the start of the program, and (3) women-only participants and couples, 
who were defined as the woman and her male partner who followed his own personal 
coaching program at the same time, which was also dependent on pregnancy status. To create 
the area under the curve (AUC) of the linear predictor as an overall measure of effectiveness 
of the program, we calculated the average of the log odds ratio at the specific time points. 
For each subgroup, this average was compared with that of its complement (eg, obese versus 
nonobese, pregnant versus nonpregnant, and couples versus women without a participating 
male partner). SPSS version 21.0 (IBM Corp, Armonk, NY) software package was used and the 
level of significance was set to 0.05 for all analyses.
Ethical approval
All data were anonymously processed. This survey was conducted according to the guidelines 
laid down in the Declaration of Helsinki and all procedures involving patients were approved 
by the Medical Ethical and Institutional Review Board of the Erasmus MC, University Medical 
Center, Rotterdam, the Netherlands. Digital informed consent was obtained from all 
participants, allowing us to use the data for analysis.
RESULTS
Compliance and usability 
Study compliance was 64.86% (1218/1878) among all participants who activated the program. 
Additional digital evaluation forms sent every 4 months to new participating women were 
received from 357 women out of 1878 (19.01%), of which 69.2% (247/357) were highly 
educated. The usability of the program was judged as positive or very positive by 54.7% of 
participants, and ranged from 39.2% (content and coaching) to 73.4% (design and interface) 
(see Figure 2).
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3Figure 2 | Results of the evaluation of usability based on 357 evaluation forms. Usability of the Smarter 
Pregnancy program was subdivided into three program characteristics (left) and by participant 
educational levels (right).
Baseline characteristics
We evaluated 1878 out of 2003 (93.76%) participants after exclusion of 125 (6.24%); these 
participants were excluded because of nonactivation due to incomplete registration or no 
data entry after subscribing to the application (see Figure 3). The baseline characteristics of 
the cohort (n= 1878) who completed or prematurely resigned from the platform are depicted 
in Table 1. They are classified according to gender and further subdivided into groups that 
(1) completed the last screening and (2) resigned prematurely from the platform. No significant 
differences were observed in women and men that completed or resigned prematurely from 
the platform with regard to age, height, BMI, percentage of overweight and obesity, mean 
vegetable and fruit intake, percentage of inadequate folic acid supplement, and tobacco 
and alcohol use. The woman-to-man ratio of the participants was 4.3 to 1. Of the total group 
of 1525 registered women, 603 (39.54%) reported to be pregnant at baseline, of which 416 
(69.0%) completed the program and 187 (31.0%) prematurely resigned (p= 0.04).
Baseline nutrition and lifestyle behaviors
Adequate nutrition and lifestyle behaviors at baseline were 21.57% (405/1878) for vegetable 
intake, 52.61% (988/1878) for fruit intake, 85.44% (1303/1525) for folic acid use, 86.79% 
(1630/1878) for no tobacco use, and 64.43% (1210/1878) for no alcohol consumption. The 
most prevalent inadequate behavior among both women and men was vegetable intake, 
which was 78.75% (1201/1525) and 77.1% (272/353), respectively. Inadequate fruit intake 
was observed in 43.21% (659/1525) of the women and 65.4% (231/353) of the men, whereas 
only 14.56% (222/1525) of the women reported no folic acid supplement use. Tobacco use 
was reported for 11.34% (173/1525) and 21.2% (75/353) of the women and men, respectively. 
Alcohol consumption was reported in 27.73% (423/1525) of all women and 69.4% (245/353) 
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of all men. Women who resigned from the platform prematurely showed a significantly higher 
percentage of alcohol consumption of 31.6% (165/522) versus 25.72% (258/1003) (p= 0.02).
Eligible,           n= 2,003 
Week 6  
Participants, n= 1,629
Week 24  
Participants n= 1,218 
Week 18  
Participants, n= 1,321  
Week 12  
Participants, n= 1,446
Week 1  
Participants, n= 1,878
No (data entry after) activation    n= 125  
Resigned between week 1 and 6  n= 249  13.3% 
Resigned between week 7 and 12   n= 183   9.7% 
Resigned between week 13 and 18  n= 125   6.7% 
Resigned between week 19 and 24  n= 103   5.5% 
Total resigned participants    n= 660  35.1%
Compliance        64.9% 
Figure 3 | Flowchart of the Smarter Pregnancy survey. Percentages are based on the total participants 
(n= 1878) in week 1.
Effectiveness
Figure 4 depicts the changes in nutrition and lifestyle behaviors of the total and specific 
subgroups. Results at every follow-up screening point have been compared to baseline values. 
At baseline, vegetable intake was inadequate in 1473 out of 1878 participants (78.43%). An 
improvement of 20.9% (95% CI 18.5 to 23.5) was observed after 6 weeks and persisted to an 
increase up to 26.3% (95% CI 23.0 to 29.9) at 6 months (see Figure 4, A). Inadequate fruit intake 
was observed in 890 out of 1878 participants (47.39%) at baseline and improved by 36.1% 
(95% CI 33.0 to 39.3) and 38.4% (95% CI 34.5 to 42.5) at 6 weeks and 6 months, respectively 
(see Figure 4, B). The figures for inadequate folic acid supplement use observed in 222 out of 
1525 women (14.56%) showed a decrease of 53.6% (95% CI 46.8 to 60.3) and 56.3% (95% CI 
48.8 to 63.6) at 6 weeks and 6 months, respectively (Figure 4, C). At baseline, the prevalence 
of tobacco and alcohol use was 248 out of 1878 (13.21%) and 668 out of 1878 (35.57%), 
respectively. Tobacco and alcohol use were further reduced by 23.8% (95% CI 16.8 to 32.6) 
and 27.0% (95% CI 22.4 to 32.1) at 6 weeks and 35.1% (95% CI 29.1 to 41.6) and 41.9% (95% 
CI 35.2 to 48.9) at 6 months, respectively (Figure 4, D and E). All percentages are depicted in 
Multimedia Appendix 1.
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Figure 4 | Vegetable intake (A), fruit intake (B), folic acid use (C), tobacco use (D), and alcohol 
consumption (E) by participants. Improvement of behavior from inadequate at baseline to adequate 
at every screening point is shown as the percentage (y-axis) of the total group or subgroup. The dotted 
lines representing the change in relation to baseline are included to improve the interpretation of the 
graphs. *p <0.05 at all screening points. All percentages (per screening point) and areas under the 
curve, including P values, are included in Multimedia Appendix 1.
Subgroup: overweighed and obese women 
Baseline screening revealed 614 out of 1525 (40.26%) and 190 out of 353 (53.8%) overweight 
and obese women and men, respectively. Subgroup analysis showed patterns of inadequate 
nutrition and lifestyle behaviors in these women and men comparable to the total group (see 
Figure 4). The AUCs of the five inadequate lifestyle behaviors were comparable in overweight 
and obese (BMI ≥25 kg/m2) and nonobese (BMI <25 kg/m2) women and men (see Multimedia 
Appendix 1).
Subgroup: women pregnant at entry
A trend of comparable improvement of vegetable, fruit, and folic acid intake was shown in 
pregnant and nonpregnant women. Cessation of tobacco and alcohol use was higher in 
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pregnant women although the groups were small (n= 10 and n= 17, respectively). The AUCs 
did not differ significantly (see Multimedia Appendix 1).
Subgroup: couples
A total of 353 couples were coached, of which 215 (60.9%) completed the 6 months of coaching. 
The program was most effective on changing inadequate nutrition and lifestyle behaviors, 
except for tobacco use, when both the women and men used the program compared to the 
group of women only (see Figure 4).
DISCUSSION
Smarter Pregnancy is the first CE-1-certified, Web-based, personal mHealth platform tailored 
to convert inadequate to adequate nutrition and lifestyle behaviors in couples during the 
prepregnancy and pregnancy periods. This survey highlights the very high prevalence of 
inadequate intake of vegetables, fruit, and folic acid supplements, as well as tobacco and alcohol 
use in both women and men in the prepregnancy and pregnancy periods. Previous research 
by Hammiche et al. and Vujkovic et al targeting the same period showed comparable results 
for inadequate vegetable and fruit intake (32.7-80.6%), inadequate folic acid supplement use 
(18.9-37.9%), tobacco use (11.3-31.0%), and alcohol use (35.5-66.0%) [9,59]. Screening tools 
and programs, such as ZwangerWijzer [97] and Healthy Pregnancy 4 All, have been developed 
and are being implemented [98,99]. However, routine preconceptional care is still only scarcely 
available. There is some evidence from other groups substantiating that eHealth and mHealth 
can support and enhance preventive preconceptional health care interventions. 
The strengths of this survey are the high number of participants (n= 1878), the high compliance 
of 64.86% (1218/1878) of participants to complete the 6 months of coaching, the positive 
feedback of the usability, participation of couples, and the analysis in which selection bias 
was limited by multiple imputation. The high appreciation of usability and initial effectiveness 
of this program on improving lifestyle behaviors suggests increased awareness and strong 
adherence to the given insights and recommendations. A possible explanation for these 
results is the multifunctional, interactive, and individual character of the coaching, which is 
distinctive compared to most eHealth and mHealth tools providing information only without 
taking individual conditions into account. Other strengths are the prospective and automatic 
data collection, as well as the subgroup analyses addressing the influence of pregnancy status, 
overweight and obesity, gender, and the participation of individuals or couples.
Our previous research has shown that a short self-administered risk score is a valid method to 
identify adequate or inadequate vegetable and fruit intake on both food group and nutrient 
levels [88]. 
Moreover, the percentages of these inadequate nutrition and lifestyle behaviors are in line 
with our data from the preconceptional outpatient clinic [6,59]. 
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Limitations of this survey are the absence of validation by biomarkers and, inherent to the 
design of a survey, the absence of a control group. Moreover, using the Internet and a website 
in the Dutch language excludes groups using other languages and those having less access 
to the Internet. In general, the endless opportunities of mHealth tools and knowing how to 
access them can be of unprecedented importance, especially with regard to health care. The 
rise of mobile technology by mobile phones, with more than one billion users worldwide, 
and other handheld devices also contributes to accessibility regarding online information 
and recommendations concerning healthy nutrition and lifestyle behaviors during the 
preconceptional period [99,100]. 
Couples contemplating pregnancy are often unaware of the availability and importance of 
these recommendations [48,59,81,101]. Unfortunately, health care professionals are often 
unfamiliar with up-to-date, evidence-based preconception care; it should be their responsibility 
to educate and increase patient awareness concerning healthy lifestyle behaviors in order to 
improve their chances to conceive and ensure a healthy prenatal environment for all couples 
[81]. Our findings contribute to previous research suggesting that both women and men 
should be involved in preconceptional care [102]. 
We demonstrated that the support of the partner by utilizing the same platform increases 
the effect of this intervention. It is known that changing inadequate nutrition and lifestyle 
behaviors and maintaining healthy behavior is hard to accomplish, especially when there is 
a possibility that the goal to become pregnant will not be reached. Currently, only a small 
group of women that will not conceive spontaneously and those with a previous complicated 
pregnancy may receive preconceptional counseling by a health care professional (eg, general 
practitioner or gynecologist). Because the Smarter Pregnancy program has the potential as an 
mHealth platform to reach and educate a much larger population, including men, its use and 
implementation in health care is of interest to patients, health care professionals, and health 
care insurance companies to reduce health care costs in the future. The initial results of this 
survey were encouraging; this opens up the opportunity of implementation and conducting 
randomized controlled trials to further substantiate the findings on changing nutrition and 
lifestyle behaviors, and to further demonstrate the clinical effectiveness and cost-effectiveness 
of this mHealth platform in several target groups. 
In conclusion, Smarter Pregnancy is a mHealth Web-based coaching platform that has the 
potential to improve and maintain healthy nutrition and lifestyle behaviors in women as well 
as men and, in particular, couples in the prepregnancy and pregnancy periods. These findings 
are important for further improvement of the quality and accessibility of preconceptional 
and pregnancy care, fertility, pregnancy course and outcome, and ultimately health from the 
earliest moment and throughout the life course.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 50
50 Chapter 3
M
ul
ti
m
ed
ia
 A
pp
en
di
x 
1
N
T=
 6
T=
 1
2
T=
 1
8
T=
 2
4
AU
C-
su
b
AU
C 
–c
om
pl
D
iff
.
P-
va
lu
e
Ve
ge
ta
bl
e 
in
ta
ke
, %
 (9
5%
 C
I)
O
bs
er
ve
d
–
20
.2
22
.8
23
.9
23
.7
N
/A
N
/A
N
/A
N
/A
To
ta
l
1,
47
3
20
.9
 (1
8.
5-
23
.5
)
23
.6
 (2
1.
2-
26
.2
)
26
.5
 (2
3.
0-
30
.2
)
26
.3
 (2
3.
0-
29
.9
)
-1
.1
5
N
/A
N
/A
N
/A
W
om
en
1,
20
1
21
.6
 (1
9.
0-
24
.4
)
25
.6
 (2
2.
8-
28
.6
)
27
.9
 (2
4.
3-
31
.9
)
27
.4
 (2
3.
8-
31
.4
)
-1
.0
7
-1
.5
6
0.
49
.0
04
M
en
27
2
17
.8
 (1
2.
8-
24
.2
)
15
.0
 (1
0.
2-
21
.3
)
20
.0
 (1
4.
5-
26
.8
)
21
.2
 (1
5.
5-
28
.3
)
-1
.5
6
-1
.0
7
-0
.4
9
.0
04
Pr
eg
na
nt
36
4
23
.2
 (1
7.
8-
29
.6
)
23
.6
 (1
8.
6-
29
.4
)
24
.7
 (1
8.
9-
31
.7
)
22
.2
 (1
6.
7-
29
.0
)
-1
.2
1
-1
.0
2
0.
19
.1
77
O
ve
rw
ei
gh
t a
nd
 o
be
se
49
5
21
.7
 (1
8.
1-
25
.7
)
25
.1
 (2
0.
7-
30
.0
)
26
.5
 (2
1.
4-
32
.3
)
25
.5
 (2
0.
0-
31
.9
)
-1
.1
2
-1
.0
4
-0
.0
8
.5
19
Co
up
le
s
29
9
27
.4
 (2
2.
4-
33
.0
)
31
.6
 (2
5.
5-
38
.3
)
36
.1
 (2
9.
5-
43
.3
)
33
.9
 (2
7.
8-
40
.5
)
-0
.7
4
-1
.2
0
0.
46
.0
00
9
Fr
ui
t i
nt
ak
e,
 %
 (9
5%
 C
I)
O
bs
er
ve
d
–
35
.4
35
.6
36
.2
39
.1
N
/A
N
/A
N
/A
N
/A
To
ta
l
89
0
36
.1
 (3
3.
0-
39
.3
)
35
.8
 (3
1.
9-
40
.0
)
38
.7
 (3
4.
0-
43
.8
)
38
.4
 (3
4.
5-
42
.5
)
-0
.5
3
N
/A
N
/A
N
/A
W
om
en
65
9
38
.5
 (3
4.
6-
42
.6
)
38
.4
 (3
3.
1-
43
.9
)
41
.3
 (3
5.
4-
47
.6
)
41
.3
 (3
6.
1-
46
.7
)
-0
.4
1
-0
.8
8
0.
47
.0
05
M
en
23
1
29
.2
 (2
3.
3-
35
.8
)
28
.6
 (2
2.
3-
35
.7
)
31
.5
 (2
5.
2-
38
.6
)
30
.0
 (2
1.
4-
40
.2
)
-0
.8
8
-0
.4
1
-0
.4
7
.0
05
Pr
eg
na
nt
14
5
36
.3
 (2
8.
2-
45
.2
)
38
.1
 (3
0.
1-
46
.8
)
36
.7
 (2
6.
7-
47
.9
)
35
.7
 (2
4.
2-
49
.0
)
-0
.5
4
-0
.3
8
0.
17
.3
55
O
ve
rw
ei
gh
t a
nd
 o
be
se
27
8
36
.7
 (2
9.
9-
44
.0
)
36
.8
 (2
8.
5-
46
.0
)
39
.6
 (3
0.
6-
49
.3
)
39
.9
 (3
0.
0-
50
.7
)
-0
.4
8
-0
.3
7
0.
11
.4
82
Co
up
le
s
17
9
47
.0
 (3
8.
2-
56
.0
)
42
.5
 (3
4.
2-
51
.1
)
45
.0
 (3
6.
0-
54
.4
)
46
.3
 (3
7.
1-
55
.6
)
-0
.2
2
-0
.4
9
0.
27
.0
87
Fo
lic
 a
ci
d 
su
pp
. u
se
, %
 (9
5%
 C
I)
O
bs
er
ve
d
–
58
.2
61
.1
61
.9
65
.8
N
/A
N
/A
N
/A
N
/A
W
om
en
22
2
53
.6
 (4
6.
8-
60
.3
)
53
.9
 (4
6.
5-
61
.1
)
56
.8
 (4
8.
7-
64
.5
)
56
.3
 (4
8.
8-
63
.6
)
0.
18
N
/A
N
/A
N
/A
Pr
eg
na
nt
10
56
.2
 (2
.3
-9
8.
6)
58
.0
 (3
.0
-9
8.
4)
52
.9
 (8
.9
-9
2.
8)
52
.7
 (7
.6
-9
3.
8)
-0
.7
2
0.
21
-0
.9
3
.5
77
O
ve
rw
ei
gh
t a
nd
 o
be
se
11
1
57
.5
 (4
7.
1-
67
.2
)
56
.4
 (4
6.
9-
65
.5
)
56
.6
 (4
5.
8-
66
.8
)
53
.5
 (4
2.
8-
64
.0
)
0.
27
0.
09
0.
18
.4
7
Co
up
le
s
61
65
.6
 (5
2.
0-
77
.0
)
66
.3
 (5
0.
1-
79
.5
)
58
.1
 (4
3.
9-
71
.0
)
65
.3
 (5
2.
5-
76
.2
)
0.
55
0.
04
0.
51
.0
99
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 51
51Personal online coaching
3
M
ul
ti
m
ed
ia
 A
pp
en
di
x 
1 
| (
Co
nt
in
ue
d) N
T=
 6
T=
 1
2
T=
 1
8
T=
 2
4
AU
C-
su
b
AU
C 
–c
om
pl
D
iff
.
P-
va
lu
e
Sm
ok
in
g,
 %
 (9
5%
 C
I)
O
bs
er
ve
d
–
17
.4
16
.8
19
.3
18
.6
N
/A
N
/A
N
/A
N
/A
To
ta
l
24
8
23
.8
 (1
6.
8-
32
.6
)
30
.4
 (2
4.
4-
37
.2
)
35
.3
 (2
8.
5-
42
.8
)
35
.1
 (2
9.
1-
41
.6
)
-0
.8
5
N
/A
N
/A
N
/A
W
om
en
17
3
25
.4
 (1
7.
4-
35
.3
)
34
.1
 (2
6.
2-
42
.9
)
38
.7
 (3
0.
1-
48
.0
)
38
.1
 (2
9.
7-
47
.4
)
-0
.7
2
-1
.1
8
0.
46
.1
10
M
en
75
20
.2
 (1
1.
3-
33
.4
)
21
.8
 (1
3.
5-
33
.3
)
27
.4
 (1
6.
7-
41
.5
)
27
.9
 (1
6.
9-
42
.5
)
-1
.1
8
-0
.7
2
-0
.4
6
.1
10
Pr
eg
na
nt
43
25
.8
 (1
2.
2-
46
.6
)
27
.4
 (1
5.
1-
44
.4
)
35
.5
 (1
5.
5-
62
.1
)
33
.3
 (1
6.
9-
55
.0
)
-0
.8
6
-0
.6
8
-0
.1
8
.6
17
O
ve
rw
ei
gh
t a
nd
 o
be
se
75
22
.0
 (1
2.
7-
35
.5
)
29
.0
 (1
8.
0-
43
.1
)
39
.7
 (2
5.
5-
55
.8
)
35
.4
 (2
2.
4-
51
.0
)
-0
.8
4
-0
.6
5
-0
.1
9
.5
52
Co
up
le
s
38
27
.2
 (1
2.
9-
48
.4
)
34
.7
 (1
9.
9-
53
.1
)
45
.3
 (2
9.
8-
61
.7
)
44
.7
 (2
9.
0-
61
.6
)
-0
.6
3
-0
.7
5
0.
12
.7
36
A
lc
oh
ol
 c
on
su
m
pt
io
n,
 %
 (9
5%
 C
I)
O
bs
er
ve
d
–
25
.3
29
.2
31
.9
33
.3
N
/A
N
/A
N
/A
N
/A
To
ta
l
66
8
27
.0
 (2
2.
4-
32
.1
)
33
.3
 (2
9.
8-
37
.1
)
39
.8
 (3
4.
3-
45
.6
)
41
.9
 (3
5.
2-
48
.9
)
0.
63
N
/A
N
/A
N
/A
W
om
en
42
3
32
.7
 (2
7.
2-
38
.6
)
42
.5
 (3
7.
0-
48
.0
)
50
.7
 (4
4.
3-
57
.1
)
55
.2
 (4
6.
1-
63
.9
)
-0
.2
2
-1
.4
9
1.
27
.0
31
M
en
24
5
17
.2
 (1
2.
3-
23
.5
)
17
.5
 (1
2.
7-
23
.7
)
21
.0
 (1
4.
6-
29
.2
)
18
.9
 (1
3.
7-
25
.5
)
-1
.4
9
-0
.2
2
-1
.2
7
.0
31
Pr
eg
na
nt
17
48
.2
 (2
5.
9-
71
.3
)
60
.0
 (3
5.
5-
80
.4
)
58
.9
 (3
1.
8-
81
.5
)
62
.4
 (3
5.
5-
83
.3
)
0.
22
-0
.2
4
0.
46
.3
25
O
ve
rw
ei
gh
t a
nd
 o
be
se
15
0
31
.9
 (2
4.
1-
40
.8
)
41
.0
 (3
3.
3-
49
.3
)
50
.9
 (4
2.
0-
59
.8
)
52
.9
 (3
7.
6-
67
.7
)
-0
.2
5
-0
.2
0
-0
.0
5
.7
88
Co
up
le
s
12
6
35
.4
 (2
6.
4-
45
.5
)
47
.8
 (3
6.
0-
59
.8
)
54
.5
 (4
1.
1-
67
.2
)
60
.7
 (5
0.
1-
70
.3
)
-0
.0
4
-0
.3
0
0.
26
.2
07
D
at
a 
ar
e 
pr
es
en
te
d 
pe
r 
ris
k 
fa
ct
or
 p
er
 s
cr
ee
ni
ng
 p
oi
nt
 a
s 
th
e 
pe
rc
en
ta
ge
 o
f i
m
pr
ov
em
en
t 
fr
om
 in
ad
eq
ua
te
 t
o 
ad
eq
ua
te
 b
eh
av
io
r 
of
 t
he
 t
ot
al
 g
ro
up
 o
r 
su
bg
ro
up
, i
nc
lu
di
ng
 t
he
 9
5%
 c
on
fid
en
ce
 
in
te
rv
al
. A
re
a 
un
de
r t
he
 c
ur
ve
 (A
U
C)
 is
 p
re
se
nt
ed
 a
s 
lo
g 
od
ds
 ra
tio
: A
U
C 
su
bg
ro
up
 v
er
su
s 
AU
C 
co
m
pl
em
en
t, 
di
ffe
re
nc
e,
 a
nd
 c
or
re
sp
on
di
ng
 P
 v
al
ue
.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 52
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 53
PART 2
Periconceptional diet and PCOS
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 54
Nicole A. Huijgen
Joop S.E. Laven
Chantal T. Labee
Yvonne V. Louwers 
Sten P. Willemsen
Régine P.M. Steegers-Theunissen
PLOS ONE DOI:10.1371/journal.pone.0142772 
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 55
C h a p t e r 4
Are dieting and dietary inadequacy a second 
hit in the association with polycystic ovary 
syndrome severity?
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ABSTRACT
Background 
The composition of the diet is of increasing importance for the development and maturation 
of the ovarian follicles. In Polycystic Ovary Syndrome (PCOS) healthy dietary interventions 
improve the clinical spectrum. We hypothesized that dieting and diet inadequacy in the 
reproductive life course is associated with impaired programming of ovarian follicles and 
contributes to the severity of the PCOS phenotype. 
Methods and Findings
To determine associations between the use of a self-initiated diet and diet inadequacy and 
the severity of the PCOS phenotype, we performed an explorative nested case control study 
embedded in a periconception cohort of 1,251 patients visiting the preconception outpatient 
clinic. 
218 patients with PCOS and 799 subfertile controls were selected from the cohort and 
self-administered questionnaires, anthropometric measurements and blood samples were 
obtained. The Preconception Dietary Risk Score (PDR score), based on the Dutch dietary 
guidelines, was used to determine diet inadequacy in all women. The PDR score was negatively 
associated to cobalamin, serum and red blood cell folate and positively to tHcy. PCOS patients 
(19.9%), in particular the hyperandrogenic (HA) phenotype (22.5%) reported more often the 
use of a self-initiated diet than controls (13.1%; p= 0.023). The use of an inadequate diet was 
also significantly higher in PCOS than in controls (PDR score 3.7 vs. 3.5; p= 0.017) and every 
point increase was associated with a more than 1.3 fold higher risk of the HA phenotype 
(adjusted OR 1.351, 95% CI 1.09-1.68). Diet inadequacy was independently associated with 
the anti-Müllerian Hormone (AMH) concentration (β 0.084; p= 0.044; 95% CI 0.002-0.165) and 
free androgen index (β 0.128; p= 0.013; 95% CI 0.028-0.229).
Conclusions
The use of a self-initiated diet and diet inadequacy is associated with PCOS, in particular with 
the severe HA phenotype. This novel finding substantiated by the association between diet 
inadequacy and AMH needs further investigation.
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INTRODUCTION
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder affecting young 
women in reproductive age, resulting in subfertility and increased risks of cardiovascular 
related disease in later life [103]. The estimated prevalence of PCOS varies between 5-15% 
[22,23]. PCOS is characterized by oligo- or anovulation (ovulatory dysfunction; OD), clinical 
and/or biochemical signs of hyperandrogenism (HA) and/or polycystic ovaries (Polycystic 
ovarian morphology; PCOM), and gene-environment interactions play a significant role in 
the variability within PCOS phenotypes [24,104]. The clinical spectrum and severity in PCOS 
is heterogeneous, including reproductive, metabolic and psychological features. Because of 
the profound cardiovascular and metabolic disturbances in hyperandrogenic PCOS patients, 
it is recommended to distinguish two subtypes of PCOS according to the severity of disease 
(HA-PCOS and non HA-PCOS) [25]. Personal behaviors, such as dieting, smoking, alcohol- and 
drug use, stress and exercise are considered environmental factors that are important for 
reproductive functioning [20,81]. The composition of the preconception diet is of increasing 
interest, because over- and undernutrition derange metabolic and endocrine pathways, 
especially the B vitamin dependent one-carbon (1-C) pathway [20,42,105]. During the 
development of the germ cells and the maturation of the ovarian follicles, the methyl groups 
mainly derived from B vitamins, methionine and choline are used for DNA synthesis and 
phospholipid and protein biosynthesis. Deficiencies of these nutrients are inversely associated 
with ovarian follicle development, the number of oocytes retrieved for IVF treatment, embryo 
quality and pregnancy outcome [20,42,105]. Worrisome is that in more than 50% of subfertile 
couples planning pregnancy the preconception diet is inadequate [59]. However it is promising 
that improvement of the diet can increase the chance of ongoing pregnancy up to 65% [6]. The 
prevalence of obesity and PCOS is increasing and although obesity is not the cause of PCOS 
it contributes to the clinical spectrum [106]. Moreover, weight loss can improve the clinical 
spectrum including menstrual regularity, insulin resistance and quality of life [33] and dietary 
interventions are therefore part of the clinical treatment of PCOS. In the polycystic ovary, an 
arrest of follicular maturation results in the accumulation of small antral follicles that produce 
elevated levels of Anti-Müllerian Hormone (AMH) [29]. AMH concentration is therefore a marker 
of PCOS severity which is inversely associated with a healthy diet, irrespective of weight loss 
[107]. Psychological co-morbidities such as depression, eating and anxiety disorders, which 
can affect the nutritional state are also more prevalent in PCOS [108]. Another potential driver 
for differences in dieting could be obesity although previous research showed that dieting 
behavior is independent of current BMI, but strongly associated with negative emotions and 
problematic behaviors [109]. Dietary behavior is acquired during childhood and remains rather 
stabile over time only varying during episodes of illnesses, dieting and increased needs [110-
113]. Dieting habits can be transferred unknowingly since the practices mothers adopt predict 
the children’s diet quality [114] and because parents contribute to adolescents’ motivation to 
diet [115].
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Here we hypothesize that regular self-initiated dieting and using an inadequate diet is 
associated with alterations in the 1-C pathway and with impaired functioning of ovarian 
follicles which contributes to the clinical spectrum of PCOS. We performed a case-cohort study 
embedded in a prospective periconception cohort study of couples referred for subfertility, to 
investigate whether the use of a self-initiated diet and dietary inadequacy are associated with 
PCOS severity and phenotype.
MATERIALS AND METHODS
Study design
Between October 2007 and March 2011, all couples planning pregnancy and visiting the 
outpatient clinic of the Department of Obstetrics and Gynaecology at the Erasmus MC, 
University Medical Center Rotterdam, a tertiary hospital in the Netherlands, were offered 
nutrition and lifestyle counselling at the preconception outpatient clinic ‘Achieving a Healthy 
Pregnancy’ [6,59]. 
In this study women completed a questionnaire from which we extracted general 
characteristics, such as age, ethnicity (Dutch or Non-Dutch), educational level (low, intermediate 
or high), the use of a diet (energy restricted, vegetarian, macrobiotic, vegan, other) and of 
six main food groups (Preconception Dietary Risk score), folic acid supplements (yes/no), 
vitamin supplements (yes/no), medication (yes/no), alcohol (yes/no), and smoking (yes/no), 
physical exercise (yes/no), and the experience of stress (yes/no). Ethnicity and education level 
were classified according to the definition of Statistics Netherlands (www.cbs.nl; 2012). The 
validated summary PDR score, based on the Dutch food based dietary guidelines was used 
to assess diet inadequacy in the outpatient clinical setting [6,88]. When patients did not meet 
the dietary guidelines for the food group, one point was administered. Since six guidelines 
were evaluated, the PDR score had a maximum of 6 points and a minimum of 0 points. Thus, 
the higher the score the more inadequate the intake according to the guideline. The adequate 
intake per food group was defined by the following guidelines: 4-5 slices of whole wheat bread 
daily, the use of monounsaturated or polyunsaturated oils/fats, 200 grams of vegetables daily, 
2 pieces of fruit daily, 3-4 servings of meat weekly and 2 servings of fish weekly [61]. During the 
visit at the outpatient clinic the questionnaires were verified by a trained counsellor. 
Subsequently non-fasting blood samples were obtained by venipuncture and anthropometrics 
(i.e. height, weight and circumferences) were measured. Patients with oligo- or anovulation 
were screened for ovulatory dysfunction by trained professionals according to a standardized 
protocol. 
The diagnose of PCOS was based on the Rotterdam criteria [24] including the presence of 
oligo- or anovulation (i.e. menstrual bleeding interval between 35-182 days or absence of 
menstrual bleeding for more than 182 days), hyperandrogenism (Ferriman-Gallwey score ≥9 
and/or a Free Androgen Index >4.5), and/ or polycystic ovaries (volume exceeding 10 cm3 and/
or the follicle count was ≥12).
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Study population
During the study period 1,348 couples visited the preconception outpatient clinic of which 
1,251 participated in the study and provided a written informed consent. Two hundred and 
fifty one patients were diagnosed with PCOS and 33 patients were excluded because of an 
uncertain diagnosis or the period between enrolment and PCOS diagnosis comprised more 
than one year. From the remaining 1,000 patients we excluded patients with an incomplete 
fertility medical record (n= 80), patients with ovulatory disorders such as imminent ovarian 
failure, WHO 1 or WHO 2 disorders (n= 107) and fertile patients (n= 14) who were referred 
because of a complicated obstetrical history. This resulted in a control group of 799 subfertile 
patients (Figure 1). According to phenotype, we divided the PCOS group (n= 218) in the HA 
(n= 112) and non HA (n= 106) phenotype.
 Patients visiting the ‘Achieving a Healthy Pregnancy’ outpatient clinic 
n= 1,251
 October 2007- March 2011  
n= 251 PCOS patients (2 out of 3  criteria )
- Ovulatory Dysfunction (OD )
- Androgen Excess (AE) 
- Polycystic Ovarian Morphology (PCOM)
Exclusion (n= 33)
- Uncertain PCOS diagnosis
- Visit -  PCOS diagnosis >1yr 
PCOS (All phenotypes )
n= 218 
n= 1,000
Exclusion (n= 201)
- Patients with IOF/WHO1/WHO2
- Missing fertility medical record
- No subfertility
Subfertile controls
n= 799 
HA PCOS
n= 112 
HA + OD + PCOM (n= 94)
HA + OD (n= 9)
HA + PCOM (n= 9)
Non HA -PCOS
n= 106
OD + PCOM
Figure 1 | Flowchart of the selection of the study population. 
Abbbreviations; IOF = imminent ovarian failure; WHO1 = hypogonadotropic hypogonadal anovulation; WHO2 = normo-
gonadotropic normoestrogenic anovulation; HA = hyperandrogenic.
Biomarkers
On the day of the visit at the outpatient clinic blood samples were drawn and processed within 
2 hours after withdrawal. Serum was stored at -20°C until assayed. In blood the biomarkers 
of 1-C metabolism serum and red blood cell (RBC) folate, serum cobalamin, and plasma total 
homocysteine (tHcy) were determined in all study participants. tHcy was measured using 
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HPLC-TandemMS. For the determination of serum folate and cobalamin an immune electro 
chemoluminescence assay was used (E170; Roche Diagnostics GmbH, Mannheim, Germany) 
and for the determination of RBC folate the ADVIA 120 Hematology Analyzer was used (Bayer 
Diagnostics, Leverkusen, Germany). 
For clinical purposes the patients with PCOS were additionally screened on hormonal 
and metabolic parameters. Testosterone was measured using radioimmunoassay (RIA) 
(Siemens DPC, Los Angeles, CA) and glucose levels were measured by using a Hitachi 917 
analyzer (Roche Diagnostics, Almere, The Netherlands). The Free Androgen Index (FAI) was 
calculated as follows; 100 x [T (nmol/L) / Sex hormone-binding globulin (SHBG) (nmol/L)]. An 
immunoluminometric assay (Immulite® platform, Siemens Diagnostic Product Corporation, 
Los Angeles, CA) was used to measure LH, FSH, SHBG, androstenedione, insulin and DHEAS. 
Serum AMH (Anti-Müllerian Hormone) levels were measured by using an in-house double-
antibody ELISA (GenII; Beckman Coulter) as previously described [116]. Intra- and interassay 
coefficients of variation were, respectively, <5% and <15% for LH, <3% and <18% for FSH, <3% 
and <5% for T, <8% and <11% for AD, <4% and <5% for SHBG, <9% and <11% for DHEAS, <5% 
and <8% for AMH, and <6% and <8% for insulin.
Statistical analyses 
Continuous variables are presented as median with interquartile range. Dichotomous 
and categorical variables are presented as count and proportions. Chi Square tests with 
comparison of column proportions were performed with a Bonferroni correction to compare 
the distribution of categorical variables between PCOS phenotypes and subfertile controls. 
Mann Whitney U Tests were performed to compare the total group of PCOS with the subfertile 
controls. Kruskal Wallis tests with pairwise comparisons adjusted for the number of pairwise 
tests were performed for comparison of controls, HA-PCOS patients and non HA-PCOS patients. 
Simple linear regression analysis were conducted to establish associations between the PDR 
score and the biomarkers of 1-C metabolism. To achieve normality a natural log transformation 
was performed for cobalamin, RBC Folate and tHcy and a square root transformation for serum 
folate. Multivariable logistic regression analysis was applied to calculate the risk of PCOS after 
one point increase of the PDR score for each phenotype separately with adjustment for the 
potential confounders body mass index (BMI), age, educational level, ethnicity, medication 
use and vitamin supplement use. These covariates were selected because of the significant 
association with the PDR score or when significant differences revealed between PCOS and 
controls. Multivariable linear regression analysis were performed to investigate associations 
between the PDR score and hormonal parameters in PCOS only with adjustments. Statistical 
analyses were performed using SPSS software for Windows (version 21.0, IBM SPSS, Statistics 
for Windows, Armonk, NY: IBM Corp). The level of significance was set to 0.05 for all analyses.
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Ethical approval
All questionnaire data and materials were processed anonymously. This study was conducted 
according to the guidelines of the Declaration of Helsinki, and all procedures involving 
patients were approved by the Medical Ethical and Institutional Review Board at the Erasmus 
MC, University Medical Center in Rotterdam, the Netherlands. Written informed consent was 
obtained from all patients. 
RESULTS
To evaluate selection bias we present the general characteristics of the included and excluded 
patients in Supplemental Table 1. The general characteristics were comparable in both groups 
except the slightly younger age, higher percentage of smoking and alcohol use and slightly 
smaller waist circumference and waist-hip ratio in the study group.
PCOS study population 
In Table 1 the general characteristics of PCOS patients (n= 218) and subfertile control patients 
(n= 799) are shown. The PCOS group was significantly younger and used less often alcohol, 
folic acid and vitamin supplements than subfertile controls, which is validated with the lower 
concentrations of serum and RBC folate observed in the PCOS group. They also used more 
often a self-initiated diet and were more frequently obese (BMI ≥30). 
PCOS phenotypes
In Table 1 we depict the PCOS group divided into the HA (n= 112) and non HA phenotype 
(n= 106) and compare the general characteristics with subfertile controls (n= 799). The HA and 
non HA phenotype patients were both significantly younger than subfertile controls. Patients 
with the HA phenotype exercised less than non HA-PCOS patients and they used less often 
alcohol than non HA-PCOS patients or subfertile controls. Patients with the HA phenotype 
were also more likely to use a self-initiated diet and used less often folic acid supplements than 
subfertile controls and showed a significantly higher BMI and waist circumference compared 
to the non HA phenotype and subfertile controls. Moreover, the waist hip ratio, used as 
indicator of central obesity, was significantly lower in the non HA phenotype, compared to the 
HA phenotype and subfertile controls. Patients with the HA phenotype showed lower levels of 
serum and RBC folate than the non HA phenotype and subfertile controls.
Dietary inadequacy assessed with the PDR score
A higher mean PDR score was observed in the PCOS group than in the subfertile controls 
(3.7 vs. 3.5; p= 0.017). Patients with the HA phenotype also showed a higher mean PDR score 
(3.9; p <0.001) than the non HA phenotypes (3.5) and the subfertile controls (3.5). The PDR 
score per food group was comparable between the groups, except for a higher percentage of 
inadequate meat and fish intake in the HA phenotype (Figure 2). 
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Figure 2 | The items of the Preconception Dietary risk score. Depicted are the percentages of inadequate 
dietary intake for each food group. Meat* and fish** intake differed significantly between the controls, 
HA and non HA phenotype (respectively p= 0.006 and p= 0.039) 
Table 2 shows that one point increase in the PDR score was associated with a 1.4 fold higher 
risk of the HA phenotype (unadjusted OR 1.427, 95% CI 1.183 to 1.721). The PDR score was 
inversely associated with age (β -0.037, 95% CI -0.051 to -0.023, p <0.001), educational level 
(category high β -0.311, 95% CI -0.522 to -0.100, p= 0.004) and the use of vitamin supplements 
(β -0.192, 95% CI -0.336 to -0.048, p= 0.009) and therefore these covariates were selected for 
adjustment of the analyses. Age was a confounder and inversely associated with the severity 
of the PCOS phenotype and positively associated with the PDR score. After adjustment in 
model 1 the risk of the HA phenotype slightly increased (OR 1.520, 95% CI 1.240 to 1.863) and 
attenuated in model 2 (OR 1.351, 95% CI 1.087 to 1.679), but remained significant. The PDR 
score was not associated with the risk of the non HA phenotype.
The PDR score and biomarkers of 1-C metabolism 
To investigate the association between dietary inadequacy and the markers of 1-C metabolism, 
we subsequently performed linear regression analyses in the PCOS patients and subfertile 
controls with the separate biomarkers cobalamin, RBC folate, serum folate and tHcy. A negative 
linear association was established between the PDR score and cobalamin (unadjusted 
β -0.052; p <0.001; 95% CI -0.074 to -0.030), RBC folate (unadjusted β -0.045; p <0.001; 95% CI 
-0.067 to -0.023) and serum folate (unadjusted β -0.193; p <0.001; 95% CI -0.295 to -0.091). A 
positive linear association was observed between the PDR score and tHcy (unadjusted β 0.030; 
p <0.001; 95% CI 0.014 to 0.045). Additional adjustment for age, BMI, ethnicity, education, 
vitamin supplement use and medication use slightly attenuated the effect estimates of the 
four biomarkers and remained significant. 
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Diet and hormonal and metabolic parameters in PCOS patients
In Table 3 the serum characteristics of the PCOS phenotypes are depicted. The PDR score was 
positively associated with AMH and FAI. A positive linear association was established between 
the PDR score and AMH (unadjusted β 0.084; p= 0.044; 95% CI 0.002 to 0.165), however after 
adjustment for age and BMI this association was no longer significant. 
This association was stronger when repeated only in the HA+OD+PCOM and OD+PCOM PCOS 
patients (unadjusted β 0.109; p= 0.011, 95% CI 0.025 to 0.193) and remained significant after 
adjustment for age (β 0.100; p= 0.022, 95% CI 0.015 to 0.185) and BMI (β 0.102; p= 0.018, 
95% CI 0.018 to 0.186). 
The PDR score was also positively associated with FAI (unadjusted β 0.128; p= 0.013; 95% CI 
0.028 to 0.229), but lost significance after adjustment for age and BMI.
Table 3 | Serum characteristics according to PCOS phenotype.
  HA-PCOS 
(n= 112)
non HA-PCOS 
(n= 106)
Hormonal Parameters
AMH (µg/L) 10.3 (6.7-14.8) 7.6 (4.8-11.2)**
FSH (U/l) 6.1 (5.2-7.2) 5.9 (3.9-7.8)
LH (U/l) 9.8 (6.7-14.6) 6.6 (4.4-11.7)**
Progesterone (nmol/l) 1.2 (0.9-1.9) 1.5 (0.9-10.2)*
17-hydroxyprogesterone (nmol/l) 2.9 (2.2-4.4) 2.7 (1.9-5.8)
Estradiol (pmol/L) 225.5 (181.0-300.5) 234.0 (143.0-363.0)
SHBG (nmol/l) 27.0 (21.4-39.7) 56.4 (45.3-81.6)**
Testosterone (nmol/l) 2.0 (1.6-2.8) 1.2 (0.9-1.6)**
FAI 7.0 (5.5-10.7) 2.2 (1.4-3.0)**
Androstenedione (nmol/l) 11.8 (9.7-17.4) 8.6 (6.4-10.4)**
DHEAS(µmol/L) 5.7 (3.9-7.4) 4.8 (3.3-6.1)**
Metabolic Parameters
Insulin (pmol/l) 67.0 (40.0-118.0) 34.0 (17.0-57.0)**
Glucose (mmol/l) 4.9 (4.6-5.3) 4.7 (4.5-5.0)**
TG (mmol/L) 1.0 (0.8-1.6) 0.9 (0.7-1.2)*
Total–C (nmol/L) 5.4 (4.6-6.7) 5.2 (4.5-6.7)
HDL-C (nmol/L) 1.4 (1.1-1.8) 1.7 (1.4-2.2)**
LDL-C (nmol/L) 3.8 (3.1-4.6) 3.4 (2.8-4.4)*
Apolipoprotein A1 209.6 (183.3-256.7) 239.4 (198.0-281.8)**
Apolipoprotein B 124.1 (103.6-148.8) 115.2 (84.1-136.1)**
Note: Values are expressed as median (interquartile range), * = p <0.05; ** = p <0.01. Abbreviations; HA = Hyperandrogenic; 
FSH = Follicle Stimulating Hormone; LH = Luteinizing Hormone; SHBG = Sex Hormone Binding Globulin; FAI = Free Androgen 
Index; DHEAS = dehydroepiandrosterone sulfate; TG = Triglycerides; Total-C = total Cholesterol; HDL-C = HDL-cholesterol; 
LDL-C = LDL-cholesterol. Mann Whitney U Tests were performed. 
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DISCUSSION
This explorative study demonstrates that patients with PCOS more often use a self-initiated 
diet and an inadequate diet than subfertile controls. This is substantiated by the use of a more 
inadequate diet in patients with the more severe HA phenotype and the positive association 
between diet inadequacy and the AMH concentration in PCOS patients.
The strength of the study is the large sample size and case-cohort design to reduce selection 
and information bias. Furthermore, standardized anthropometric measurements were 
performed by trained counsellors who verified all questionnaire data individually during the 
preconception visit at the outpatient clinic. Several adjustments were made including BMI to 
minimize the presence of underreporting and overreporting of dietary intake. The PDR score 
was previously validated in the same study population and is shown to be a sensitive and 
simple tool to assess diet inadequacy [88]. Another strength of the study is that biomarkers 
were measured to validate the PDR score and that all laboratory determinations were 
measured in the same hospital. The PDR score estimates dietary inadequacy and not unhealthy 
overconsumption which is a limitation [88]. We are aware that although the PDR score covers 
the six main food groups, it does not reflect the total nutrient and energy intake. The control 
group consisted of patients referred for subfertility which reduces the external validity of the 
study. We were able to use clinical and laboratory data for PCOS diagnosis, which were not 
available for subfertile controls. Despite numerous efforts, genetic research does not elucidate 
the developmental origin of PCOS. We suggest that this can be due to a more significant role of 
gene-nutrient interactions affecting epigenetic mechanisms of multiple pathways regulating 
ovarian function during the course of life. Previous research demonstrated that genes are 
prenatally programmed by androgen exposure in utero, resulting in disturbed ovarian and 
adrenal steroidogenesis [117], impaired oocyte development [118] and PCOM [119]. The diet 
is important in epigenetics by supplying substrates and methyl groups that are important for 
gene methylation, programming and subsequent expression and silencing of the genome. 
Dietary inadequacies can therefore lead amongst other pathways to derangements in the 
1-C pathway, resulting in hypomethylation and altered gene expression [20,120]. As a first 
hit the nutritional environment in-utero can affect reproductive function in the offspring 
through impaired gonadal organogenesis before birth [120-122]. In rabbits, Leveille et al. 
showed prenatal and postnatal effects of the diet on ovarian function and morphology by the 
number of atretic follicles [123]. Not only during early life but also postnatally through puberty 
and adolescence, diet can affect gene expression as second or third hit influencing disease 
occurrence and severity. Adolescents suffering from overweight and psychological problems 
are at risk to develop nutritional inadequacies [108,124]. Therefore these data support our 
hypothesis that the use of a self-initiated diet and dietary inadequacies can contribute to a 
clinical heterogeneous spectrum of PCOS phenotype development. This study showed an 
association between the use of a more inadequate diet in PCOS patients and disease severity 
which is further underlined by a lower serum and RBC folate. Homocysteine concentrations 
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were higher as well, although this did not reach statistical significance. The study of Rodrigues 
et al supports this finding showing a poor diet quality in PCOS patients (56% inadequacy 
according to the Brazilian healthy eating index) [125]. Studies comparing diet quality in PCOS 
to controls are contradictory. Comparable dietary compositions in PCOS and controls are 
reported [126-128], whereas the group of Moran et al observed a higher diet quality in PCOS 
[129]. A high prevalence of folate deficiency and increased levels of homocysteine is previously 
observed in PCOS substantiating our results and the association with the involvement of the 
one-carbon pathway [130,131]. An explanation for the different findings in other studies is that 
in all other studies the assessment of diet inadequacy was performed always after diagnosing 
PCOS. Moreover, due to the exclusion of dieting, non-stabled weighted or normal weighted 
PCOS patients in other studies, selection bias could explain the different results. Information 
bias due to the awareness of PCOS and the intention to treat can also explain the differences 
with other studies. Finally, in contrast to other studies, we also investigated the association 
with the severity of the PCOS phenotypes and compared them with subfertile controls.
Our results are in line with studies showing the importance of dietary treatment in PCOS 
for reproductive and metabolic outcome [107,132,133]. Furthermore, in overweighed PCOS 
patients it is observed that folate supplement use had beneficial effects on metabolic profiles 
[134], which indicates the involvement of an impaired 1-C pathway in PCOS.
The positive linear association between the PDR score and AMH concentration, and PCOS 
severity very much supports the function of AMH as marker of the spectrum [135]. This 
is supported by Nybacka et al showing a decrease in AMH in PCOS patients following a 4 
month calorie restricted, well-balanced diet [107]. Another observation is that PCOS gradually 
disappears during ageing [136,137]. We suggest that the known improvement of the diet 
during the course of life also contributes to its disappearance which is supported by the 
gradual decrease of AMH during ageing [138]. FAI as marker for androgen excess was also 
positively associated with diet inadequacy, which is in line with the findings of others [132]. 
According to the biological gradient criteria of Hill, the associations of AMH and FAI with the 
PDR score strengthen the relationship between diet inadequacy and PCOS severity. This is 
substantiated by a stronger linear association between the PDR score and AMH after exclusion 
of the subpopulation without PCOM (HA+OD) or without OD (HA+PCOM). After adjustment 
for age and BMI this association remained significant, demonstrating the heterogeneity of the 
hyperandrogenic phenotype.
To conclude, this explorative study shows for the first time that the use of a self-initiated diet 
and diet inadequacy are associated with PCOS as well as PCOS phenotype. These findings 
emphasize the need for prospective research from the reproductive life course onwards with a 
focus on the role of the inadequacy of the diet in the developmental origins of PCOS. Moreover, 
in PCOS treatment more attention should be given to the adherence of an adequate diet.
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Supplemental Table 1 | Sensitivity analysis.
Study population
(n= 1017)
Excluded population
(n= 234)
Age (years) 32.1 (28.4 -35.8) 33.1 (29.6-37.2)**
Ethnicity
Dutch 567 (56.0%) 122 (53.5%)
Other 446 (44.0%) 106 (46.5%)
Educational level
Low 150 (15.5%) 31 (14.2%)
Intermediate 433 (44.8%) 103 (47.2%)
High 383 (39.6%) 84 (38.5%)
Lifestyle Parameters
Diet (Yes) 148 (14.6%) 38 (16.5%)
PDR score (mean; sd) 3.54 (1.14) 3.47 (1.20)
Folic acid supplement use (No) 360 (35.4%) 89 (38.0%)
Vitamin supplement use (No) 616 (61.2%) 129 (55.6%)
Medication use (Yes) 330 (32.6%) 78 (33.9%)
Alcohol (Yes) 540 (53.1%) 100 (42.7%)**
Smoking (Yes) 226 (22.5%) 35 (15.2%)*
Physical exercise (No) 464 (49.7%) 110 (50.5%)
Stress (Yes) 309 ( 33.7%) 87 (40.7%)
Measurements
BMI (kg/m2) 24.8 (22.0-28.9) 24.8 (22.5-28.8)
BMI in categories (kg/m2)
<20 75 (7.4%) 17 (7.3%)
≥20 <25 455 (45.0%) 109 (46.6%)
≥25 <30 280 (27.7%) 57 (24.4%)
≥30 201 (19.9%) 51 (21.8%)
Waist circumference (cm) 84 (75-94) 85 (77-97)*
Waist hip ratio 0.81 (0.75-0.87) 0.82 (0.77-0.90)*
Biochemical Parameters
Cobalamin (pmol/L) 309.0 (236-409) 313.5 (246-431)
RBC Folate (nmol/L) 1022.0 (817-1303) 994.5 (815-1268.5)
Folate (nmol/L) 28.5 (18.0 -40.3) 25.6 (17.8-37.4)*
tHcy (µmol/L) 8.50 (7.1-10.0) 8.5 (7.1-10.2)
Note: Values are expressed as median (interquartile range) or number (%),* = p <0.05; ** = p <0.01. Abbreviations;  PDR score 
= Preconception Dietary Risk score; BMI = Body Mass Index; RBC Folate = Red Blood Cell Folate; tHcy = homocysteine.
 Normal range biochemical parameters; Folate ≥8 nmol/L, RBC folate ≥500 nmol/L, Cobalamin ≥145 pmol/L, tHcy <15 µmol/L. 
Chi Square tests and Mann Whitney U Tests were performed. 
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Dietary patterns and the phenotype  
of polycystic ovary syndrome: 
the chance of ongoing pregnancy
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ABSTRACT
Polycystic ovary syndrome (PCOS) is generally considered a complex disorder caused by 
interactions between genetic and environmental factors. In a sub-cohort of women with 
PCOS visiting the preconception outpatient clinic of a tertiary hospital with follow-up in a 
periconception cohort, we identified specific dietary patterns and adherence in patients with 
PCOS with and without hyperandrogenism and the chance of ongoing pregnancy. 
Food frequency questionnaires were available from 55 patients diagnosed with PCOS during 
follow-up in routine clinical practice, including 25 with hyperandrogenism and 30 without 
hyperandrogenism. Strong adherence to the healthy dietary pattern was inversely associated 
with the hyperandrogenic PCOS phenotype (Adjusted OR 0.27; 95% CI 0.07 to 0.99). 
In women with PCOS overall, a strong adherence to the healthy dietary pattern showed a 
three-fold higher chance of ongoing pregnancy (adjusted OR 3.38; 95% CI 1.01 to 11.36) and an 
association with anti-Müllerian hormone concentration (β -0.569 μg/L; 95% CI -0.97 to -0.17). 
The effect of this dietary pattern on the chance of ongoing pregnancy and AMH suggests 
causality, which needs further investigation in prospective studies in the general population.
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INTRODUCTION
Polycystic ovary syndrome (PCOS) is an endocrine disorder with a prevalence of 5-10% 
and characterized by oligo- or anovulation, hyperandrogenism (HA) and/or polycystic 
ovaries [22,24,139]. Nowadays, PCOS is generally considered a complex genetic disorder 
with interactions between environmental factors, such as diet, obesity, and genetic 
susceptibility caused by single nucleotide polymorphisms [140,141]. These nutrient-gene 
interactions, in particular, influence gene expression, resulting in a variety of diseases even 
with transgenerational effects [21]. The one-carbon (1-C) pathway plays an essential role in 
epigenetics, in which methyl groups derived from nutrients such as B vitamins are used for DNA 
synthesis and phospholipid and protein biosynthesis [20]. Previous studies have shown that 
dietary patterns rich in these B vitamins are associated with increased chances of pregnancy 
and decreased chances of adverse pregnancy outcome, confirming the involvement of the 
1-C pathway [7,8,52,58,59,67,142]. Dietary intervention studies of specific nutrients have shown 
various improvements in the features of PCOS, substantiating the hypothesis that nutrition 
affects biological processes involved in the clinical spectrum of PCOS phenotypes [32,35-
40,143]. Moreover, we recently showed that the use of a self-initiated diet and diet inadequacy 
are associated with PCOS and with the severity of the PCOS phenotype, which is further 
substantiated by a positive association between diet inadequacy and the Anti-Müllerian 
Hormone concentration [144]. In this continuous search for the best treatment for PCOS, to 
the best of our knowledge no observational studies have assessed dietary patterns in relation 
to the heterogeneity of the PCOS phenotype. Therefore, we explored which dietary patterns 
are distinctive for women with PCOS and whether these dietary patterns are associated with 
the more severe hyperandrogenic PCOS phenotype or the mild non-hyperandrogenic PCOS 
phenotype [25,144]. Additionally, we investigated whether the established dietary patterns 
are associated with the chance of ongoing pregnancy.
MATERIALS AND METHODS
Design
Couples referred to our hospital because of subfertility visited the preconception tailored 
nutrition and lifestyle counselling clinic during their first visit at the Department of Obstetrics 
and Gynaecology at the Erasmus MC, University Medical Center Rotterdam, a tertiary hospital 
in the Netherlands, between October 2010 and October 2012. They were additionally invited 
to participate in the ongoing Rotterdam. Periconceptional Cohort, the Predict study [59,145]. 
Women with oligoovulation or anovulation were screened for ovulatory dysfunction. Trained 
professionals diagnosed PCOS according to a standardized protocol, based on the Rotterdam 
criteria [24] including the presence of oligoovulation or anovulation, hyperandrogenism 
(Ferriman-Gallweyscore ≥9, a Free Androgen Index >4.5, or both), polycystic ovaries, or 
both. Two subtypes of PCOS were distinguished according to the severity of the phenotype: 
hyperandrogenic PCOS and non-hyperandrogenic PCOS [25,144]. The AMH was also used as 
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marker of PCOS severity, as elevated levels are the result of an arrest of the selection of the 
dominant follicle with a concomitant increase in the number of small (pre)-antral follicles in 
the polycystic ovary. During the visit at the outpatient clinic, standardized anthropometric 
measurements, i.e. height, weight and circumferences, and non-fasting blood samples, were 
obtained. Participants completed a general questionnaire and a food frequency questionnaire 
(FFQ) at baseline, which were used for counselling during the visit. Couples were counselled 
twice with a fixed time interval of 3 months [59]. From the general questionnaire, data 
were obtained on age, ethnicity, educational level, the use of a diet, the use of folic acid or 
vitamin supplements, medication, alcohol or tobacco and physical exercise. The validated 
semi-quantitative FFQ consisting of 196 food items was developed by the division of Human 
Nutrition, Wageningen University, The Netherlands, and was used to estimate habitual food 
intake over the previous 4 weeks before the preconception visit [62,64,88]. To calculate the 
individual micro- and macro-nutrient intakes, the nutrient densities as reported in the Dutch 
Food Composition Database of 2011 were multiplied by the consumed amounts of foods with 
consideration of preparation methods and portion sizes [146]. Twenty-three food groups were 
classified, to reduce the 196 food items by the summation of food items with a similar nutrient 
content (Supplementary Table 1) [8,147]. Dietary patterns were extracted from the women 
with PCOS only, because of the heterogeneity of the subfertile control group comprising 
women with ovulatory disorders (such as imminent ovarian failure, WHO 1), tubal infertility 
or unexplained subfertility. Clinical and fertility outcome parameters, such as type of fertility 
treatment, ongoing pregnancy (intrauterine pregnancy with positive heart action confirmed 
by ultrasound at 12 weeks gestation; yes/no), and time to pregnancy were extracted from 
medical records and follow-up stopped in January 2015.
Biomarkers
Venous blood samples were collected and the biomarkers of 1-C metabolism were determined; 
serum and red blood cell (RBC) folate, serum cobalamin and plasma total homocysteine (tHcy). 
At the preconception visit, venous blood samples were drawn in a vacutainer ethylenediamine 
tetraacetate (EDTA) tube and in a dry vacutainer tube (BD Diagnostics, Plymouth, UK). The dry 
vacutainer tubes were centrifuged at 2000 g for 15 min. The serum was collected and analyzed 
using an immunoelectro-chemoluminescence assay for the measurement of serum folate and 
cobalamin (E170; Roche Diagnostics GmbH, Mannheim, Germany). EDTA-blood was kept on 
ice and, immediately after blood sampling, 0.1 ml EDTA blood was haemolysed with 0.9 ml 
freshly prepared 1.0% ascorbic acid. The ADVIA 120 Hematology.
Analyzer (Bayer Diagnostics, Leverkusen, Germany) was used to determine the haematocrit. 
Within 1 h, the haemolysate was centrifuged for 5 min at 1000 g after which folate was 
determined on a Sysmex XE-2100 (Goffin Meyvis, Etten-Leur, The Netherlands). The RBC folate 
was calculated using the following formula: (nM haemolysate folate × 10/haematocrit) – [nM 
serum folate × (1- haematocrit) /haematocrit] = nM RBC folate. Plasma tHcy was determined 
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using a sensitive liquid chromatography tandem mass spectrum method (HPLC-Tandem 
MS, Waters Micromass Quattro Premier XE Mass Spectrometer with Acquity UPLC system, 
Milford, Massachusetts, USA). Inter-assay coefficients of variation for serum folate were 4.5% 
at 13 nmol/L and 5.7% at 23 nmol/L, for serum cobalamine 3.6% at 258 pmol/L and 2.2% 
at 832 pmol/L; for plasma tHcy were 4.8% at 14.6 μmol/L and 3.3% at 34.2 μmol/L. Serum 
AMH levels were measured by using a commercially available ELISA assay (AMH Gen II 
ELISA, A79765, Beckman Coulter; Inc., USA) [148]. Radioimmunoassay was used to measure 
testosterone (Siemens DPC, Los Angeles, CA) and the Hitachi 917 analyser was used to 
measure glucose levels (Roche Diagnostics, Almere, The Netherlands). The Free Androgen 
Index (FAI) was calculated as follows; [100 × T (nmol/L) / Sex hormone-binding globulin (SHBG) 
(nmol/L)]. LH, FSH, SHBG, androstenedione, insulin and dehydroepiandrosterone sulphate 
were determined by immunoluminometric assay (Immulite® XPi, Siemens, Los Angeles, CA). 
Intra- and interassay coefficients of variation were as follows, respectively: <5% and <8% for 
AMH, <3% and <18% for FSH, <5% and <15% for LH, <4% and <5% for sex hormone binding 
globulin, <3% and <5% for testosterone, <8% and <11% for androstenedione, <9% and <11% 
for dehydroepiandrosterone sulphate and <6% and <8% for insulin. Homeostatic model 
assessment-insulin resistance was calculated using the following formula (insulin (pmol/l) × 
glycaemia (mmol/l) /135).
Statistical analyses 
Principal component factor analysis was used to summarize dietary patterns by unrotated 
extraction in PCOS patients. The number of identified dietary patterns was based on an eigen 
value over 1 and the break point in the scree plot (depicting the eigen values of each pattern; 
the components plotted on the steep slope contribute highly to the patterns) [149]. After 
examining the contents of all identified dietary patterns, one and three were interpreted as, 
respectively, an unhealthy and healthy dietary pattern (Supplementary Table 1 and Figure 1). 
Patterns two and four were not distinctively healthy or unhealthy and were, therefore, not 
further considered. Each participant was assigned personalized scores for the two patterns, 
which represents the comparability of the individual’s diet to the two dietary patterns. All 
participants were subsequently classified based on ranking into a poor (lower half ) or strong 
(upper half ) adherence to the healthy and the unhealthy dietary pattern. The adherence to 
both patterns are uncorrelated, although a participant with a high score of adherence to the 
healthy dietary pattern will very likely have a low score of adherence to the unhealthy dietary 
pattern. When a participant has a moderate diet not consisting of very healthy or unhealthy 
items, the degree of adherence for both patterns would be low and the participant will be 
scored in both analyses in the group ‘poor adherence’. The physical activity level (PAL), an 
estimate for underreporting, was calculated using the Schofield formula for basal metabolic 
rate [150]. Chi-squared tests were carried out to compare categorical variables and Mann-
Whitney U Tests to compare continuous variables. Multivariable logistic regression analysis 
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was applied to calculate the risk of the more severe hyperandrogenic PCOS phenotype in 
case of a strong adherence to the healthy pattern and unhealthy pattern, adjusted for total 
energy intake (respectively model 1 and 3). In model 2, several confounders were considered 
and age and body mass index (BMI) were added to the logistic regression analyses. Ethnicity 
and educational level showed no significant correlation with the dietary patterns, and were 
therefore not added to the adjusted model. Multivariable logistic regression analysis was 
also used to predict the chance of ongoing pregnancy in case of strong adherence to the 
healthy pattern and unhealthy pattern. Multivariable linear regression analyses was applied to 
investigate the association between natural logtransformed AMH and the two patterns. SPSS 
software for Windows (version 21.0, IBM SPSS, Statistics for Windows, Armonk, NY: IBM Corp) 
was used for statistical analyses. The level of significance was set to P ≤0.05 for all analyses.
Ethical approval
All data and materials were processed anonymously. Written informed consent was obtained 
from all patients to participate in both studies. This study was conducted according to the 
guidelines of the Declaration of Helsinki, and all procedures involving patients were approved 
by the Medical Ethical and Institutional Review Board at the Erasmus MC, University Medical 
Center in Rotterdam, the Netherlands on 6 August, 2013; reference number MEC-2013-378.
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Figure 1 | Food group factor loadings for an unhealthy (dark grey) and healthy (light grey) dietary 
pattern; extracted from food frequency questionnaires of 55 women with PCOS. The overlap 
between the two patterns is coloured the middle gradient of grey. Factor loadings over 0.20 can be 
considered as foods highly related to the dietary pattern. Food group factor loadings range from -1 (no 
correspondence) to 1 (highly corresponding).
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RESULTS
A total of 1017 sub-fertile women visited the preconception outpatient clinic between 2010 
and 2012, of which follow-up of 453 (44.5%) women was ensured in the Predict Study. In 164 
out of 1017 women (16.1%), a diagnosis of PCOS was made, of which 81 (49.4%) participated 
in the Predict study. In 55 women with PCOS, a completed FFQ was available for analysis, 
revealing a response rate of 67.9%. To evaluate selection bias, we present the general 
characteristics of the included and excluded patients with or without PCOS in the Predict 
study in (Supplementary Table 2). The general characteristics were comparable except for a 
younger age, higher BMI, higher waist circumference and waist-hip ratio in the included group 
of women with PCOS. The women with PCOS without a FFQ were slightly younger than the 
women with PCOS in the study group. The non-PCOS study participants showed the oldest 
median age and the lowest BMI, waist circumference and waist-hip ratio compared with 
the PCOS participants without a FFQ and the included women with PCOS. Dietary patterns 
in women with PCOS were identified with principal component factor analysis and the first 
component or ‘dietary pattern’ (14.3% variance explained; the highest proportion of variance 
in total food consumption with the least loss of information per dietary pattern) represented 
a pattern high in refined grains, liquid fat, margarine, sauces, snacks and sugars, and low in 
fruits, whole grain, soup, diary, nuts and fish and was therefore labelled ‘unhealthy’.
The third component (9.3% variance explained) represented a pattern high in vegetables, 
cereals and legumes and low in fat (solid, margarine and liquid), meat, snacks, eggs and 
alcohol and was labelled ‘healthy’. We did not further investigate the less distinctive second 
and fourth dietary pattern, comprising both healthy and unhealthy items within one pattern.
In Table 1 we presented the general characteristics of 55 women with PCOS stratified into 
25 patients with the hyperandrogenic PCOS phenotype and 30 patients with the non-
hyperandrogenic PCOS phenotype. In contrast to non-hyperandrogenic PCOS, women with 
hyperandrogenic PCOS were more often of non-Dutch origin, had a lower level of education, 
were more frequently obese and showed a higher median BMI, waist circumference and waist-
hip ratio. All lifestyle parameters were comparable in both groups except a stronger adherence 
to the healthy dietary pattern in women with non-hyperandrogenic PCOS compared with 
women with hyperandrogenic PCOS. In addition, we observed a lower median serum and RBC 
folate concentration in women with hyperandrogenic PCOS. A similar PAL was observed for 
women with hyperandrogenic PCOS (1.08) and for women with non-hyperandrogenic PCOS 
(1.29).
Dietary patterns and the risk of the hyperandrogenic phenotype
The results of the multivariable logistic regression analyses are presented in Table 2. Strong 
adherence to the healthy dietary pattern was inversely associated with the hyperandrogenic 
PCOS phenotype only (β -1.26; OR 0.28; p= 0.03; 95% CI 0.09 to 0.88, adjusted for total energy 
intake), which remained significant after additional adjustment for BMI and age (β -1.31; OR 
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0.27; p= 0.047; 95% CI 0.07 to 0.99). The adherence to the unhealthy dietary pattern, however, 
was not associated with the hyperandrogenic or non-hyperandrogenic PCOS phenotype.
Table 1 | Preconception characteristics of women with hyperandrogenic and non-hyperandrogenic 
polycystic ovary syndrome
 
HA-PCOS  
(n=25)
non HA-PCOS  
(n=30)
Age (years) 29 (28-31) 29 (27-33) NS
Ethnicity, n (%) 
Dutch 11 (44.0%) 25 (83.3%) 0.002
Other 14 (56.0%) 5 (16.7%)
Educational level, n (%) 
Low 3 (12.5%) 1 (3.3%) 0.04
Intermediate 14 (58.3%) 10 (33.3%)
High 7 (29.2%) 19 (63.3%)
Healthy dietary pattern, n (%)
Strong adherence 8 (32.0%) 19 (63.3%) 0.02
Poor adherence 17 (68.0%) 11 (36.7%)
Unhealthy dietary pattern, n (%)
Strong adherence 13 (52.0%) 14(46.7%) NS
Poor adherence 12 (48.0%) 16 (53.3%)
Diet (weight reducing; Yes), n (%) 1 (0.04%) 6 (20.7%) NS
Energy intake (kJ/day) 7935 (6053–8758) 8028 (6791–9881) NS
Folic acid supplement use (No) , n (%) 12 (48.0%) 5 (16.7%) NS
Vitamin supplement use (Yes), n (%) 7 (28.0%) 13 (43.3%) NS
Medication use (Yes), n (%) 11 (44.0%) 14 (46.7%) NS
Alcohol (Yes), n (%) 16 (64.0%) 14 (46.7%) NS
Smoking (Yes), n (%) 5 (20.0%) 7 (23.3%) NS
Physical exercise (No), n (%) 13 (52.0%) 10 (34.5%) a NS
Measurements
BMI (kg/m2) 31.0 (28.9-34.5) 24.6 (21.2-28.7) 0.000
<20, n (%) 0 (0.0%) 2 (6.7%) 0.004
≥20 <25, n (%) 2 (8.0%) 13 (43.3%)
≥25 <30, n (%) 7 (28.0%) 8 (26.7%)
≥30, n (%) 16 (64.0%) 7 (23.3%)
Waist circumference (cm) 93 (86-106) 83 (74-94) 0.001
Waist hip ratio 0.84 (0.82-0.86) 0.78 (0.73-0.82) 0.001
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Table 1 | (Continued)
 
HA-PCOS  
(n=25)
non HA-PCOS  
(n=30)
Biochemical Parameters
Cobalamin (pmol/L) 312.0 (246-419) 333.5 (260-460) NS
RBC Folate (nmol/L) 1108 (956-1223) 1238 (1082-1417) 0.03
Folate (nmol/L) 22.6 (14.8-36.1) 32.1 (26.0-45.40) 0.02
tHcy (µmol/L) 8.5 (7.3-9.9) 8.4 (7.3-9.0) NS
Poor (lower half ) or strong (upper half ) adherence based on ranking. Chi-square tests and Mann-Whitney U Tests were 
conducted to compare groups. Normal biochemical parameters; folate ≥8 nmol/L, red blood cell folate ≥500 nmol/L, 
cobalamin ≥145 pmol/L, homocysteine <15 µmol /L. PCOS, polycystic ovary syndrome; NS, not statistically significant.a One 
missing in physical exercise item; total n= 29.
Table 2 | Multivariable logistic regression analyses for the risk of hyperandrogenic polycystic ovary 
syndrome.
Β values OR 95% CI P value
Healthy dietary pattern
Model 1
Strong adherence (>p50)a -1.26 0.28 (0.09 to 0.88) 0.03
Energy intake (kJ/day) 0.00 1.00 (1.00 to 1.00) NS
Model 2 
Strong adherence (>p50) -1.31 0.27 (0.07 to 0.99) 0.047
Energy intake (kJ/day) 0.00 1.00 (1.00 to 1.00) NS
Age (years) -0.10 0.91 (0.75 to 1.11) NS
Body Mass Index 0.20 1.22 (1.07 to 1.39) 0.003
Unhealthy dietary pattern
Model 1
Strong adherence (>p50) 0.87 2.39 (0.56 to 10.26) NS
Energy intake (kJ/day) 0.00 1.00 (1.00 to 1.00) NS
Model 2 
Strong adherence (>p50) 1.10 3.01 (0.59 to 15.40) NS
Energy intake (kJ/day) 0.00 1.00 (1.00 to 1.00) NS
Age (years) -0.08 0.92 (0.77 to 1.12) NS
Body Mass Index 0.20 1.23 (1.08 to 1.40) 0.002
NS, not statistically significant. a Strong adherence is based on ranking (upper half ).
General characteristics of patients with poor or strong adherence to the healthy 
dietary pattern
The PCOS characteristics, stratified according to a poor or strong adherence to the healthy 
dietary pattern are presented in Supplementary Table 3. Women with poor adherence to the 
healthy pattern more often had hyperandrogenic PCOS than those with a strong adherence. 
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Table 3 | Patient characteristics according to the occurrence of ongoing pregnancy.a
  Ongoing Pregnancy 
(n= 24)
No Pregnancy
(n= 26)
P value
PCOS phenotype 
HA PCOS, n (%) 8 (33.3%) 15 (57.7%) NS
Non-HA PCOS, n (%) 16 (66.7%) 11 (42.3%)
Healthy dietary pattern
Strong adherence, n (%) 15 (62.5%) 9 (34.6%) 0.049
Poor adherence, n (%) 9 (37.5%) 17 (65.4%)
Unhealthy dietary pattern
Strong adherence, n (%) 10 (41.7%) 15 (57.7%) NS
Poor adherence, n (%) 14 (58.3%) 11 (42.3%)
Fertility treatment 
No 5 (20.8%) 4 (15.4%) NS
Yes 19 (79.2%) 22 (84.6%)
Weight reduction only 4 14
IUI 2 –
Ovulation induction 9 2
IVF 4 5
Vaso-vasostomy – 1
Time to pregnancy (days) 
Fertility treatment 415 (93-925) –
No fertility treatment 229 (63-797) –
Female Subfertility 
Primary 20 (83.3%) 17 (65.4%) NS
Secondary 4 (16.7%) 9 (34.6%)
Male subfertility (VCM <10) b 
Yes 5 (20.8%) 3 (14.3%) NS
No 19 (79.2%) 18 (85.7%)
Values are expressed as mean (range). Poor (lower half ) or strong (upper half ) adherence based on ranking. Chi-squared 
tests were conducted to compare groups. Dashes mean zero/not applicable. IUI, intrauterine insemination; NS, not 
statistically significant; PCOS, polylcystic ovary syndrome; VCM, volume × concentration × percentage progressively moving 
spermatozoa.
a Five patients were excluded; one unkown pregnancy outcome and four miscarriages b Five semen analyses were missing.
The anthropometric measurements, hormonal and metabolic assessments were comparable 
between the two groups except for AMH. The median AMH concentration was significantly 
higher in patients with a poor adherence to a healthy dietary pattern. Subsequently, 
multivariable linear regression analyses showed a significant inverse association between 
the adherence to the healthy dietary pattern and AMH concentration (β -0.57 g/L; p= 0.006; 
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95% CI -0.97 to -0.17), with adjustment for total energy intake. Additional adjustment for age 
and BMI, did not change this association (β -0.56; p= 0.008; 95% CI -0.97 to -0.15).
Clinical outcome parameters
Women with PCOS (hyperandrogenic and non-hyperandrogenic) and an ongoing pregnancy, 
more often strongly adhered to the healthy dietary pattern compared with non-pregnant 
women with PCOS (Table 3). When we applied multivariable logistic regression analysis, 
we observed a three-fold higher chance of ongoing pregnancy in patients with a strong 
adherence to the healthy pattern (OR 3.38; p= 0.049; 95% CI 1.01 to 11.36), which attenuated 
after adjustment for age and BMI (OR 3.09; p= 0.08; 95% CI 0.86 to 11.05). No association was 
found between the unhealthy pattern and the chance of ongoing pregnancy. In women with 
PCOS with an ongoing pregnancy, the number receiving fertility treatment for primary or 
secondary subfertility or male subfertility was comparable with nonpregnant women with 
PCOS. The androgenic profile of women with PCOS with hyperandrogenism and without 
hyperandrogenism are presented in Supplementary Table 4.
DISCUSSION
In this periconceptional cohort study, we observed that strong adherence to a healthy 
dietary pattern, comprising of fruits, vegetables, fish and whole grains, was associated with 
the non-hyperandrogenic PCOS phenotype and a lower AMH concentration. Moreover, 
hyperandrogenic and non-hyperandrogenic PCOS patients with strong adherence to a 
healthy dietary pattern also demonstrated a three-fold higher chance of ongoing pregnancy. 
These findings are in line with our recent study, in which we observed that dieting and diet 
inadequacy was associated with alterations in the 1-C pathway, contributing to the clinical 
spectrum of PCOS [144]. Patients with hyperandrogenic PCOS more often reported the use of a 
self-initiated diet than controls, and the use of an inadequate diet was associated with a higher 
risk of the hyperandrogenic phenotype. Diet inadequacy was also independently associated 
with the AMH concentration, suggesting a more significant role of gene-nutrient interactions 
affecting epigenetic mechanisms of multiple pathways regulating ovarian function during the 
course of life [20]. 
In a study estimating dietary intake with a 7-day food diary, Barr et al. observed a higher 
percentage energy from fat in PCOS patients compared with data of women participating 
in a national dietary survey [151]. Another study using the combination of a FFQ and a 4-day 
food diary did not observe differences in nutrient intake in women with PCOS compared 
with healthy control women. The intake of only high glycaemic foods, however, was assessed 
separately, and the PCOS group consumed significantly more white bread than controls [127]. 
Graff et al. also observed that, in PCOS, a high dietary glycemic index was associated with a 
less favourable anthropometric and metabolic profile [143]. No differences in the total energy 
intake were observed between HA and non-HA PCOS patients, although an overall increase 
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in energy intake with a higher diet quality in PCOS patients is previously reported [129]. In 
these observational studies, nutrient contents were compared instead of food groups. Food 
group analyses are easier to interpret and the derived dietary patterns are more suitable in 
communication with patients. More recently Moran et al. showed that women with PCOS 
were more likely to consume a Mediterranean dietary pattern compared with women without 
PCOS. This finding is supposed to be the effect of adopting a healthy dietary pattern after 
being diagnosed with PCOS [152]. Unfortunately PCOS phenotypes were not determined 
in this study and, to our knowledge, the present study is the first to observe associations 
between dietary patterns and the severity of the PCOS phenotype. Numerous studies have 
investigated the composition of the ideal PCOS weight loss diet to improve PCOS features, 
such as hyperandrogenism, cycle regularity, metabolic and psychiatric outcome, but so far the 
results are rather conflicting. These diets vary from high to low in carbohydrates, proteins, and 
fat or combinations of the previous [32,35-40]. 
Therefore, weight loss should always be accomplished by adequate intakes of healthy 
foods [33]. Our study showed alterations in biomarkers of 1-C metabolism in women with 
hyperandrogenism and PCOS, more specifically lower serum and red blood cell folate levels, 
whereas Hcy and cobalamin levels were comparable to women with non-hyperandrogenic 
PCOS. Other studies reporting lower Hcy levels in women with PCOS when folic acid 
supplements were used also observed an improvement in metabolic profile and biomarkers 
for oxidative stress [134,153,154]. This substantiates the involvement of 1-C metabolism, in 
which an inadequate intake of nutrients interferes with the metabolic profile of the PCOS 
phenotype. Moreover, we observed that a healthy diet, rich in B vitamins, may be a crucial 
factor associated with the hyperandrogenic phenotype; in fact it was recently shown that 
this phenotype constitutes the most severe metabolic phenotype in women with PCOS. The 
beneficial effect of a healthy diet on hyperandrogenism is supported by studies observing 
a decrease in FAI and testosterone [35,40,155]. Although we found comparable FAI and 
testosterone levels between the groups, others observed significant differences [32,37,38]. The 
association between dietary composition and an improvement in AMH has been described 
previously [107]. The latter observation might indicate a similar improvement in follicle 
dynamics. Women in this study who adhered more to the healthy diet showed an increased 
chance of becoming pregnant, which is in line with previous research showing beneficial 
effects of supplementation of B vitamins on levels of Hcy and consequently on pregnancy rate 
in women with PCOS undergoing infertility treatment [154]. 
This is also substantiated by previous research in subfertile women undergoing IVF–ICSI, in 
which a ‘Mediterranean’ diet containing high intakes of not only fruits and vegetables, but also 
vegetable oils increased vitamin B6 in blood and in follicular fluid and improved the chance of 
pregnancy after IVF–ICSI [8]. Nutrition and lifestyle counselling of couples planning pregnancy 
leads to an improved diet adequacy and also increases the chance of ongoing pregnancy [7, 
59]. 
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This emphasizes the importance of an adequate dietary intake in women planning pregnancy, 
but especially in those with PCOS. Although we have to keep in mind that increasing age and 
obesity might be stronger factors influencing pregnancy chance, as the chance of ongoing 
pregnancy was attenuated after adjustment of the multivariable logistic regression analysis. 
The present study has some limitations. Although all FFQs were checked for completeness, 
the FFQ estimates the consumption of the previous 4 weeks instead of recording the actual 
consumed foods during the periconceptional period of 14 weeks before until 10 weeks after 
conception [20]. 
An underestimation of dietary intake can occur in obese or overweighed patients [62], and 
the study population of women with PCOS were more obese than the excluded participants 
who did not have PCOS. All analyses were adjusted for BMI and total energy intake, although 
the intake could have been underestimated more in the hyperandrogenic phenotypes. In 
both groups, under-reporting occurred; however, we have to bear in mind that the minimum 
PAL of 1.35 is only plausible for individuals who have a stable bodyweight [150]. Furthermore, 
significant differences were found between the groups in ethnicity and educational level, 
although no significant correlation was found with the two dietary patterns. Further research 
is, therefore, necessary to investigate the effect of social and cultural factors. We could not use 
a control group of healthy individuals, which limits the generalizability of our results to other 
populations. Distinctive differences in food groups in the subfertile women with ovulatory 
disorders, tubal infertility or unexplained subfertility makes these women less appropriate to 
pool as control group for dietary pattern analyses. Overcorrection of the estimates would very 
likely occur when adjusting for all covariates caused by the limited sample size; therefore, we 
choose for adjustment of energy intake, BMI and age as most important covariates and are 
aware that residual confounding cannot be excluded.
Finally, all lifestyle factors were assessed at baseline and lifestyle changes during follow-
up could have influenced pregnancy chance as well. Some strengths of the study are the 
preconceptional recruitment and prospective design in one tertiary hospital setting, the 
sensitivity analysis showing no selection bias and the high response rate. The standardized 
diagnosis of PCOS according to the Rotterdam criteria limited the occurrence of measurement 
errors; similarly, all blood sampling and analysis were carried out in one laboratory following a 
standardized protocol, which further increased the validity of the data. Finally, the biomarkers 
of 1-C metabolism were used as extra validation of the FFQ data.
In conclusion we show that, in women with PCOS, strong adherence to a healthy dietary 
pattern is related to the non-hyperandrogenic phenotype and to an increased chance of 
ongoing pregnancy. Therefore, information on the importance of the diet and offering of 
validated interventions should be part of the initial assessment and treatment of women 
with PCOS. Future prospective studies in the general population should be conducted to 
further validate our findings and to investigate intergenerational effects of the diet in the 
developmental origin of PCOS in offspring.
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Supplementary Table 1 | Food group loadings for eligible dietary patterns.
First dietary  
pattern
Second dietary 
pattern
Third dietary 
pattern
Fourth dietary 
pattern
Variance explained a (%) 14.3% 10.3% 9.3% 9.1%
Initial Eigen value 3.290 2.374 2.135 2.087
Alcoholic Drinks 0.255 -0.228 -0.053 -0.190
Cereals 0.023 0.263 0.619 -0.229
Dairy -0.063 0.601 0.112 0.157
Eggs 0.315 -0.492 -0.160 -0.126
Fish -0.033 -0.138 0.156 -0.329
Fruits -0.320 -0.192 0.374 0.422
Legumes 0.233 0.091 0.560 -0.426
Mayonnaise 0.374 0.270 0.371 -0.337
Meat 0.322 0.317 -0.353 0.272
Non Alcoholic Drinks 0.054 0.323 0.103 0.324
Nuts -0.068 0.055 0.166 0.347
Potatoes 0.456 0.559 0.165 0.082
Sauces 0.586 -0.498 0.179 0.177
Snacks 0.551 0.390 -0.091 0.057
Soup -0.161 -0.242 0.176 0.277
Sugars 0.511 0.335 0.213 -0.015
Vegetables 0.037 -0.269 0.638 0.344
Solid fat 0.170 -0.098 -0.411 -0.197
Margarine 0.609 0.053 -0.252 0.424
Liquid fat 0.695 -0.102 -0.122 0.452
Vegetable Oils 0.314 -0.447 0.280 0.135
Refined Grains 0.749 -0.342 0.073 -0.345
Whole grains -0.161 -0.099 0.225 0.529
Extraction Method: Principal Component Analysis. aThe highest proportion of variance in total food consumption with the 
least loss of information per dietary pattern.
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Supplementary Table 2 | Participants in the Predict study.
  Included PCOS 
study participants 
with FFQ
(n= 55)
Excluded; PCOS 
study participants 
without FFQ 
(n= 26)
Excluded;  
non-PCOS study 
participants
(n= 372)
P value
Age (years) 29 (27-32) 27.5 (26-31) 32.0 (29.0-36.0) <0.001
Ethnicity, n (%) 
Dutch 36 (65.5) 15 (57.7) 225 (60.6) NS
Other 19 (34.5) 11 (42.3) 146 (39.4)
Educational level, n (%) 
Low 4 (7.4) 3 (12.0) 53 (14.6) NS
Intermediate 24 (44.4) 14 (56.0) 166 (45.6)
High 26 (48.1) 8 (32.0) 145 (39.8)
Diet (weight reducing; yes), n (%) 7 (13.0)a 5 (19.2%) 43 (11.7%)b NS
Folic acid supplement use (no), n (%) 17 (30.9) 12 (46.2) 129 (34.7) NS
Medication use (yes), n (%) 25 (45.5) 14 (53.8) 192 (51.6) NS
Alcohol (yes), n (%) 30 (54.5) 8 (30.8) 171 (46.0) NS
Smoking (yes), n (% 12 (21.8) 10 (38.5) 84 (22.6) NS
Physical exercise (no), n (%) 23 (42.6)c 13 (52.0)d 162 (44.0)e NS
Measurements
Body mass index (kg/m2) 28.6 (22.9-33.3) 26.3 (22.6-34.2) 24.6 (21.8-28.3) 0.001
<20, n (%) 2 (3.6) 1 (3.8) 34 (9.2) 0.003
≥20 <25, n (%) 15 (27.3) 9 (34.6) 161 (43.5)
≥25 <30, n (%) 15 (27.3) 6 (23.1) 104 (28.1)
≥30, n (%) 23 (41.8) 10 (38.5) 71 (19.2)
Waist circumference (cm) 87 (77-99) 86 (78-98) 81 (73-90) 0.001
Waist-hip ratio 0.81 (0.76-0.85) 0.82 (0.77-0.88) 0.78 (.74-0.84) 0.025
Biochemical parameters
Cobalamin (pmol/L) 333 (249-449) 356 (290-514) 328 (250-437) NS
RBC folate (nmol/L) 1158 (1027-1353) 1235 (954-1454) 1213 (955-1427) NS
Folate (nmol/L) 31.0 (20.6-45.4) 24.8 (15.9-36.0) 31.2 (18.6-42.7) NS
Homocysteine (µmol/L) 8.5 (7.3-9.4) 8.0 (7.1-9.4) 8.2 (6.9-9.7) NS
Values are expressed as median (interquartile range) or number (%). Chi-squared and Kruskal-Wallis tests were conducted to 
compare groups. Onea and threeb items missing for diet, and onec, oned and foure items missing for physical exercise. Normal 
biochemical parameters: folate ≥8 nmol/L, RBC folate ≥500 nmol/L, cobalamin ≥145 pmol/L, homocysteine <15 µmol/L. NS, 
not statistically significant; PCOS, polycystic ovary synrome; RBC, red blood cell. 
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Supplementary Table 3 | Characteristics of PCOS patients with a poor or strong adherence to the 
healthy dietary pattern
  Poor adherence to a 
healthy dietary pattern
 (n= 28)
Strong adherence to a 
healthy dietary pattern 
(n= 27)
P value
PCOS phenotype, n(%)
HA PCOS 17 (60.7%) 8 (29.6%) 0.02
Non-HA PCOS 11 (39.3%) 19 (70.4%)
Hyperandrogenism , n(%) 17 (60.7%) 8 (29.6%) 0.02
Ovulatory dysfunction, n(%) 28 (100%) 26 (96.3%) NS
Polycystic ovarian morphology, n(%) 26 (92.9%) 27 (100%) NS
Measurements NS
BMI (kg/m2) 29.0 (24.3-34.0) 27.7 (22.6.7-32.9) NS
Waist circumference (cm) 86 (83-100) 88 (74-98) NS
Waist-Hip ratio 0.82 (0.78-0.85) 0.80 (0.74-0.85) NS
RR Systolic 110 (107-122) 112 (109-125) NS
RR Diastolic 71 (70-80) 75 (70-82) NS
Hormonal Parameters
AMH (µg/L) 8.30 (6.20-13.59) 5.90 (3.30-7.30) 0.008
FSH (U/l) 5.45 (4.10-7.60) 5.30 (4.30-6.60) NS
LH (U/l) 6.95 (5.15-10.25) 5.80 (4.30-13.70) NS
Progesterone (nmol/l) 1.10 (0.65-2.45) 1.00 (0.60-4.90) NS
17- hydroxyprogesterone (nmol/l) 2.35 (1.50-3.40) 2.00 (1.50-5.70) NS
Estradiol (pmol/L) 198.50 (170.50-261.50) 166.00 (110.00-390.00) NS
SHBG (nmol/l) 39.55 (21.90-61.45) 41.10 (33.70-70.40) NS
Testosterone (nmol/l) 1.46 (1.20-2.00) 1.50 (1.00-1.90) NS
FAI 5.15 (2.32-6.47) 3.70 (1.78-4.61) NS
Androstenedione (nmol/l) 11.20 (7.49-14.35) 8.44 (5.64-12.10) NS
DHEAS(µmol/L) 4.93 (3.26-6.20) 4.26 (3.31-5.54) NS
Metabolic Parameters
Insulin (pmol/l) 41.50 (19.00-89.50) 43.00 (18.00-86.00) NS
Glucose (mmol/l) 4.90 (4.65-5.20) 4.80 (4.60-5.20) NS
HOMA-IR 1.50 (0.66-3.31) 1.37 (0.61-3.10) NS
Note: Values are expressed as median (interquartile range). Poor (lower half ) or strong (upper half ) adherence based on 
ranking. Mann Whitney U Tests were conducted. NS, not statistically significant.
Abbreviations; HA = Hyperandrogenic; FSH = Follicle Stimulating Hormone; LH = Luteinizing Hormone; SHBG = Sex 
Hormone Binding Globulin; FAI = Free Androgen Index; DHEAS = dehydroepiandrosterone sulfate; HOMA-IR = homeostatic 
model assessment – insulin resistance.
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Supplementary Table 4 | The androgenic profile of the women enrolled.
Hyperandrogenic PCOS 
(n= 25)
Non-hyperandrogenic PCOS  
(n= 30)
Hormonal parameters
SHBG (nmol/l) 24.20 (19.10-38.80) 62.50 (40.30-77.60)
Testosterone (nmol/l) 1.70 (1.30-2.20) 1.25 (1.00-1.70)
FAI 6.22 (5.26-7.38) 2.32 (1.70-3.49)
Androstenedione (nmol/l) 11.30 (8.96-14.90) 8.09 (5.74-11.90)
DHEAS (µmol/L) 5.40 (3.94-6.51) 4.09 (3.01-5.18)
Definition of hyperandrogenism 
Ferriman–Gallwey score ≥9 8 –
FAI >4.5 23 –
Values are expressed as median (interquartile range) or number. Abbreviations; DHEAS = dehydroepiandrosterone sulphate; 
FAI =  Free Androgen Index; PCOS = polycystic ovary syndrome; SHBG = sex hormone binding globulin.
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ABSTRACT 
Introduction
Gastric acid-related symptoms are highly prevalent in the general population (21-40%) and 
more than 11% of individuals use medication for the treatment of these symptoms. The uptake 
of micronutrients is dependent on the gastrointestinal potential of hydrogen (pH). 
Objective
We hypothesized that medication affecting the gastrointestinal pH reduces the availability of 
B vitamins thereby deranging 1-C metabolism and detrimentally affecting spermatogenesis. 
Methods
This explorative nested case-control study in men of subfertile couples investigated 
associations between medication used for gastric acid-related symptoms and semen 
parameters. We included 40 men using medication for gastric acid-related symptoms and 
843 men not using medication. Semen analyses were performed between 70 days before and 
21 days after the visit.
Results
The use of medication was associated with a twofold higher risk of a low total motile sperm 
count (TMSC <1x106, OR 2.090, p= 0.049) and negatively with sperm concentration (β -0.320, 
p= 0.028). Red blood cell folate was positively associated with TMSC (β 0.257, p= 0.026), sperm 
count (β 1.679, p= 0.013) and ejaculate volume (β 0.120, p= 0.023) and total homocysteine was 
negatively associated with sperm count (β -0.077, p= 0.021). 
Conclusion
Here we delineate associations between the use of medication for gastric acid-related 
symptoms and poor semen quality in men of subfertile couples. The use of medication for 
gastric acid-related symptoms is associated with a twofold higher risk of a low TMSC and 
a decreased sperm concentration. Although these findings warrant further research on 
causality, the associations between folate, tHcy and semen quality emphasize the importance 
of preconception counselling in male subfertility.
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INTRODUCTION
Around 15% of couples are subfertile -pregnancy not achieved after 1 year of unprotected 
intercourse- of which half remain involuntarily childless [3]. In 45% the cause can be attributed 
to a male factor [156]. To contribute to future treatment and prevention of male subfertility it is 
of great importance to investigate causes and the underlying pathophysiology.
In 20-40% of the general population gastric acid-related symptoms are present, and in about 
11% medication is used [157,158]. However, its impact on semen parameters has scarcely been 
studied. Antacids, proton-pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs) induce 
a prolonged increase in gastric pH, impairing the gastro intestinal absorption of nutrients, 
including folate and cobalamin, these being essential for spermatogenesis [12,159,160]. 
B vitamin shortages derange 1-C metabolism and induce hyper-homocysteinemia, which 
causes excessive oxidative stress and interferes with biological processes and DNA structures 
[20]. 
Seminal plasma folate, cobalamin and total homocysteine (tHcy) are associated with the 
sperm DNA fragmentation index and sperm concentration [45,46]. This is supported by 
the detrimental effects of poor nutrition and beneficial effects of a healthy diet, on sperm 
parameters [9,45,161]. In addition, folic acid and zinc supplements increase sperm count, 
concentration and seminal plasma folate concentration [45,50,162]. 
Therefore this explorative study aims to investigate whether the use of medication for 
gastric acid-related symptoms is associated with semen parameters and biomarkers of 1-C 
metabolism in men of subfertile couples.
MATERIALS AND METHODS
Study design
Between 2007 and 2012, couples contemplating pregnancy and visiting the outpatient clinic 
of the department of Obstetrics and Gynaecology at the Erasmus MC, University Medical 
Center in Rotterdam, The Netherlands, were offered preconception counselling. 
These couples were referred because of subfertility, i.e. when pregnancy is not achieved 
after 1 year of unprotected intercourse [3]. Men were invited to participate in the study and 
completed a self-administered questionnaire to obtain data on medication use (type, dosage 
and frequency), smoking (yes/no), use of alcohol (yes/no), recreational drugs (yes/no) and 
folic acid supplements (yes/no). At the visit the questionnaires were verified by a trained 
counselor, and height and weight were measured to calculate body mass index (BMI kg/m2). 
The information on nutrition and lifestyle was screened for risk factors, and individual advice 
on inadequacies was given during the visit. Men who provided written informed consent and 
a semen analysis between 70 days before and 21 days after the visit were included in the 
study. This window was defined because it covers 3 months of spermatogenesis during which 
medication use was assessed and reduces confounding by counselling. We excluded men with 
semen samples provided by microsurgical epididymal sperm aspiration (MESA), percutaneous 
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epididymal sperm aspiration (PESA) or retrograde ejaculation. Men with incomplete data and 
men using other medication for gastric acid-related symptoms were excluded as well.
Semen sample collection and analysis
Semen analyses were performed on the clinical indication of subfertility and these data were 
obtained from medical records. The examination and processing were performed before 2010 
according to the fourth edition of the World Health Organization (WHO) laboratory manual 
and afterwards according to the fifth edition [163,164]. Men received a leaflet with instructions 
on how to provide a semen sample. The obligatory abstinence period for producing a semen 
sample was 3-5 days. The sample had to be collected in a non-toxic plastic container provided 
by the laboratory and had to be delivered within 1 h of production at the outpatient clinic 
of the Division of Reproductive Medicine at the Erasmus MC, University Medical Center, 
Rotterdam, The Netherlands. To avoid large changes in temperature, the semen sample had to 
be kept at ambient temperature during transport [165]. 
After liquefaction the following sperm parameters were assessed by using a Zeiss microscope 
(Carl Zeiss, Oberkochen, Germany): ejaculate volume (normal range: >2.0 mL); sperm 
concentration (normal range: >20x106 sperm/mL); and percentage of motile and immotile 
spermatozoa (normal range: >50% with grade A+B motility). Sperm concentration was 
determined with an improved Neubauer Hemocytometer counting chamber. Total sperm 
count was calculated as the product of ejaculate volume and sperm concentration. Sperm 
motility parameters type A (rapid progressive motility); type B (slow or sluggish progressive 
motility); type C (local motility); and type D (immotility) were assessed at 37°C. Total Motile 
Sperm count (TMSC) was calculated as the product of ejaculate volume, sperm concentration 
and grade A+B motility. A total motile sperm count <1x106 was defined as low because it 
represents severe oligoasthenoteratozoospermia [166,167]. All semen analyses were performed 
in one center and laboratory which participates in the external quality control scheme of the 
Dutch Foundation for Quality Assessment in Clinical Laboratories (SKML). The staff performing 
these analyses are trained and tested annually according to the certified ESHRE course for 
performing semen analyses. 
The laboratory of the Erasmus Medical Center received the certification of the International 
Organization for Standardization (ISO9001), the international standard for quality 
measurement. The between technician variation for sperm concentration was 1.6% (Intra class 
correlation coefficient (ICC) 0.992, 95 % CI 0.978 to 0.997). The between technician variation for 
sperm motility was 2.4% (ICC 0.988, 95% CI 0.972 to 0.996).
Biomarkers
At the preconception visit, venous blood samples were drawn in a vacutainer ethylenediamine 
tetraacetate (EDTA) tube for the determination of red blood cell (RBC) folate and plasma 
tHcy; for serum folate and cobalamin, a dry vacutainer tube (BD diagnostics, Plymouth, 
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UK) was used. EDTA-blood was kept on ice and plasma was separated by centrifugation 
within one hour for determination of tHcy. Immediately after blood sampling, 0.1 ml EDTA 
blood was hemolysed with 0.9 ml freshly prepared 1.0% ascorbic acid. The haematocrit 
in EDTA blood was determined on an ADVIA 120 Hematology Analyzer (Bayer Diagnostics, 
Leverkusen, Germany). The hemolysate was centrifuged for 5 minutes at 1000 xg after 
which folate was measured in the hemolysate. RBC folate was calculated with the following 
formula: (nM haemolysate folate × 10/haematocrit) – [nM serum folate × (1- haematocrit) /
haematocrit] = nM RBC folate. tHcy was determined using a sensitive liquid chromatography 
tandem mass spectrum method (HPLC-Tandem MS, Waters Micromass Quattro Premier XE 
Mass Spectrometer with Acquity UPLC system, Milford, Massachusetts, United States). Blood 
obtained in dry vacutainer tubes was centrifuged at 2,000 xg, serum was collected and during 
routine laboratory procedures analyzed using an immunoelectro-chemoluminescence assay 
(E170; Roche Diagnostics GmbH, Mannheim, Germany). Inter-assay coefficients of variation 
for serum folate were 4.5% at 13 nmol/L and 5.7% at 23 nmol/L, for serum cobalamine 3.6% at 
258 pmol/L and 2.2% at 832 pmol/L and for plasma tHcy were 4.8% at 14.6 μmol/L and 3.3% 
at 34.2 μmol/L.
Statistical analyses
Chi-Squared tests and Mann-Whitney U tests were performed to evaluate differences between 
the groups. To perform linear and logistic regression analyses, a normal distribution of the 
sperm parameters was achieved with root transformation of ejaculate volume and sperm 
count, and fourth root transformation of TMSC and sperm concentration. Univariable and 
multivariable linear and logistic regression models were applied to study associations between 
medication use and sperm parameters. For the univariable linear regression analyses of sperm 
parameters, RBC folate was assessed in pmol/L for better interpretation of the estimate 
(pmol/L= nmol/Lx103). Age, ethnicity, smoking and alcohol use were selected as potential 
confounders based on associations with semen parameters. The cut off concentration for 
serum folate of ≥22.5 nmol/L was used to confirm folic acid supplement use [168]. Statistical 
analyses were performed using SPSS software for Windows (version 21.0, IBM SPSS, Statistics 
for Windows, Armonk, NY: IBM Corp) with a level of significance of 0.05.
RESULTS
A total of 2255 men visiting the preconception outpatient clinic were eligible for participation, 
from whom we excluded 137 who did not provide written informed consent and 846 who did 
not provide a semen analysis between 70 days before and 21 days after the visit. From the 
remaining 1272 men, we excluded 23 with MESA, PESA or retrograde ejaculation samples, 
ten with incomplete data, 329 using any other medication and 27 without information on 
medication use. This resulted in the analysis of 883 men, of whom 40 used medication for 
gastric acidrelated symptoms (PPIs n= 34, antacids n= 3, and H2RAs n= 3), and 843 controls 
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not using any medication. Of the 40 medication users, the use was daily in 29 men, weekly 
in two men and when needed in seven men. This data was missing in two men. General 
characteristics of included (n= 883) and excluded (n= 1235) men of subfertile couples are 
presented in Supplemental Table 1. All characteristics were comparable between the groups 
except a slightly lower age (34 y vs. 35 y, p= 0.003) and higher percentage of no medication 
use in the study population (95.5% and 52.6% non-users, p <0.001) inherent to the selection. 
Table 1 shows the general characteristics of medication users (n= 40) and controls (n= 843). 
In medication users, age was significantly higher (38 and 34 years, p= 0.002) and alcohol and 
drug use was lower than in controls (55% and 71%, p= 0.031 and 0.0% and 7.7%, p= 0.029 
respectively). Serum and RBC folate tended to be higher and cobalamin and tHcy tended to be 
lower in medication users, albeit not significantly. The abstinence period and time to semen 
analysis were comparable between the groups. All sperm parameter values were slightly 
but not significantly lower in medication users except for a higher ejaculate volume (3.4 
and 2.8 mL, p= 0.036). Figure 1 depicts the median values and interquartile ranges of sperm 
concentration, TMSC and sperm motility.
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Figure 1 | A Sperm concentration (p= 0.090), B total motile sperm count (p= 0.209) and C motility 
(A+B%) (p= 0.095) in men using medication for gastric acid-related symptoms (n= 40) and controls 
(n= 843).
The Box plots display the 25th and 75th percentile, the horizontal line marks the median value and the 
whiskers extend to the minimum and maximum observations that are within 1.5 times the interquartile 
range
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Table 1 | General characteristics of the study population of men of subfertile couples visiting the 
preconception outpatient clinic.
 
Users of medication for gastric  
acid-related symptoms  
(n= 40)
Controls
 
(n= 843)
Age (years) 38 (34-42)** 34 (30-39)
BMI (kg/m2) 25.9 (23.4-29.3) 26.1 (23.9-28.6)
Ethnicity (Dutch) 24 (60.0%) 533 (63.5%)
Previous child (Yes) 9 (23.7%) 157 (19.4%)
Stress (Yes) 5 (15.6%) 99 (13.1%)
Smoking (Yes) 17 (42.5%) 281 (33.4%)
Alcohol (Yes) 22 (55.0%)* 597 (71.0%)
Recreational drugs (Yes) 0 (0.0%)* 65 (7.7%)
Folic acid supplement use (Yes) 11 (28.9%) 175 (22.6%)
Biochemical Parameters
Folate (nmol/L) 17.6 (12.6-25.0) 17.2 (13.4-21.8)
RBC Folate (nmol/L) 987 (828-1109) 952 (779-1126)
Cobalamin (pmol/L) 279 (240-399) 299 (239-381)
tHcy (µmol/L) 11.0 (9.7-13.5) 11.5 (9.7-13.5)
Sperm Parameters
Sperm count (106/ejaculate) 58.6 (8.4-119.6) 66.3 (20.7-147.6)
Ejaculate volume (mL) 3.4 (2.4-4.2)* 2.8 (1.8-3.9)
Sperm concentration (106/mL) 20 (3-46) 26 (9-59)
Sperm motility (A+B%) 32 (11-47) 39 (23-49)
Total motile sperm count (106/ejaculate) 20.3 (0.8-51.3) 25.2 (4.2-68.9)
Abstinence period (days) 4 (3-5) 4 (3-6)
Time to semen analysis (min) 40 (25-55) 45 (30-60)
Values are expressed as median (IQR) or number (%); Chi Square and Mann Whitney Tests were performed: * = p <0.05 
** = p <0.01; 
Abbreviations; BMI = Body Mass Index; RBC Folate = Red Blood Cell Folate; tHcy = homocysteine. Normal range biochemical 
parameters; Folate ≥8 nmol/L, RBC folate ≥500 nmol/L, Cobalamin ≥145 pmol/L, tHcy <15 µmol/L.
Being a Dutch native was associated with a lower sperm concentration (β -0.128, 95% CI -0.23 
to -0.02, p= 0.016) and a higher ejaculate volume (β 0.126, 95% CI 0.07 to 0.18, p <0.001). 
Smoking was negatively associated with TMSC (β -0.173, 95% CI -0.30 to -0.05, p= 0.008), 
sperm count (β -1.138, 95% CI -1.88 to -0.40, p= 0.003) and ejaculate volume (β -0.093, 95% CI 
-0.15 to -0.04, p= 0.001). Alcohol use was positively associated with sperm motility (β 2.506, 
95% CI 0.26 to 4.75, p= 0.029), TMSC (β 0.130, 95% CI 0.001 to 0.26, p= 0.048) and ejaculate 
volume (β 0.069, 95% CI 0.01 to 0.13, p= 0.020). Age, BMI, folic acid supplement use and drug 
use were not significantly associated with sperm parameters.
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Table 2 presents associations between medication for gastric acid-related symptoms and a 
decreased sperm concentration (β -0.311, SE 0.144). Backwards transformation to the original 
scale, resulted in a decrease in sperm concentration of 10.5x106/mL in medication users. 
Moreover a two-fold higher risk of low total motile sperm count was observed in medication 
users (unadjusted OR 2.158, 95% CI 1.05 to 4.43, p= 0.036). After adjustment for smoking this 
risk slightly increased (OR 2.161, 95% CI 1.05 to 4.44, p= 0.036). Additional adjustment for 
alcohol use, age and ethnicity slightly attenuated the risk estimate (OR 2.090, 95% CI 1.00 to 
4.35, p= 0.049). Adjustment of the latter model for the WHO manual edition did not affect the 
results (OR 2.148, 95% CI 1.02 to 4.48, p= 0.042). The multivariable linear regression analysis 
showed the same (β -0.323, SE 0.146, p= 0.027).
Univariable linear regression analyses revealed positive associations between RBC folate 
(pmol/L) and TMSC (β 0.257, 95% CI 0.03 to 0.48, p= 0.026), sperm count (β 1.679, 95%CI 0.35 
to 3.01, p= 0.013) and ejaculate volume (β 0.120, 95%CI 0.02 to 0.22, p= 0.023). tHcy was 
negatively associated with sperm count (β -0.077, 95% CI -0.14 to -0.01, p= 0.021). Serum folate 
and cobalamin were not associated with any sperm parameter.
DISCUSSION
This explorative study shows that use of antacids, PPIs and H2RAs is associated with impaired 
semen parameters in men of subfertile couples visiting a tertiary hospital in the Netherlands. 
These medication users showed a decreased sperm concentration and a two-fold higher risk 
of low TMSC. 
The strengths of the study are the standardized semen sample collection and semen analyses 
in a single and qualified laboratory center, thereby limiting risks of methodological and 
measurements errors. Protocols were used by trained counselors for data collection, verification 
of medication use in a defined window, and measurements. To exclude selection bias we also 
showed that general characteristics were largely comparable in included and excluded men. 
Weaknesses are, firstly, that due to the small sample sizes, the individual medicines (PPIs, H2RAs 
and antacids) could not be evaluated, and, secondly, confounding by indication, because in 
all medication users gastro intestinal symptoms were present. Although no abnormal semen 
parameters were shown in men with digestive diseases, these issues have to be addressed in 
future research [169]. Under-reporting of medication use is an issue to be considered, because 
previous research reported that 11% of Dutch men and women used medication for gastric 
acid-related symptoms, which is much higher than the 5% in our study [157]. Because these 
medicines are also available over-the-counter, a validation through pharmacy databases was 
not possible. In addition, frequency of medication use, but not duration of use, was taken into 
account, which is a limitation but compensates the reliability of current use. Therefore this 
study can also not assess the -although very unlikely- harmful pharmacological effects of a 
single dose on semen quality.
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One semen sample of each man was available which does not account for intra-individual 
variation of semen parameters. Residual confounding by a sedentary lifestyle, sauna visits, 
nutritional behavior or incompleteness of the sample collection cannot be excluded as well and 
has to be addressed in future [170,171]. Confounding however was reduced by selecting semen 
samples only in a strictly defined window which was independent of exposures and bias due 
to the exclusion of conditions affecting semen parameters, i.e. varicoceles or cryptorchidism. 
Our findings are supported by Hayashi et al who reported that quitting or switching H2RAs 
improved semen quality [172]. Others have shown a reduction in sperm viability in a dose- and 
time-dependent manner, when liquefied semen samples were exposed to H2RAs [173]. Both 
Ranitidine and Cimetidine were considered to be acting as anti-androgens, but only the use 
of cimetidine impaired hypothalamic-pituitary-gonadal function [174]. Ranitidine, the only 
H2RA reported in our study, did not bind to androgen receptors or influence basal serum 
concentrations of testosterone, luteinizing hormone, follicle stimulating hormone or prolactin 
in fertile men. The mean sperm count decreased during Ranitidine treatment, although this 
difference was not significant [175]. The higher ejaculate volume in medication users is new 
and so far cannot be explained by a pharmacological mechanism of action. Our previous 
study investigating the effect of the duration of PPIs only on semen quality substantiates the 
potential harmful effects observed in this study. A three-fold higher risk of a low TMSC was 
observed in men visiting the general practitioner when PPIs were used between 12 and 6 
months preceding semen analysis, suggesting that a long-term increase in gastric pH results 
in a decline of sperm quality [176].
Detrimental effects of BMI, age or alcohol consumption on semen quality were not observed. 
This may be due to the small variation of these conditions and effect estimates relative to the 
large variations in sperm parameters. Our studies and that of others reported that obesity 
or central adiposity are associated with impaired sperm motility, ejaculate volume, sperm 
concentration, TMSC [57,177] and azoospermia or oligozoospermia [178]. The latter study also 
reported no differences in sperm concentration across BMI categories. Age above 60 has been 
associated with a raised sperm DNA fragmentation index, but similar to our results, was not 
significantly associated with other sperm parameters [179]. The association between alcohol 
use and semen parameters is not substantiated by the rather conflicting literature and is 
complicated because the majority of men in this study used alcohol [180-184]. In addition, 
smoking negatively influenced TMSC, ejaculate volume and sperm count, which is in line 
with studies of others [185,186]. From these data we conclude that differences in general 
characteristics of the study populations, sample sizes, precision of exposure assessment, and 
the effects at the extremes of conditions only (BMI >30, excessive alcohol consumption) might 
explain the differences in associations between BMI, age, alcohol use and sperm parameters. 
Associations between the biomarkers of 1-C metabolism RBC folate, tHcy and semen quality 
are in line with our studies and that of others [45,46,187]. Moreover, these observations are 
supported by studies demonstrating associations between folate intake by supplements or 
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food and semen quality [161,188]. A traditional Dutch diet is positively associated with RBC 
folate and with sperm concentration, and a diet rich in fruits and vegetables is negatively 
associated with seminal plasma tHcy and sperm DNA fragmentation index (DFI) [9,45]. In 
our study, the slightly lower cobalamin level in medication users did not differ significantly 
from non-users. This may be explained by a higher percentage of vitamin supplement users 
in medication users resulting in higher serum and RBC folate, albeit not significantly, and the 
small sample size. The use of folic acid supplements was not associated with semen quality 
and therefore not included in the multivariable analyses [45,50,161,162]. This is very likely due 
to the limited folic acid supplement use in our study. 
CONCLUSION
The use of medication for gastric acid-related symptoms is associated with impaired semen 
parameters in men of subfertile couples contemplating pregnancy. These first findings have 
to be interpreted with caution and emphasize the need for further research on causality and 
awareness of potential detrimental effects of medication for gastric acid-related symptoms on 
semen quality. 
Supplemental Table 1 | General characteristics of the study population and the excluded population.
 
 
Study population
(n= 883)
Excluded population
(n= 1235)
Age (years) 34 (30-39) 35 (30-40)**
BMI (kg/m2) 26.1 (23.9-28.6) 26.3 (23.9-29.0)
Ethnicity (Dutch) 557 (63.4%) 735 (60.9%)
Smoking (Yes) 298 (33.8%) 378 (31.1%)
Alcohol (Yes) 619 (70.3%) 842 (69.2%)
Recreational drugs (Yes) 65 (7.4%) 101 (8.3%)
Folic acid supplement use (Yes) 186 (22.9%) 252 (23.6%)
Medication use 
No 843 (95.5%) 631 (52.6%)**
Medication for gastric acid-related symptoms 40 (4.5%) 27 (2.3%)
Other – 542 (45.2%)
Biochemical Parameters
Folate (nmol/L) 17.2 (13.4-21.8) 17.4 (13.7-22.1)
RBC Folate (nmol/L) 956 (783-1124) 962 (807-1134)
Cobalamin (pmol/L) 298 (239-383) 301 (238-390)
tHcy (µmol/L) 11.5 (9.7-13.5) 11.3 (9.6-13.6)
Values are expressed as median (IQR) or number (%); Chi Square and Mann Whitney Tests were performed: ** = p <0.01; 
Abbreviations; BMI = Body Mass Index; RBC Folate = Red Blood Cell Folate; tHcy = homocysteine. Normal range biochemical 
parameters; Folate ≥8 nmol/L, RBC folate ≥500 nmol/L, Cobalamin ≥145 pmol/L, tHcy <15 µmol/L.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 102
Nicole A. Huijgen
Maria A.J. de Ridder
Katia M. Verhamme
Gert R. Dohle
Ann M. Vanrolleghem
Miriam C.J.M. Sturkenboom
Joop S.E. Laven
Régine P.M. Steegers-Theunissen
Fertility and Sterility 2016; 0015-0282, http://dx.doi.org/10.1016/j.fertnstert.2016.09.010
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 103
C h a p t e r 7
Are proton-pump inhibitors harmful for the 
semen quality of men in couples who are 
planning pregnancy?
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ABSTRACT 
Objective
To determine associations between proton-pump inhibitor (PPI) use and semen parameters in 
young men of couples who are planning pregnancy.
Design 
Case-control study of a population-based registry. General practitioner patients comprising 
2,473 men from couples planning pregnancy with a recorded semen analysis: 241 with a low 
total motile sperm count (TMSC ≤1) and 714 with TMSC >1 as matched controls.
Main Outcome Measure(s) 
Exposure to PPI; PPI dosage.
Result(s) 
The study of data from between 1996 and 2013 from the Integrated Primary Care Information 
database in the Netherlands, which incorporates the medical records of 1.5 million patients 
from 720 general practitioners, found that the use of PPIs in the period between 12 and 
6 months before semen analysis was associated with a three-fold higher risk of low TMSC 
(odds ratio 2.96; 95% confidence interval 1.26-6.97) adjusted for age and other medication. 
Use of PPIs during the 6 months immediately before the semen analysis was not statistically 
significantly associated with low TMSC.
Conclusion(s)
The use of PPIs in the period 12 to 6 months preceding semen analysis is associated with a three-
fold higher risk of low TMSC, which suggests that a long-term increase in gastric pH results in a 
decline of sperm quality. This finding emphasizes the need for more preconceptional research 
and counseling on the potential effects of medication use on semen quality.
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INTRODUCTION
In one out of ten couples, pregnancy is not achieved after one year of unprotected intercourse 
[3,189]. Subfertility is a major burden affecting 48.5 million people worldwide and in a 
considerable number a male factor is involved [156]. A method for quantifying the severity 
of male factor subfertility is the assessment of sperm parameters, among which total motile 
sperm count (TMSC) is a reliable parameter for predicting the chance of a spontaneous 
ongoing pregnancy [190]. The observed continuous decline in sperm quality over the last 
decades has been worrisome, as it seems to be related to increased exposure to endocrine 
disruptors, unhealthy lifestyles, obesity, and increased age [179,191,192]. Health status declines 
accompany aging, which goes together with an increase in medication use. In the Netherlands 
the use of prescribed medication in men between 20 and 25 years of age is 18.7%, and rises to 
52.9% by the ages of 55 to 65 years [193]. 
Proton-pump inhibitors (PPIs) are the most commonly used medication for gastro-
oesophageal reflux disease and peptic ulcer disease. Its prevalence is 26.9% in men and 
women with gastrointestinal symptoms and 5% in those without gastrointestinal symptoms 
[157]. In comparison with H2-receptor antagonists (H2RAs) and antacids, PPIs are most 
effective in decreasing gastric acidity [194]. A strong disulfide bond, binding irreversibly to 
the hydrogen-potassium ATPase pump, leads to a specific inactivation of the enzyme, which 
results in a long-lasting impairment of gastric acid secretion [195]. 
The increase in pH that accompanies PPI use reduces the uptake of B vitamins, which are essential 
for biologic processes involved in DNA synthesis and cellular growth and development such as 
spermatogenesis [12,45,46]. Thus, patients on long-term PPI treatment should be periodically 
screened for nutrient deficiencies [12,160]. The other suggested adverse effects of PPIs are 
direct gonadotoxic effects and interactions with the hypothalamic-pituitary-gonadal axis. To 
explore these effects further, we examined whether the use of PPIs is associated with impaired 
semen quality in a population based study of men in couples who are planning pregnancy 
and have been visiting a general practitioner.
MATERIALS AND METHODS
Design
Our case-control study was conducted using the Dutch Integrated Primary Care Information 
(IPCI) database. The IPCI database, which consists of medical records of 1.5 million patients 
from 720 general practitioners (GPs) spread across the Netherlands, is validated to be used 
for pharmacoepidemiologic research [196]. It complies with European Union guidelines on 
the use of data for medical research. More details concerning the IPCI-database have been 
provided elsewhere [197]. 
Patients who visited a GP between 1996 and 2013 are registered in the IPCI database with 
anonymous longitudinal information (coded and in free text) on age, symptoms, test results, 
disease outcome, referrals, and prescription data. The database comprises all men with at 
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least 12 months of data registered before the study period (1996 and 2013). We extracted 
additional information on obesity, weight, smoking, and the use of alcohol in the period of 
15 months preceding the visit until the day of the semen analysis by using search codes and 
text strings. From the prescription files we extracted data on dosage, frequency, and duration 
of medication use in the same time window based on the Anatomical Therapeutic Chemical 
(ATC) classification system. The Scientific Advisory Board of the IPCI Project approved the study
protocol and use of IPCI data (Project number: 01/13).
Study population 
A study cohort was selected of men aged ≥18 years during the study period and found via one 
of the following search codes; ‘A97.02’ (wish to become parents), ‘Y10’ (male sub/infertility), 
‘W15’ (female sub/infertility), or the additional text strings ‘sperm’, ‘semen’, ‘ferti’, ‘androl’, and 
‘YS’ (the text code for semen analysis). Records including the text ‘vasectomy’, ‘sterilisation’, 
‘spermatocele’, ‘hematospermia’, or ‘epididymitis’ in the same notation were automatically 
excluded. Every medical record was manually validated and the semen analysis data were 
extracted. The manual review excluded the false hits such as patients without semen analysis 
data or without the wish to become parents. In the study population we only included men in 
couples who were planning a pregnancy and with a recorded semen analysis at the first visit 
(Table 1). We excluded men with a history of testicular surgery, chemotherapy or radiotherapy, 
congenital absence of the vas deferens, varicocele, or who had an incomplete or unreliable 
semen analysis (for example, due to fever). Subsequently, we excluded men without any 
recorded prescription data or with an incomplete medication history (Figure 1).
Cases and controls
Cases were defined as men with a low TMSC ≤1 which is the clinical diagnosis of severe 
oligoasthenoteratozoospermia [167]. All men with a TMSC >1 were selected as controls and 
were matched with cases managed by the same GP.
 
Proton-pump inhibitor exposure
Proton-pump inhibitor exposure (ATC code A02BC) was assessed for the period 12 to 6 months 
preceding the semen analysis (period 1) and in the period 6 months immediately before 
the semen analysis (period 2). Men without PPI exposure in the corresponding period were 
defined as non-users. Exposure to other ATC-coded drugs in the period 12 to 0 months before 
the semen analysis was defined as ‘‘Medication use other.’’ We expressed PPI dosage as the 
defined daily dosage (DDD) – the assumed average maintenance dose per day for a drug used 
for its main indication in adults – to account for differences in the standard dosing regimen 
between the types of PPIs. The cumulative PPI dose was calculated by multiplying the DDD 
and the duration of use. If the duration of use was missing, we imputed a value calculated by 
dividing the prescribed number of units by the dosing regimen. 
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Table 1 | General characteristics of cases and controls in sperm analysis and proton-pump inhibitor use 
analysis based on the Integrated Primary Care Information database in the Netherlands.
Cases (TMSC ≤1) 
(n= 241)
Controls (TMSC >1) 
(n= 714)
Age (years) 34 (30-39) 34 (31-38)
Body mass index >25 (kg/m2) 
Yes 21 (77.8%) 43 (72.9%)
No 6 (22.2%) 16 (27.1%)
Missing 214 655
Smoking
Yes 38 (63.3%) 71 (46.7%)
No 22 (36.7%) 81 (53.3%)
Missing 181 562
Alcohol use
Yes 16 (59.3%) 65 (77.4%)
No 11 (40.7%) 19 (22.6%)
Missing 214 630
Sperm Parameters:
pH 8.0 (7.7-8.1) 8.0 (7.7-8.0)
Sperm count (106/ejaculate) 2.6 (1.1-9.2) * 103.7 (48.0-198.0)
Ejaculate volume (mL) 2.5 (1.5-3.5) * 3.0 (2.0-4.0)
Sperm concentration (106/mL) 2.1 (0.3-9.0) * 43.0 (21.0-81.0)
Sperm motility (A+B%) 0.0% (0.0%-5.0%) * 43.6% (31.3%-56.0%)
Total motile sperm count (106/ejaculate) 0.0 (0.0-0.3) * 47.2 (16.6-96.8)
Abstinence period (days) 3 (2-5) 3 (2.5-5)
Time to semen analysis (min) 0:40 (0:30-1:00) 0:40 (0:30-0:55)
Values are expressed as median (IQR) or as number (%); TMSC = total motile sperm count. * p <0.01
Semen sample data
The following semen sample data were extracted; ejaculate volume (mL); sperm concentration 
(106/mL); sperm motility parameters type A (rapid progressive motility, %) and type B (slow 
or sluggish progressive motility, %); total sperm count (106/ejaculate); and total motile 
sperm count (TMSC, 106/ejaculate) calculated as the product of ejaculate volume, sperm 
concentration and grade A+B motility. Additional information was collected on the abstinence 
period, time between semen collection and analysis, pH, and completeness of the sample. 
Semen analyses were performed in hospital-affiliated laboratories participating in the external 
quality control scheme of the Dutch foundation for quality assessment in clinical laboratories 
(www.SKML.nl). The staff performing these analyses has trained and tested annually according 
to the certified European Society of Human Reproduction and Embryology (ESHRE) course for 
performing semen analyses. Both clinical and nonclinical laboratories have to be ISO15189 
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certified (the worldwide standard for medical laboratories) and are controlled by the Dutch 
institute for accreditation of laboratories (www.cckl.nl).
1.5 million medical records of more than 720 Dutch General Practitioners 
 
 
52,347 male patients included in data sample (positive search term)
 
22,108 male patients with active database registration (1996 to 2013)
 
 
 
Exclusion: (n= 428)
- history of testicular surgery
- history of chemo- or radiotherapy
- congenital absence of the vas deferens
- varicocele
- incomplete or unreliable semen sample
Cases (n= 241)
Men with total motile sperm count ≤1 
Controls (n= 714) 
Men with total motile sperm count >1 
2,473 men with a registered semen analysis and planning pregnancy 
Exclusion: (n= 676) 
- Men with incomplete medication history 
   and no medication use
Exclusion: (n= 414 ) 
- Unmatched controls
n= 1,369
Proton-pump inhibitor users and non-users
 in period 1 and/or 2
 
Figure 1 | Flowchart of data acquisition for model 1 of the conditional logistic regression analysis.
Statistical analyses 
Chi-square tests and Mann-Whitney U tests were used to test differences between cases and 
controls, and Chi-square tests and Kruskal Wallis tests in case of comparisons of more than 
two groups. In PPI users and non-users, the effects of PPI use in two consecutive periods of 6 
months preceding semen analysis were analyzed for cases matched to controls by GP using 
conditional logistic regression with adjustment for age and other medication use (Table 2, 
model 1). To investigate possible confounding by ejaculate volume, this variable was added 
to the logistic regression analysis (model 2). In model 3 the analysis was repeated with a 
modification of the window of PPI exposure of 12-0 months preceding semen analysis. The 
effect of PPI use on TMSC was also analyzed using a multivariate linear mixed model analysis 
only in men with a TMSC ≥1, adjusted for age and clustered by GP and with a fourth root 
transformation to TMSC because of a left-skewed distribution (Table 3). The analysis was 
repeated after the exclusion of men using other medication (Table 3). Statistical analyses 
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were performed using SPSS (version 21.0, IBM SPSS) and SAS 9.2 (SAS Institute). P <0.05 was 
considered statistically significant for all analyses.
Table 2 | Proton-pump inhibitor use and the risk of low total motile sperm count.
OR P value 95% CI
Unadjusted model cases n= 241, controls n= 714
PPI use in period 1 
PPI use in period 2
2.90
0.70
0.01
0.41
(1.24-6.76)
(0.30-1.65)
Model 1 cases n= 241, controls n= 714
PPI use in period 1 2.96 0.01 (1.26-6.97)
PPI use in period 2 0.72 0.47 (0.30-1.74)
Age 1.00 0.83 (0.98-1.02)
Medication use other 0.85 0.32 (0.61-1.17)
Model 2 cases n= 183, controls n= 667
PPI use in period 1 2.95 0.02 (1.18-7.39)
PPI use in period 2 0.60 0.33 (0.22-1.67)
Age 1.00 0.77 (0.98-1.03)
Medication use other 0.77 0.14 (0.53-1.10)
Ejaculate volume 0.91 0.09 (0.82-1.01)
Model 3 cases n= 241, controls n= 714
PPI use 1 year preceding semen analysis 1.52 0.17 (0.83-2.79)
Age 1.00 0.70 (0.98-1.03)
Medication use other 0.84 0.30 (0.61-1.17)
Note: Results from conditional logistic regression analyses in which we defined men with a total motile sperm count (TMSC) 
≤1 (106/ejaculate) as cases and >1 as controls. Model 1: adjusted for age and other medication use. Model 2: model 1 with 
additional adjustment for ejaculate volume. Model 3: modification of the window of proton-pump inhibitor (PPI) exposure 
to 12–0 months preceding semen analysis. CI = confidence interval; OR = odds ratio. 
RESULTS
General characteristics of the 241 cases and the 714 matched controls are shown in Table 1. No 
significant differences were observed in the general characteristics. The median abstinence 
period and time to semen analysis were similar, respectively 3.0 vs. 3.0 days (p= 0.78) and 
40 vs. 40 minutes (p= 0.77). In cases a lower median sperm count, ejaculate volume, sperm 
concentration, sperm motility and TMSC was observed (all p <0.01).
Risk of low motile sperm count (TMSC ≤1)
Table 2 shows the results of the case-control analyses. Use of a PPI in period 1 (12-6 months 
before semen analysis) was associated with a three-fold higher risk of low TMSC (odds ratio 
[OR] 2.96; 95% confidence interval [CI], 1.26-6.97). Use of a PPI in period 2 was not associated 
with TMSC. Because of the differences in ejaculate volume between cases and controls 
(Table 1), we adjusted the analysis for ejaculate volume, which slightly attenuated this risk (OR 
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2.95; 95% CI, 1.18-7.39). When the window of PPI exposure was modified into 12-0 months 
preceding semen analysis, PPI use was no longer statistically significantly associated with low 
TMSC (OR 1.52; 95% CI, 0.83-2.79). The interaction between PPI use in the two periods was 
tested and showed no statistically significant interaction (OR 1.56; p= 0.64; 95% CI, 0.25-9.95).
Multivariate linear mixed model analysis
The use of PPIs in periods one and two was not statistically significantly associated with TMSC 
(β -0.17 and β -0.001, respectively; see Table 3) when the analysis was performed in PPI users 
and non-users.
After the exclusion of men using other medication (n= 786, ST1), this analysis was repeated 
in PPI users and men using no medication. The use of PPIs in period 1 was associated with a 
decrease in TMSC (β -0.33; Table 3), but not PPI use in period 2 (β 0.18). For example, a man of 
30 years, using PPIs in period 1 would have a TMSC that is 17.99 (106/ejaculate) lower than a 
man of the same age who was not using any medication, when both were not using PPIs in 
period 2. This difference increases with age, as shown by a 22.89 (106/ejaculate) lower TMSC in 
a PPI user compared with a man aged 50 years who was not using any medication.
Table 3 | Multivariate linear mixed model analysis of total motile sperm count.
β estimate P value 95% CI
Effects in PPI users and non-users a
Intercept 2.40 <0.001 (2.02 to 2.79)
PPI use in period 1 -0.17 0.20 (-0.44 to 0.09)
PPI use in period 2 -0.001 0.99 (-0.24 to 0.24) 
Age 0.001 0.83 (-0.01 to 0.01)
Medication use other -0.005 0.93 (-0.10 to 0.09)
Effects in PPI users and no medication users, after 
exclusion of men using other medication than PPIs b
Intercept 2.25 <0.001 (1.75 to 2.76)
PPI use in period 1 -0.33 0.047 (-0.66 to -0.01)
PPI use in period 2 0.18 0.28 (-0.15 to 0.52)
Age 0.01 0.32 (-0.01 to 0.02)
Note: CI = confidence interval; PPI = proton-pump inhibitor; TMSC = total motile sperm count. Total motile sperm count is 
transformed to achieve normality 4√   (TMSC 106/ejaculate).
a Multivariate linear mixed model analysis of TMSC in association to the use of PPIs in the two periods, adjusted for age and 
other medication use and using the general practice (GP) as clustering variable. 
b Multivariate linear mixed model analysis of TMSC in association to the use of PPIs in the two periods, adjusted for age and 
using the general practice (GP) as clustering variable.
For 86 men the PPI dose was known. In Supplemental Figure 1 we plotted TMSC against 
cumulative DDD in the 12 months preceding semen analysis. Subsequently, the cumulative 
DDD was categorized into low dose (1-30) and high dose (>30) groups of 43 men each, and 
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the allocation was assessed between five clinical relevant TMSC categories; ≤1, >1 to ≤3, >3 
to ≤10, >10 to ≤20 , >20. In TMSC category ≤1 we observed more men using a high dose 
than men using a low dose (n= 8, 66.7% vs. n= 4, 33.3%). In TMSC category >20 more men 
used a low dose than a high dose (n= 28, 51.9% vs. n= 26, 48.1%). However, we observed no 
statistically significant trend in the five TMSC categories (linear-by-linear association, p= 0.64). 
To evaluate selection bias, in Supplemental Table 1 we presented the general characteristics 
of PPI users compared with non-users, with users of other medication, with non-users who 
had an incomplete medication history, and with those meeting the study exclusion criteria. 
The general characteristics were comparable, except for a statistically significantly higher age 
in PPI users. Sperm parameters were statistically significantly different among the groups; 
the group of excluded men showed on average a lower median sperm count, concentration, 
motility, and TMSC. The PPI users showed a lower TMSC (median 23.8 vs. 40.0; p= 0.005 for 
pairwise comparison) and a lower ejaculate volume (median 2.5 vs. 3.0 mL; p= 0.02) than non-
users.
DISCUSSION
To our knowledge, our study is the first to show negative associations between PPI use and 
semen parameters. In men of couples planning pregnancy and visiting a GP, a three-fold higher 
risk of a low TMSC ≤1 was observed when using PPIs between 12 and 6 months before semen 
analysis. This association was substantiated in men with a TMSC ≥1, showing a decrease in 
TMSC when PPIs were used in the same period in comparison with men using no medication. 
We found that PPI use in the 6 months preceding semen analysis was not associated with a 
low TMSC. 
The effect of PPI use on semen quality has scarcely been studied before. A study in mice 
treated with omeprazole during spermatocytes meiosis observed no effect on chromosome 
nondisjunction [198]. Unfortunately, sperm parameters were not assessed. Direct genotoxicity 
was tested by exposing purified eukaryotic DNA of salmon sperm to omeprazole and was 
found to be safe [199]. The only study performed in humans addressed men testing positive 
for Helicobacter pylori IgA antibody, and omeprazole use was combined with tinidazole and 
clarithromycin. Three months after triple therapy, an amelioration of sperm motility was 
observed [200]. This seems contradictory to our results, although a longer follow-up period 
up of 6 to 12 months was not achieved. The eradication of H. pylori itself could have led to a 
general improved wellbeing, causing a restoration of sperm motility. 
To our knowledge there have been no other attempts to investigate semen parameters in PPI 
users. Use of H2RA to neutralize gastric acidity was previously related to a deterioration of 
semen parameters [172], although H2RAs in comparison with PPIs are far less frequently used 
[157]. 
Our study showed that only PPI use between 12 and 6 months preceding semen analysis 
was associated with a lower TMSC, not PPI use in the 6 months preceding semen analysis nor 
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when the two periods were combined in one window of PPI exposure 1 year preceding semen 
analysis. This suggests that spermatogenesis, which covers a time span of around 10 weeks, 
is not directly affected by PPI use. A possible mechanism explaining the long period between 
PPI exposure and sperm quality decline may be that PPIs induce a prolonged increase in 
gastric pH resulting in B vitamin and other micronutrient deficiencies as a consequence of 
impaired gastrointestinal absorption [12,20,46]. Apparently the resources of these vitamins are 
exhausted after 4 to 6 months, resulting in a subsequent dramatic decrease in semen quality. 
The previous studies investigating cobalamin malabsorption were not conclusive in assessing 
the time window of the development of these micronutrient deficiencies. Two weeks after PPI 
use a dose dependent decrease in cobalamin absorption was observed [160]. 
Lam et al. [12] investigated only the effect of a 2 or more years’ supply of PPIs and also observed 
a dose dependent increased risk of cobalamin deficiency. Periodically assessing cobalamin 
levels in patients who are on long-term treatment with PPIs is therefore recommended [160]. 
To our knowledge deficiencies in folate absorption and the adverse effects of a shorter time 
span of PPI use have not been studied. Along with a lower TMSC, we also observed a lower 
ejaculate volume in PPI users. It is interesting to speculate about whether this is due to PPI 
exposure; it is more important to note that there was no confounding because ejaculate 
volume is used to calculate TMSC. Additional adjustment for ejaculate volume only slightly 
attenuated the association. In addition, confounding due to differences in abstinence or time 
to semen analysis can be excluded because this was similar in the cases and controls and 
in PPI users and non-users. To exclude selection bias we also showed that in included and 
excluded men the general characteristics were largely comparable. In this study we did not 
observe a linear association between PPI use and TMSC when the PPI users were compared 
with PPI non-users. However, when the PPI users were compared with relatively healthy men-
after the exclusion of men using other medication, by selecting men not using any medication 
as nonexposed group-a statistically significant decrease in TMSC was observed. This can be 
explained by confounding by indication because medication use is a proxy for the presence of 
disease that may affect semen parameters as well [169]. 
Inherent to the observational character of the study is that we cannot control for the effect 
of gastrointestinal disease itself because all medication users will suffer from gastrointestinal 
symptoms. Furthermore, when interpreting these data we must keep in mind that prescription 
data were used to identify PPI users and non-users. The use of prescription data minimizes 
the risk of information bias, although misclassification could have occurred in patients with 
low compliance to PPI use. On the other hand, PPIs are approved by the U.S. Food and Drug 
Administration as over-the-counter drugs, and underreporting of PPI use might have been 
occurred in the non-exposed group. However, the comparable prevalence of PPI use (8%) in our 
study compared with a large population-based study makes underreporting or overreporting 
not very likely [157]. The IPCI database is a very reliable and validated data source composed 
of a large cohort of medical records [196].
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General practitioners play a pivotal role in cases of difficulty conceiving as they are the first 
medical professionals to be consulted and they provide further referral to a gynecologist if 
needed. Our search strategy was very comprehensive; it expanded the amount of records 
for manual review and reduced the chance of missing cases. The manual review allowed us 
to classify all individuals accurately. We thus assume that these first observations serve as an 
acceptable representative of the general population. Ethnic background information was 
not available in this database, but it is related to semen quality and to PPI use [179,201]. By 
matching cases and controls by GP management, we attempted to reduce confounding; 
patients visiting the same GP are more likely to live in the same neighborhood, which is a 
proxy not only for ethnic background but also for socioeconomic status, health, and other 
characteristics [202]. Matching by GP also accounts for confounding due to interlaboratory 
differences in semen analyses and for differences among GPs in reporting and prescribing. 
Inherent to a database study are limitations that need to be addressed. Unfortunately, the 
effect of body mass index, smoking, or alcohol use could not be assessed because of poor 
registration data (see Table 1 and Supplemental Table 1) [57,203-205]. Another study limitation 
was that we could not account for intraindividual variation in semen quality because only one 
semen analysis was used per patient. Instead of repeating the sample, it is more likely for GPs 
to refer the patient onward in cases of poor semen quality. Due to the study sample size, it was 
not possible to match cases and controls on age in addition to GP. Finally, although semen 
abnormalities are not observed in digestive diseases, we cannot exclude that the observations 
in this study are caused by the gastroesophageal reflux disease itself, because all patients who 
received a prescription for PPIs reported gastrointestinal symptoms [169]. 
The cumulative dose–effect association substantiates the findings, but we have to interpret 
them with caution because this analysis showed no statistically significant trend, was 
performed in a small sample of PPI users, and was performed without matching for GP.
CONCLUSION
This study showed in a population-based cohort, the novel finding that PPI use 12-6 months 
preceding semen analysis is associated with a three-fold higher risk of low TMSC in the general 
male reproductive population. This emphasizes the need for preconceptional research and 
counseling on the side effects of medication use on semen quality.
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In this thesis we investigated the role of nutrient deficiencies in human subfertility, promoted 
by an inadequate intake or a drug-induced malabsorption. In this chapter we will describe the 
main findings and discuss the methodological considerations, and the suggestions for future 
research.
MAIN FINDINGS
New screening tools and mHealth intervention
In chapter 2 we observed that the Preconception Dietary Risk (PDR) score is a sensitive, quick 
and simple screening tool to assess diet inadequacy, ideal for use in clinical practice with a 
sensitivity of more than 80% for inadequate intakes of bread, vegetables, fruit, meat and fish. 
Diet inadequacy was present in the majority of women and men and a significant correlation 
was observed between PDR score and serum cobalamin concentration. We are aware that 
dietary interventions only cover one of the modifiable risk factors and do not offer the overall 
solution for the treatment of reproductive disorders, but we really want to emphasize that 
its contribution is important. Changing your diet into a healthy and adequate diet can be 
achieved with personal counselling or coaching and is necessary since in the majority of 
couples, diet inadequacy was present. 
The PDR score covered the inadequacy of the six most important food groups and was 
previously used for the assessment of dietary inadequacy [6,59]. However, unhealthy food 
groups are not included in this score and therefore only assessed inadequacy in terms of 
insufficient intake of the six healthy food groups. Therefore with the PDR score we cannot 
investigate a harmful effect of intake of unhealthy food groups and that is why in the m-health 
program ‘Smarter Pregnancy’, extra questions were added to cover the intake of unhealthy 
food groups as well. It is also interesting to speculate whether all six items contribute 
beneficially in the same quantity. Especially, since Hammiche et al. observed a beneficial effect 
of omega-3 polyunsaturated fatty acids on embryo morphology and maybe justifies that the 
item fish should account for a more significant contribution in the calculation of the summary 
PDR score [7]. To elaborate on this issue further, a gender specific calculation of the PDR score 
could be proposed since different beneficial effects are observed for women and men. 
We presented a simple score for health care providers to use in clinical practice in which they 
can assess diet inadequacy with six short questions. For simplicity the options per PDR score 
item are adequate or inadequate according to the guideline, but in daily practice it might 
be better to nuance the degree of inadequacy. Because when a person is not eating any 
vegetables and a person is eating every day 195 grams of vegetable, they are both scored 
as inadequate for that PDR item (both <200 grams daily). Other variants of the PDR score 
worldwide struggle with the same issue; that adding more details to the score is actually a 
trade-off for being less usable for clinical use [74,206-208]. Furthermore, a cumulative effect 
can be achieved when other modifiable risk factors such as smoking, alcohol use, drugs use 
are improved as well and can be considered to add to the score as well [59]. 
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These observations were used for the further personalization of the preconceptional 
counselling and treatment of couples during the periconception period. In chapter 3 we 
observed that M-health digital coaching is an effective tool to improve and additionally 
maintain healthy lifestyle behaviors in women and men in the preconception period 
and during pregnancy as well and is in line with the current rise in use and possibilities of 
mobile technology. One or two consultations in a clinical setting cannot match the effects 
accomplished with information send weekly by e-mail or sms messages, and can contribute 
to a higher compliance when dietary advice is given in the shape of tasty recipes. Although 
it is known that a vis a vis contact with a doctor in a white coat will propagate a paternalistic 
relationship and increases the confidence in the doctor’s competence which can benefit the 
effectiveness of counselling [209].
Periconceptional diet and PCOS
In the second part of this thesis we gained new insights in the role of the diet in the 
development of PCOS. 
In chapter 4 diet inadequacy assessed with the PDR score was associated with PCOS and in 
particular with the HA phenotype. Diet inadequacy was also independently associated with 
AMH, the marker for ovarian function, and with the free androgen index. This was substantiated 
when we observed the beneficial effects of strong adherence to a healthy dietary pattern 
on the severity of the PCOS phenotype (chapter 5). PCOS patients with a strong adherence 
to the healthy dietary pattern also showed a 3-fold higher chance of ongoing pregnancy, 
irrespective of PCOS phenotype. Again the adherence to the healthy dietary pattern was also 
inversely associated with AMH. The latter two chapters established the suggested association 
between 1-C metabolism and disease severity, suggesting that nutrition plays an important 
role, probably as second hit in the development of PCOS disease.
It is very interesting to speculate whether the effect of sufficient intake of healthy foods alone 
is different to sufficient intake of healthy foods next to additional intake of unhealthy food. 
In contrast to the first study, in chapter 5 we investigated the effect of an unhealthy intake. 
However, these analyses showed no associations with PCOS disease severity or chance of 
ongoing pregnancy. This might be best explained by the principal component analysis (PCA) 
itself to extract dietary patterns. PCA organizes and pools food groups in order to obtain patterns 
dominated by certain food groups. The pattern labeled as unhealthy was dominated by the 
unhealthy intake of fats, snacks, sugars and refined grains but might be more or less sufficient 
in the intake of the healthy food items as well. On the long term, this type of an unhealthy diet 
will promote obesity due to high total energy intake and stimulation of excessive oxidative 
stress responses and metabolic disturbances, with or without a deficiency of nutrients [210]. 
Obesity alone has a strong impact on fertility since it is associated with a reduced probability 
of successful fertility treatment, with more complications during pregnancy and with higher 
costs [211,212]. 
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In part 2 all analyses were adjusted for BMI and total energy intake and because the studies 
in this thesis were observational and assessed data of one visit we did not investigate the 
associations of weight loss alone, irrespective to a specific dietary intervention. In the majority 
of couples a switch to a healthy diet will go hand in hand with weight loss, which in turn makes 
it difficult to tease out the cause of this weight reduction. In other words is it due to either the 
intervention itself or is it due to an adequate intake of healthy nutrients or a combination of 
both?
The general recommendation for PCOS patients is promoting weight loss regardless dietary 
composition [33,213]. Weight loss intervention with a 20 weeks hypocaloric dietary program 
showed improvements in reproductive function without a change in AMH levels [213] whereas 
others found a decrease in AMH and androgen levels [107].The latter study also investigated 
the effect of exercise and the combined effect of exercise and a dietary intervention. They 
observed the most pronounced effects in the group with diet alone, with regards to a decrease 
in BMI, levels of free T and AMH [107]. Unfortunately, this implies that there is no decisive 
answer on our question what part of the intervention did lead to the improved outcome, the 
weight loss or the dietary intervention?
The results of the dietary pattern analyses are essential steps in unravelling dietary habits 
in PCOS patients and contribute to simple advices for PCOS patients in daily life. For clinical 
practice a motivational advice should be given to PCOS patients to achieve weight loss with a 
healthy diet which can be assessed with the 6 items of the PDR score. Subsequently the use for 
specific coaching programs should be encouraged since it is developed to coach and support 
patients and gives extensive background on all modifiable risk factors (Chapter 3). 
Periconceptional medication use and semen parameters
In part three we observed adverse effects of medication use on male fertility, suggesting a 
drug-induced malabsorption of nutrients important for 1-C metabolism. The use of medication 
for gastric acid-related symptoms was significantly associated with a 2-fold higher risk of a 
low total motile sperm count and a decreased sperm concentration. This was observed in 
men visiting our tertiary hospital (Chapter 6) and we validated this finding in men visiting 
the general practitioner (Chapter 7). Although we did not observe significant differences in 
biomarkers of 1-C metabolism between medication users and non-users in chapter 6, we 
presume this was due to the small sample size since the overall biomarker profile tended to be 
worse in medication users. 
In chapter 7 the use of proton-pump inhibitors, the most commonly used and most effective 
medication for gastric acid-related symptoms use, in the period of 12-6 months preceding 
semen analysis was associated with a three-fold higher risk of a low motile sperm count. 
Biomarkers of 1-C metabolism were not available in this study, however the observation 
that a time window of >6 months is necessary for adverse effects on semen parameters is 
very confirmative for our hypothesis since it would take a certain time to develop B vitamin 
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deficiencies that derange the 1-C pathway. In chapter 6, current use of medication during 
the preconception visit resulted in adverse outcome as well. This is conflicting with this 
latter hypothesis, although we think this might be due to the fact that the majority of the 
medication users in our study could have been chronic users, but unfortunately this issue will 
remain indecisive since only current medication was assessed in this cohort.
The high prevalence of medication use in men and women stresses the importance of this 
part of the thesis further [214]. Especially since the effect of commonly used medication is not 
often studied yet. The FDA did wrote in 2011 a recommendation for guidance of applicants 
of new drug applications towards developmental and reproductive risks [215]. However this 
guide actually means that it is suggested or recommended, but not required which now leads 
to the issue that conclusive evidence is often limited [216]. Furthermore, the adverse effects 
of medication use are mostly correlated to central hormonal effects, direct gonadotoxicity, 
to sperm function or to sexual function [216] but not yet to malabsorption of nutrients. In 
our studies we could not exclude that the adverse effects observed were due to a central 
hormonal mechanism or due to direct gonadotoxicity. Although the long period between 
exposure and outcome is more directive towards our hypothesis of nutrient malabsorption. 
Finally, the studies reporting adverse effects of medication use on male fertility will hopefully 
raise awareness of this deteriorating effect and will emphasize why the contribution of men in 
preconception counselling is important as well.
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METHODOLOGICAL CONSIDERATIONS
Inherent to the observational nature of the studies in this thesis there are several methodological 
considerations to address. 
Study design
Observational studies without randomization and interventions show associations but are not 
designed to demonstrate causality. Nevertheless, the prospective cohort design combined 
with case control analyses and the analogy of the observations with previous studies results, 
approximate causality in the observed associations. Observational studies are necessary as first 
attempt to generate evidence for a new hypothesis and eventually initiate a shift in the current 
thinking, resulting in the development of new interventions studies proving the causation of 
the hypothesis. Furthermore the criteria of Hill [217] are commonly used to provide evidence 
of causality in observational studies. In this thesis we complied to these criteria for as much 
as possible. In all studies for example, we critically evaluated the effect size of the association 
and we attempted to observe a biological gradient in the observed associations with regard to 
the outcome variable. We tested the consistency of the findings in different study populations 
and in similar factors and we tried to find coherence between epidemiological and laboratory 
findings. Lastly, causality is more plausible when a distinct mechanism is present between 
cause and effect and in this thesis derangements in 1-C metabolism were the fundament of 
all study hypotheses.
Study population
The majority of the data used in this thesis were derived from the preconception outpatient 
clinic ‘Achieving a Healthy Pregnancy’, the clinic for cycle disturbances ‘COLA’ and the Predict 
study [59,63] and investigated the effect of nutrition and lifestyle factors on fertility outcome, 
embryonic and fetal growth and development. Eventually, these new insights are used to coach 
couples on individual risk factors, to improve the chance of a healthy pregnancy outcome for 
mother, child and future offspring [59]. When interpreting these results we have to keep in 
mind that all of the studies in this thesis were performed in subfertile couples visiting the 
tertiary hospital of the Erasmus Medical Center or in couples seeking first consultation at the 
general practitioner because of the wish to conceive. Moreover, in the studies investigating 
dietary inadequacy and the severity of the PCOS phenotype the control group consisted of 
subfertile women instead of healthy women. Therefore caution is necessary when translating 
these results to other, maybe ‘healthier’ populations or to patients with a different ethnic 
background since dietary intake will be cultural defined.
Accuracy of data
All biomarker measurements were performed in one laboratory of the Erasmus MC, University 
Medical Center which diminishes the chance of measurement errors. As previously stated, 
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inter-assay coefficients of variation for serum folate were 4.5% at 13 nmol/L and 5.7% at 
23 nmol/L, for serum cobalamine 3.6% at 258 pmol/L and 2.2% at 832 pmol/L and for plasma 
tHcy were 4.8% at 14.6 μmol/L and 3.3% at 34.2 μmol/L. Intra- and interassay coefficients of 
variation were, <5% and <15% for LH, <3% and <18% for FSH, <3% and <5% for T, <8% and 
<11% for AD, <4% and <5% for SHBG, <9% and <11% for DHEAS, <5% and <8% for AMH, and 
<6% and <8% for insulin.
For the semen analyses performed in the Erasmus MC, University Medical Center, the between 
technician variation for sperm concentration was 1.6% (Intra class correlation coefficient (ICC) 
0.992, 95 % CI 0.978 to 0.997). The between technician variation for sperm motility was 2.4% 
(ICC 0.988, 95% CI 0.972 to 0.996).
The between technician variation (ICC) for semen analyses recorded in the IPCI database 
were unknown, although all hospital-affiliated laboratories in the Netherlands are obliged 
to participate in the external quality control scheme of the Dutch foundation for quality 
assessment in clinical laboratories (www.SKML.nl). Which ensures that the staff is trained and 
tested annually according to the certified European Society of Human Reproduction and 
Embryology (ESHRE) course for performing semen analyses in order to receive the ISO15189 
certificate (the worldwide standard for medical laboratories).
Questionnaires versus biomarkers in blood
We very much assume that our recorded dietary intake and medication use are a valid 
resemblance of the actual intake or use, as well as for the recordings of all other general 
characteristics [218]. 
Previous research from our group showed that FFQ estimated levels of micro- and 
macronutrients were highly correlated to actual blood measurements of serum folate, RBC 
folate and serum vitamin B12. Thereby concluding that it is a sufficient tool for the investigation 
of nutrient-disease associations [64]. 
Nevertheless, when data is gathered with self-administered questionnaires recall and 
information bias could have occurred. Underreporting in for example medication use probably 
could have led to a stronger association between medication use and low semen quality, 
if the control group also comprised medication users. On the other hand a low medication 
compliance could have occurred as well, and in that case the observed association between 
medication use and low semen quality was also underestimated, since the deteriorating effect 
was found in less frequently PPI users. The high participation and response rates in our studies 
plead against the occurrence of selection bias and because we observed mainly similarities 
in general characteristics between included and excluded groups in all sensitivity analyses. 
The studies from this thesis are explorative and reveal further insights of the importance of 
1-C metabolism and disease outcome, therefore confounding due to other factors have to be 
studied in future such as effects of psychological stress, work-related effects, pesticides etc. 
[219-221].
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CLINICAL IMPLICATIONS AND FUTURE RESEARCH
The aim for this thesis originated from previous studies such as the ‘The Food Lifestyle and 
Fertility Outcome study’ (FOLFO) which was conducted between 2004 and 2007 and examined 
the influence of preconception lifestyle exposures in subfertile couples on fertility parameters 
and pregnancy outcome [7-9]. The observed associations in this study and others, together 
with the food-based dietary guidelines of the Dutch Nutrition Center in the Netherlands 
were the reason to develop the ‘Achieving a healthy Pregnancy’ outpatient clinic in 2007 
[59]. The implementation of this counselling was one of the first initiatives to help health 
care professionals in the guidance of couples planning pregnancy into a healthier lifestyle 
and raise awareness for the adverse effects of risk factors on pregnancy outcome. Due to the 
subsequent observation that an improvement in the PDR score resulted in a 65% increased 
chance of ongoing pregnancy in couples attending this preconception counselling [6] and 
due to the work of Boxmeer et al. [41-43,45,46], we were intrigued by the possible effect of 
deranged 1-C metabolism and fertility outcome.
There are several studies, testing the effect of dietary compositions on clinical, and metabolic 
features of PCOS, only most of them are controversial [32,33,35-40]. The study populations 
differ in composition, struggle with small sample sizes, with different control groups and with 
different ways of adjustments. Hence, it is almost impossible to compare and interpret those 
results and additionally constitute simple advice for PCOS patients in daily life. Therefore, it is 
necessary to first understand and evaluate in large observational cohorts whether there are 
differences in eating behavior underlying PCOS before we initiate randomized controlled trials 
aimed to investigate the effects of specific nutrients.
Together with this thesis, the amount of evidence is numerous, however more important 
is the challenge of making health care providers and couples planning pregnancy aware 
of these results. In the future, the key initiative therefore should be to investigate the most 
effective method to reach as much couples as possible, and preferably starting <14 weeks 
before conception [20]. M-health emerged as the new medium for counselling and personal 
coaching on nutrition and lifestyle and seems very promising, since this is an impressive new 
field offering many opportunities in the digital era we are in [90]. Our survey with the mHealth 
web based coaching ‘Smarter Pregnancy’ showed impressive abilities in improving inadequate 
behavior effectively, which already resulted in the start of two large randomized controlled 
trials testing this coaching tool in different populations with follow up into pregnancy. The 
compliance is high when participants enjoy personally tailored healthy recipes and involve 
the partner in this program as well. In future we presume that this coaching will improve the 
chance of ongoing pregnancy, prevent adverse pregnancy outcome and will be cost effective 
in reducing the costs for subfertility treatment and pregnancy complications [222]. 
The emerging interests in the developmental origins of health and disease (DOHaD) is driven 
by the evidence that nutrigenomics not only affect parents to be, but also disease occurrence 
in adulthood of the offspring due to heritable changes in the gene expression [21,223-225]. 
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A periconceptional improvement of inadequate behavior can therefore contribute to the 
prevention of disease, in later life and may alter fertility outcome and disease prevalence in 
offspring as well. For future research it is important to follow offspring into adolescence and 
into adulthood and support them to maintain a healthy lifestyle. Therefore a new program 
was already launched to guide new parents and provide recipes and advice for a healthy start 
after birth.
The studies in this thesis will hopefully stimulate that in new phase 3 studies the testing of 
drug safety will require the investigation of adverse effects on fertility parameters as well. The 
FDA could contribute to this issue by changing the current recommendation into a mandatory 
guideline for safety studies. All medication that is used commonly in men and women in 
reproductive age should therefore additionally be tested and evaluated for safety. When 
couples attend preconception counselling in future, extra advice to stop or switch certain 
medicines can be given. Or in case of impaired 1-C metabolism, the use of additional vitamin 
supplements can be motivated, although new studies have to investigate the effect of this 
intervention.
To conclude, it will be very interesting to investigate the role of diet and 1-C metabolism 
in other reproductive diseases as well, for example in couples with unexplained cause of 
infertility and in comparison to healthy, fertile control women. Moreover, in this thesis we 
started observing adverse effects on semen parameters of only one group of medication and 
more work has to be done to elucidate the adverse effects on human fertility of other groups 
of medication that is commonly used in the reproductive population. 
GENERAL CONCLUSION 
The studies performed in this thesis demonstrate the importance of diet and medication use 
and their impact on human subfertility.
Firstly, we showed that diet inadequacy is very common in subfertile couples and that it 
promotes derangements in 1-C metabolism. For clinical practice we designed an accurate and 
easy tool to measure the diet inadequacy, which was further developed to the M-health tool 
‘Smarter pregnancy’ and we demonstrated that it is effective in improving and maintaining 
a healthy lifestyle in women and men. This exciting new development can be seen as an 
additional tool for future personal preconception counselling and coaching on nutrition, 
lifestyle, and medication use. 
Secondly, in women, dietary inadequacy was related to the clinical spectrum of polycystic 
ovary syndrome and the chance of ongoing pregnancy. 
Lastly, in men the use of medication, interfering with the absorption of nutrients important for 
1-C metabolism, was associated to male subfertility. 
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Summary
Subfertility is a reproductive disorder defined by the inability to achieve a clinical pregnancy 
after 12 months which affects 10-15% of couples worldwide. Causes can be attributed to a 
male factor, female factor, a combination of both and in 30% of these couples no medical cause 
can be identified. Deranged 1-C metabolism can contribute to reproductive failures since 
this pathway is essential for developing oocytes and spermatocytes and adequate nutrition 
provides for the necessary cofactors (cobalamin, folate). The aim of this thesis was to study 
the influences of 1-C metabolism on female and male subfertility, more specifically in women 
the effect of diet on PCOS disease and in men the effect of drug-induced malabsorption of 
nutrients on semen parameters. In chapter 1, we provide background information on 1-C 
metabolism, PCOS and male subfertility and we clarify the aim, objectives and methodology 
of this thesis. 
PART 1 | New screening tools and mHealth intervention
In the first part of this thesis , in chapter 2, we evaluate the use of the Preconception Dietary 
Risk score as a tool to determine the inadequacy of the habitual diet. We investigated couples 
planning pregnancy at the outpatient clinic and a summary Preconception Dietary Risk 
score was calculated from seven questions to assess the inadequacy of the diet using the six 
Dutch guidelines for the consumption of bread, oils/fats, vegetables, fruit, meat and fish. An 
inadequate habitual diet was present in 55.4% of women and 54.2% in men. The tool revealed 
a sensitivity of more than 80% and a linear positive trend for saturated fat intake, and negative 
trends for the intake of protein, EPA, DHA, fiber, folate and vitamin B6, B12 and C intake. The 
Preconception Dietary Risk score was also significantly correlated to serum vitamin B12. From 
these results we concluded that the PDR score is a sensitive, quick and simple tool which can 
be used in clinical practice to assess the inadequacy of the habitual diet.
The implementation of the digital, m-health, coaching tool ‘Smarter Pregnancy’ is discussed 
in Chapter 3. A compliance of 64.9% and a positive or very positive usability of 54.7% were 
assessed. After 6 months of coaching the lifestyles improved by 26.3% for vegetables, 38.4% 
for fruits, 56.3% for folic acid use, 35.1% for smoking and 41.9% for alcohol use. Participating 
couples showed the strongest effectiveness, emphasizing the importance of including women 
and men together in preconception counselling. This novel m-Health platform is promising 
for future preventive medicine by showing a high compliance, usability and effectiveness in 
improving lifestyle behaviors.
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PART 2 | Periconceptional diet and PCOS
Subsequently the PDR score was used in chapter 4, to assess diet inadequacy in women with 
PCOS. Our hypothesis was that dieting and diet inadequacy in the reproductive life course 
leads to an impaired programming of ovarian follicles and contributes to the severity of the 
PCOS phenotype. We observed that PCOS patients, in particular the HA phenotype reported 
more often the use of a self-initiated diet than controls. The PDR score was also higher in 
PCOS than in controls and every point increase was associated with a higher risk of the HA 
phenotype. The PDR score was also independently associated with AMH concentration, a 
marker for ovarian function, and with free androgen index. This suggests that the use of a 
self-initiated diet and diet inadequacy is associated with PCOS, in particular with the severe 
HA phenotype. 
In chapter 5, our aim was to investigate whether a specific dietary pattern is related to the HA 
PCOS phenotype and if this dietary pattern is associated to the chance of ongoing pregnancy. 
Principal component factor analysis was used to summarize dietary patterns in PCOS patients 
and a strong adherence to the healthy dietary pattern (comprising fruits, vegetables, fish and 
whole grains) was inversely associated to the severe HA PCOS phenotype. A higher chance 
of ongoing pregnancy was observed in the PCOS patients with strong adherence to the 
healthy dietary pattern. The healthy dietary pattern was also inversely associated with AMH 
concentration. This affirms the influence of nutritional composition on disease severity.
PART 3 | Periconceptional medication use and semen parameters
In the third part of this thesis we investigate if the use of medication interfering with the 
absorption of nutrients, contributes to impaired semen quality. Medication for gastric acid-
related symptoms is often used in the general population and affect the gastrointestinal pH.
In chapter 6, we observed that the use of medication for gastric acid-related symptoms was 
significantly associated with a higher risk of a low total motile sperm count and a decreased 
sperm concentration. RBC folate was positively associated with TMSC, sperm count and 
ejaculate volume and tHcy was negatively associated with sperm count. Although serum and 
RBC folate tended to be higher and cobalamin and tHcy tended to be lower in medication 
users, this did not reach the statistical level of significance. This emphasizes the importance 
of preconception counselling of subfertile men and that medication should be evaluated for 
safety of use in couples planning pregnancy. 
To validate these results we investigated in chapter 7, in men visiting the general practitioner 
if the use of proton pump inhibitors was associated to semen quality as well, since PPIs are 
the most commonly used medication for gastric acid-related symptoms and are also the 
most effective in decreasing gastric acidity. Men planning pregnancy with a recorded semen 
analysis were identified in the Integrated Primary Care Information database, comprising 
medical records of 1.5 million patients.
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The use of PPIs 12-6 months preceding semen analysis was associated with a three-fold higher 
risk of a low TMSC, whereas PPI use in the 6 months before semen analysis was not associated 
with low TMSC. Apparently spermatogenesis is not directly affected by PPI use, since only after 
6 months exhausted resources of vitamins might result in the dramatic decrease of semen 
quality.
In chapter 8 we discuss the clinical implications and the methodological considerations of this 
thesis, and we elaborate on recommendations for future research. The results of these studies 
affirm that a healthy lifestyle with adequate intake of nutrients and without medication 
interfering the absorption of these nutrients, promote a good functioning of the 1C pathway, 
which contributes to an improvement in fertility outcome.
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Samenvatting
Subfertiliteit is een stoornis in de vruchtbaarheid en is gedefinieerd als het onvermogen om 
een zwangerschap te bewerkstelligen na meer dan een jaar onbeschermde gemeenschap. 
Het komt wereldwijd voor in ongeveer 10-15% van de paren. Oorzaken kunnen worden 
toegeschreven aan de vrouw, aan de man of aan de combinatie van beide en in ongeveer 
30% van de gevallen blijft de oorzaak geheel onbekend. Een verstoring in het cellulaire 1-C 
metabolisme kan bijdragen aan het ontstaan van subfertiliteit omdat dit proces essentieel is 
voor zich ontwikkelende eicellen en zaadcellen. Gezonde voeding bevat de nodige cofactoren 
voor dit proces zoals vitamine B12, B6, B1 en foliumzuur.
Het doel van dit proefschrift is het bestuderen van de invloed van het 1-C metabolisme op 
vrouwelijke en mannelijke onvruchtbaarheid. Meer specifiek onderzoeken we in vrouwen 
het effect van voeding op de ontwikkeling van het polycysteus ovarieel syndroom (PCOS) 
en in mannen het effect van medicatie afhankelijke malabsorptie van nutriënten. In 
hoofdstuk 1 beschrijven we de achtergrond informatie ten behoeve van het 1-C metabolisme, 
PCOS en mannelijke subfertiliteit en we verhelderen de doelstellingen en methodologie van 
dit proefschrift. 
DEEL 1 | Nieuw screeningsinstrument en mHealth interventie
In het eerste deel van dit proefschrift, in hoofdstuk 2, evalueren we het gebruik van de 
preconceptionele voedingsrisico score (de PDR score) als instrument voor het determineren 
van inadequate inname van gezonde voeding. In de subfertiele paren die het  ‘Gezond 
Zwanger Worden’ spreekuur in het Erasmus MC bezochten werd de PDR score berekend 
op basis van de 6 Nederlandse richtlijnen Goede Voeding voor een inadequate inname van 
brood, vloeibare vetten, groente, fruit, vlees of vis. Een inadequate inname was aanwezig in 
55,4% van de vrouwen en in 54,2% van de mannen.
De sensitiviteit van de PDR score was meer dan 80% en was positief geassocieerd met de 
inname van verzadigd vet en negatief geassocieerd met de inname van eiwitten, met de 
omega 3-visvetzuren EPA en DHA, vezels, foliumzuur, vitamine B6, B12 en C. De PDR was ook 
significant gecorreleerd aan het serum vitamine B12 gehalte. Concluderend is de PDR score 
een sensitief, snel en simpel instrument voor gebruik in de dagelijkse praktijk waarmee de 
mate van voedingsinadequaatheid kan worden ingeschat.
Hoofdstuk 3 van dit proefschrift omvat de eerste resultaten van het digitale, mHealth 
coachingsprogramma ‘Slimmer Zwanger’. Ongeveer 65% van de gebruikers voltooiden het 
complete 26 weken durende programma en 54.7% was positief tot zeer positief over de 
gebruiksvriendelijkheid. 
Het programma verbeterde de inname van groente (26.3%), fruit (38.4%) en foliumzuur 
(56.3%) en verminderde het roken (35.1%) en alcoholgebruik (41.9%). In gebruikers die 
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deelnamen als koppel bleek het programma het meest effectief, daarmee benadrukkend dat 
preconceptionele counseling gericht moet zijn op zowel de vrouw als de man. Dit nieuwe 
mHealth coachingsprogramma is veelbelovend voor de preventieve geneeskunde van de 
toekomst met niet alleen een goede compliantie als ook een goede gebruiksvriendelijkheid 
en effectiviteit in het verbeteren van leefstijlrisicofactoren.
DEEL 2 | Periconceptionele voeding en PCOS
Vervolgens hebben we in hoofdstuk 4, de PDR score bepaald in vrouwen met PCOS. Onze 
hypothese was dat bepaalde diëten en dieet inadequaatheid kunnen leiden tot een minder 
goede programmering van ovariële follikels en daarmee kunnen bijdragen aan de ernst van 
het PCOS fenotype. PCOS patiënten en met name de patiënten met hyperandrogenisme 
volgden vaker een dieet dan de controle groep. De PDR score was ook hoger in PCOS 
patiënten en een stijging van deze risicoscore met 1 punt was geassocieerd met een verhoogd 
risico op het hyperandrogene fenotype. De PDR score was ook onafhankelijk geassocieerd 
met de AMH concentratie in het bloed, welke ook wel wordt gebruikt als indicatie voor 
de ovariële functie. Dit bevestigt het vermoeden dat dieet en voedingsinadequaatheid 
geassocieerd zijn met PCOS, en in het bijzonder met het hyperandrogene PCOS fenotype. In 
hoofdstuk 5, hebben we onderzocht of er specifieke dieetpatronen gerelateerd zijn aan het 
hyperandrogene PCOS fenotype en of deze patronen ook geassocieerd zijn met de kans op een 
doorgaande zwangerschap. Door middel van principale component factor analyse konden 
de verschillende dieetpatronen worden geëvalueerd. Patiënten waarbij het eetpatroon sterke 
overeenkomsten vertoonde met het gezonde dieetpatroon (inname van voornamelijk fruit, 
groente, vis en volkoren producten) hadden minder vaak het hyperandrogene PCOS fenotype 
en vaker een doorgaande zwangerschap. Het gezonde patroon was eveneens omgekeerd 
evenredig geassocieerd met de AMH concentratie in het bloed. Dit bevestigt de associatie van 
voedingssamenstelling en PCOS fenotype.
DEEL 3 | Periconceptioneel medicatiegebruik en semenkwaliteit
In het derde deel van dit proefschrift hebben we onderzocht of medicatiegebruik de 
opname van nutriënten kan beïnvloeden, en zo kan bijdragen aan een verminderde 
semenkwaliteit. Medicatie voor zuurbanden wordt veel gebruikt in de algemene populatie 
en beïnvloedt de pH balans in de maag. In hoofdstuk 6 beschrijven we dat het gebruik van 
zuurremmers geassocieerd is met een hoger risico op een laag aantal goed bewegende 
zaadcellen (VCM) en met een verlaagde concentratie zaadcellen. Het foliumzuurgehalte in 
de rode bloedcellen was positief geassocieerd met het aantal goed bewegende zaadcellen, 
het totale aantal zaadcellen en het ejaculaat volume. De homocysteineconcentratie in het 
bloed was negatief geassocieerd met het aantal zaadcellen. Er was geen verschil in het rode 
bloed cel foliumzuur- of homocysteineconcentratie tussen de gebruikers en niet-gebruikers.
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Preconceptionele counseling is daarom belangrijk voor subfertiele mannen en deze uit-
komsten benadrukken dat bij het testen van gebruiksveiligheid van medicatie ook gekeken 
moet worden naar het effect op de vruchtbaarheid. Voor het valideren van deze bevindingen 
in een andere onderzoekspopulatie, hebben we in hoofdstuk 7 onderzocht of het gebruik 
van protonpompremmers is geassocieerd met semenkwaliteit in mannen die vanwege 
een (onvervulde)kinderwens de huisarts bezochten. We hebben gekeken naar het gebruik 
van protonpompremmers omdat dit de meest gebruikte en meest effectieve zuurremmer 
is. Het gebruik van protonpompremmers in de periode van 12 maanden tot 6 maanden 
voorafgaand aan de semenanalyse was geassocieerd met een 3 keer verhoogd risico op een 
laag aantal goed bewegende zaadcellen. Het gebruik in de periode van 6 maanden tot aan de 
semenanalyse was niet geassocieerd met een laag aantal goed bewegende zaadcellen. Deze 
bevindingen suggereren dat de spermatogenese niet direct beïnvloed wordt door het gebruik 
van protonpompremmers, maar dat pas na 6 maanden een vermindering van semenkwaliteit 
optreed, mogelijk als late termijneffect op een daling in de B vitaminereserves. 
In hoofdstuk 8 bediscussiëren we de klinische consequenties en de methodologische 
overwegingen van dit proefschrift. Daarnaast beschrijven we onze aanbevelingen voor 
toekomstig onderzoek. 
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 136
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 137
A d d e n d u m
References 
Authors and affiliations
List of abbreviations
Bibliography
PhD portfolio
About the author
Acknowledgements
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 138
138 Addendum
References
1. van Balen F, Bos HM. The social and cultural consequences of being childless in poor-resource areas. 
Facts Views Vis Obgyn. 2009;1(2):106-21.
2. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. International 
Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health 
Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 2009;92(5):1520-4.
3. Evers JL. Female subfertility. Lancet. 2002;360(9327):151-9.
4. Van den Broeck U, D’Hooghe T, Enzlin P, Demyttenaere K. Predictors of psychological distress in patients 
starting IVF treatment: infertility-specific versus general psychological characteristics. Hum Reprod. 
2010;25(6):1471-80.
5. Busnelli A, Papaleo E, Del Prato D, La Vecchia I, Iachini E, Paffoni A, et al. A retrospective evaluation of 
prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria. Hum 
Reprod. 2015;30(2):315-22.
6. Twigt JM, Bolhuis ME, Steegers EA, Hammiche F, van Inzen WG, Laven JS, et al. The preconception diet 
is associated with the chance of ongoing pregnancy in women undergoing IVF/ICSI treatment. Hum 
Reprod. 2012;27(8):2526-31.
7. Hammiche F, Vujkovic M, Wijburg W, de Vries JH, Macklon NS, Laven JS, et al. Increased preconception 
omega-3 polyunsaturated fatty acid intake improves embryo morphology. Fertil Steril. 2011;95(5):1820-
3.
8. Vujkovic M, de Vries JH, Lindemans J, Macklon NS, van der Spek PJ, Steegers EA, et al. The preconception 
Mediterranean dietary pattern in couples undergoing in vitro fertilization/intracytoplasmic sperm 
injection treatment increases the chance of pregnancy. Fertil Steril. 2010;94(6):2096-101.
9. Vujkovic M, de Vries JH, Dohle GR, Bonsel GJ, Lindemans J, Macklon NS, et al. Associations between dietary 
patterns and semen quality in men undergoing IVF/ICSI treatment. Hum Reprod. 2009;24(6):1304-12.
10. Sturniolo GC, Montino MC, Rossetto L, Martin A, D’Inca R, D’Odorico A, et al. Inhibition of gastric acid 
secretion reduces zinc absorption in man. J Am Coll Nutr. 1991;10(4):372-5.
11. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use 
and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol. 2004;57(4):422-8.
12. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist 
use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-42.
13. Mintzer S, Skidmore CT, Sperling MR. B-vitamin deficiency in patients treated with antiepileptic drugs. 
Epilepsy Behav. 2012;24(3):341-4.
14. de Jager J, Kooy A, Lehert P, Wulffele MG, van der Kolk J, Bets D, et al. Long term treatment with 
metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo 
controlled trial. BMJ. 2010;340:c2181.
15. Palopoli JJ, Waxman J. Colchicine neuropathy or vitamin B12 deficiency neuropathy? N Engl J Med. 
1987;317(20):1290-1.
16. Andres E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, et al. Vitamin B12 (cobalamin) 
deficiency in elderly patients. CMAJ. 2004;171(3):251-9.
17. Endresen GK, Husby G. Folate supplementation during methotrexate treatment of patients with 
rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol. 2001;30(3):129-34.
18. Matsui MS, Rozovski SJ. Drug-nutrient interaction. Clin Ther. 1982;4(6):423-40.
19. Desouza C, Keebler M, McNamara DB, Fonseca V. Drugs affecting homocysteine metabolism: impact on 
cardiovascular risk. Drugs. 2002;62(4):605-16.
20. Steegers-Theunissen RP, Twigt J, Pestinger V, Sinclair KD. The periconceptional period, reproduction 
and long-term health of offspring: the importance of one-carbon metabolism. Hum Reprod Update. 
2013;19(6):640-55.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 139
139References
21. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and 
enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20(1):63-8.
22. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the 
polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-9.
23. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic 
ovary syndrome in unselected black and white women of the southeastern United States: a prospective 
study. J Clin Endocrinol Metab. 1998;83(9):3078-82.
24. Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks 
related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
25. Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, et al. Cardiovascular and 
metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil 
Steril. 2014;102(5):1444-51 e3.
26. Kar S. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A 
prospective study of PCOS women. J Hum Reprod Sci. 2013;6(3):194-200.
27. Marshall K. Polycystic ovary syndrome: clinical considerations. Altern Med Rev. 2001;6(3):272-92.
28. Burt Solorzano CM, Beller JP, Abshire MY, Collins JS, McCartney CR, Marshall JC. Neuroendocrine 
dysfunction in polycystic ovary syndrome. Steroids. 2012;77(4):332-7.
29. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian 
hormone. Reproduction. 2002;124(5):601-9.
30. Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. Novel role for anti-Mullerian hormone in 
the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016;7:10055.
31. Meng Y, Chen X, Peng Z, Liu X, Sun Y, Dai S. Association between High Serum Homocysteine Levels and 
Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and 
Meta-Analysis. PLoS One. 2016;11(6):e0157389.
32. Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R. Role of diet in the treatment of polycystic 
ovary syndrome. Fertil Steril. 2006;85(3):679-88.
33. Moran LJ, Ko H, Misso M, Marsh K, Noakes M, Talbot M, et al. Dietary composition in the treatment of 
polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 
2013;113(4):520-45.
34. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment 
of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 
2013;98(12):4565-92.
35. Vargas ML, Almario RU, Buchan W, Kim K, Karakas SE. Metabolic and endocrine effects of long-chain 
versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism. 
2011;60(12):1711-8.
36. Toscani MK, Mario FM, Radavelli-Bagatini S, Wiltgen D, Matos MC, Spritzer PM. Effect of high-protein 
or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in 
southern Brazilian women with polycystic ovary syndrome: a randomized study. Gynecol Endocrinol. 
2011;27(11):925-30.
37. Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS. A randomized trial of the effects 
of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. 
Fertil Steril. 2004;81(3):630-7.
38. Sorensen LB, Soe M, Halkier KH, Stigsby B, Astrup A. Effects of increased dietary protein-to-carbohydrate 
ratios in women with polycystic ovary syndrome. Am J Clin Nutr. 2012;95(1):39-48.
39. Mehrabani HH, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F. Beneficial effects of a high-protein, 
low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: 
a randomized controlled intervention study. J Am Coll Nutr. 2012;31(2):117-25.
40. Gower BA, Chandler-Laney PC, Ovalle F, Goree LL, Azziz R, Desmond RA, et al. Favourable metabolic 
effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin Endocrinol (Oxf ). 
2013;79(4):550-7.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 140
140 Addendum
41. Boxmeer JC, Brouns RM, Lindemans J, Steegers EA, Martini E, Macklon NS, et al. Preconception 
folic acid treatment affects the microenvironment of the maturing oocyte in humans. Fertil Steril. 
2008;89(6):1766-70.
42. Boxmeer JC, Steegers-Theunissen RP, Lindemans J, Wildhagen MF, Martini E, Steegers EA, et al. 
Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation. Hum Reprod. 
2008;23(11):2570-6.
43. Boxmeer JC, Macklon NS, Lindemans J, Beckers NG, Eijkemans MJ, Laven JS, et al. IVF outcomes are 
associated with biomarkers of the homocysteine pathway in monofollicular fluid. Hum Reprod. 
2009;24(5):1059-66.
44. Twigt JM, Vujkovic M, de Vries JH, Lindemans J, Laven JSE, Steegers-Theunissen RPM. A healthy 
dietary pattern lowers the ovarian response and improves the chance of pregnancy after ovarian 
hyperstimulation treatment. Submitted. 2015.
45. Boxmeer JC, Smit M, Utomo E, Romijn JC, Eijkemans MJ, Lindemans J, et al. Low folate in seminal plasma 
is associated with increased sperm DNA damage. Fertil Steril. 2009;92(2):548-56.
46. Boxmeer JC, Smit M, Weber RF, Lindemans J, Romijn JC, Eijkemans MJ, et al. Seminal plasma cobalamin 
significantly correlates with sperm concentration in men undergoing IVF or ICSI procedures. J Androl. 
2007;28(4):521-7.
47. Statistics Netherlands: 2012. Available from: http://www.cbs.nl//.
48. Inskip HM, Crozier SR, Godfrey KM, Borland SE, Cooper C, Robinson SM, et al. Women’s compliance with 
nutrition and lifestyle recommendations before pregnancy: general population cohort study. BMJ. 
2009;338:b481.
49. Rossum CTMv, Fransen HP, Verkaik-Kloosterman J, Buurma-Rethans EJM, Ocke MC. Dutch National 
Food Consumption Survey 2007-2010 : Diet of children and adults aged 7 to 69 years. National Institute 
for Public Health and the Environment, Environment NIfPHat; 2011 350050006.
50. Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP. Effects of folic 
acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. 
Fertil Steril. 2002;77(3):491-8.
51. Gardiner PM, Nelson L, Shellhaas CS, Dunlop AL, Long R, Andrist S, et al. The clinical content of 
preconception care: nutrition and dietary supplements. Am J Obstet Gynecol. 2008;199(6 Suppl 
2):S345-56.
52. Timmermans S, Steegers-Theunissen RP, Vujkovic M, den Breeijen H, Russcher H, Lindemans J, et al. The 
Mediterranean diet and fetal size parameters: the Generation R Study. Br J Nutr. 2012:1-11.
53. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult 
health and disease. New England Journal of Medicine. 2008;359(1):61-73.
54. Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and 
antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007;13(2):163-
74.
55. Zain MM, Norman RJ. Impact of obesity on female fertility and fertility treatment. Womens Health 
(Lond Engl). 2008;4(2):183-94.
56. McKnight J, Satterfield M, Li X, Gao H, Wang J, Li D, et al. Obesity in pregnancy: problems and potential 
solutions. Frontiers in bioscience (Elite edition). 2011;3:442.
57. Hammiche F, Laven JS, Twigt JM, Boellaard WP, Steegers EA, Steegers-Theunissen RP. Body mass index 
and central adiposity are associated with sperm quality in men of subfertile couples. Hum Reprod. 
2012;27(8):2365-72.
58. Vujkovic M, Steegers EA, Looman CW, Ocke MC, van der Spek PJ, Steegers-Theunissen RP. The maternal 
Mediterranean dietary pattern is associated with a reduced risk of spina bifida in the offspring. BJOG. 
2009;116(3):408-15.
59. Hammiche F, Laven JS, van Mil N, de Cock M, de Vries JH, Lindemans J, et al. Tailored preconceptional 
dietary and lifestyle counselling in a tertiary outpatient clinic in The Netherlands. Hum Reprod. 
2011;26(9):2432-41.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 141
141References
60. de Weerd S, van der Bij AK, Cikot RJLM, Braspenning JCC, Braat DDM, Steegers EAP. Preconception Care: 
A Screening Tool for Health Assessment and Risk Detection* 1. Preventive medicine. 2002;34(5):505-11.
61. The Netherlands Nutrition Centre. Richtlijnen voedselkeuze [in Dutch]2011 01-Feb-2012. Available 
from: http://www.voedingscentrum.nl/Assets/Uploads/Documents/Voedingsvoorlichters/Richtlijnen_
voedselkeuze_2011.pdf.
62. Siebelink E, Geelen A, de Vries JH. Self-reported energy intake by FFQ compared with actual energy 
intake to maintain body weight in 516 adults. Br J Nutr. 2011;106(2):274-81.
63. van Uitert EM, van der Elst-Otte N, Wilbers JJ, Exalto N, Willemsen SP, Eilers PH, et al. Periconception 
maternal characteristics and embryonic growth trajectories: the Rotterdam Predict study. Hum Reprod. 
2013;28(12):3188-96.
64. Verkleij-Hagoort AC, de Vries JH, Stegers MP, Lindemans J, Ursem NT, Steegers-Theunissen RP. Validation 
of the assessment of folate and vitamin B12 intake in women of reproductive age: the method of triads. 
Eur J Clin Nutr. 2007;61(5):610-5.
65. Nederlands Voedingsstoffenbestand; The Dutch Food Composition Database (NEVO). Den Haag: 
Voedingscentrum. , 2006.
66. Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for plasma total homocysteine and 
cysteine in a clinical laboratory setting. Clinical chemistry. 1999;45(2):290.
67. Vujkovic M, Ocke MC, van der Spek PJ, Yazdanpanah N, Steegers EA, Steegers-Theunissen RP. Maternal 
Western dietary patterns and the risk of developing a cleft lip with or without a cleft palate. Obstet 
Gynecol. 2007;110(2 Pt 1):378-84.
68. Ortega RM, Lopez-Sobaler AM, Gonzalez-Gross MM, Redondo RM, Marzana I, Zamora MJ, et al. Influence 
of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men. J Am 
Coll Nutr. 1994;13(1):68-72.
69. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine--
low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87(4):265-73.
70. Hirsch S, Ronco AM, Vasquez M, de la Maza MP, Garrido A, Barrera G, et al. Hyperhomocysteinemia in 
healthy young men and elderly men with normal serum folate concentration is not associated with 
poor vascular reactivity or oxidative stress. J Nutr. 2004;134(7):1832-5.
71. Sevak L, Mangtani P, McCormack V, Bhakta D, Kassam-Khamis T, dos Santos Silva I. Validation of a food 
frequency questionnaire to assess macro- and micro-nutrient intake among South Asians in the United 
Kingdom. Eur J Nutr. 2004;43(3):160-8.
72. Brants HA, Lowik MR, Brussaard JH, Kistemaker C, Van Erp-Baart AM. Food consumption methods. 
Development, reproducibility and validation of a food frequency questionnaire for vitamin B6. Eur J 
Clin Nutr. 1997;51 Suppl 3:S12-8.
73. Kranz S, Hartman T, Siega-Riz AM, Herring AH. A diet quality index for American preschoolers based 
on current dietary intake recommendations and an indicator of energy balance. J Am Diet Assoc. 
2006;106(10):1594-604.
74. Kennedy ET, Ohls J, Carlson S, Fleming K. The Healthy Eating Index: design and applications. J Am Diet 
Assoc. 1995;95(10):1103-8.
75. Thompson FE, Subar AF. Dietary assessment methodology. In: Coulston AM, Rock CL, Monsen ER, 
editors. Nutrition in the Prevention and Treatment of Disease. San Diego, US: Academic Press; 2001. 
p. 3-30.
76. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, et al. Reproducibility and 
validity of food intake measurements from a semiquantitative food frequency questionnaire. Journal 
of the American Dietetic Association. 1993;93(7):790-6.
77. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and 
intergenerational perspectives. Trends Endocrinol Metab. 2010;21(4):199-205.
78. Temel S, van Voorst SF, Jack BW, Denktas S, Steegers EA. Evidence-based preconceptional lifestyle 
interventions. Epidemiol Rev. 2014;36(1):19-30.
79. Moran L, Tsagareli V, Norman R, Noakes M. Diet and IVF pilot study: Short-term weight loss improves 
pregnancy rates in overweight/obese women undertaking IVF. Aust Nz J Obstet Gyn. 2011;51(5):455-9.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 142
142 Addendum
80. Stephenson J, Patel D, Barrett G, Howden B, Copas A, Ojukwu O, et al. How Do Women Prepare for 
Pregnancy? Preconception Experiences of Women Attending Antenatal Services and Views of Health 
Professionals. PLoS One. 2014;9(7).
81. Anderson K, Nisenblat V, Norman R. Lifestyle factors in people seeking infertility treatment – A review. 
Aust N Z J Obstet Gynaecol. 2010;50(1):8-20.
82. de Graaf JP, Steegers EA, Bonsel GJ. Inequalities in perinatal and maternal health. Curr Opin Obstet 
Gynecol. 2013;25(2):98-108.
83. van der Pal-de Bruin KM, le Cessie S, Elsinga J, de Jong-Potjer LC, van Haeringen A, Neven AK, et al. 
Pre-conception counselling in primary care: prevalence of risk factors among couples contemplating 
pregnancy. Paediatr Perinat Epidemiol. 2008;22(3):280-7.
84. Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, et al. The Effectiveness of Mobile-Health 
Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care 
Consumers: A Systematic Review. Plos Medicine. 2013;10(1) :e1001363.
85. Slimmer Zwanger. URL: https://www.slimmerzwanger.nl/ 2012 [2015-10-02].
86. Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial 
of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 
2011;34(9):1934-42.
87. Rizvi SL, Dimeff LA, Skutch J, Carroll D, Linehan MM. A pilot study of the DBT coach: an interactive 
mobile phone application for individuals with borderline personality disorder and substance use 
disorder. Behav Ther. 2011;42(4):589-600.
88. Huijgen N, van de Kamp M, Twigt j, de Vries J, Eilers P, Steegers E, et al. The Preconception Dietary Risk 
score; a simple tool to assess an inadequate habitual diet for clinical practice. Eur. Soc. Clin. Nutr. Metab. 
2013; 9, e13-e19
89. Barker D, Barker M, Fleming T, Lampl M. Support mothers to secure future public health. Nature. 
2013;504(7479):209-11.
90. Steegers-Theunissen RP, Steegers EA. Embryonic health: new insights, mHealth and personalised 
patient care. Reprod Fertil Dev. 2015. Mar 16;27(4):712-715.
91. The Netherlands Nutrition Centre. Zwangerschap URL: http://www.voedingscentrum.nl/professionals/
zwangerschap 2015.
92. Kroeze W, Oenema A, Campbell M, Brug J. The efficacy of web-based and print-delivered computer-
tailored interventions to reduce fat intake: Results of a randomized, controlled trial. Journal of Nutrition 
Education and Behavior. 2008;40(4):226-36.
93. Bandura A. Health promotion from the perspective of social cognitive theory. Psychol Health. 
1998;13(4):623-49.
94. Prochaska JO, Diclemente CC. Trans-Theoretical Therapy - toward a More Integrative Model of Change. 
Psychother-Theor Res. 1982;19(3):276-88.
95. Fogg BJ. A Behavioral Model for Persuasive Design. Persuasive ‘09. 2009. ISBN 978-1-60558-376-1/09/04
96. Bolman C, de Vries H. Psycho-social determinants and motivational phases in smoking behavior of 
cardiac inpatients. Preventive Medicine. 1998;27(5):738-47.
97. ZwangerWijzer. URL: https://www.zwangerwijzer.nl/ [2016-03-24].
98. Landkroon AP, de Weerd S, van Vliet-Lachotzki E, Steegers EAP. Validation of an Internet Questionnaire 
for Risk Assessment in Preconception Care. Public Health Genomi. 2010;13(2):89-94.
99. Denktas S, Poeran J, van Voorst SF, Vos AA, de Jong-Potjer LC, Waelput AJM, et al. Design and outline of 
the Healthy Pregnancy 4 All study. Bmc Pregnancy Childb. 2014;14.
100. Hyers K. Strategy Analytics. 2012 Oct 09. Global smartphone installed base forecast by operating 
system for 88 countries 2007 to 2017 URL: https://www.strategyanalytics.com/access-services/devices/
mobile-phones/smartphone/smartphones/reports/report-detail/global-smartphone-installed-base-
forecast-by-operating-system-for-88-countries-2007-to-2017 [2016-03-26].
101. Tripp N, Hainey K, Liu A, Poulton A, Peek M, Kim J, et al. An emerging model of maternity care: 
Smartphone, midwife, doctor? Women Birth. 2014;27(1):64-7.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 143
143References
102. Frey KA, Navarro SM, Kotelchuck M, Lu MC. The clinical content of preconception care: preconception 
care for men. American Journal of Obstetrics and Gynecology. 2008;199(6):S389-S95.
103. Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS. Evidence for an 
association between metabolic cardiovascular syndrome and coronary and aortic calcification among 
women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(11):5454-61.
104. Kosova G, Urbanek M. Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373(1-
2):29-38.
105. Kralikova M, Melounova J, Crha I, Matejovicova M, Zakova J, Jarkovsky J, et al. Intraindividual 
variability of homocysteine and related thiols concentrations in follicular fluid. J Assist Reprod Genet. 
2011;28(9):863-8.
106. Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med. 
2012;30(6):496-506.
107. Nybacka A, Carlstrom K, Fabri F, Hellstrom PM, Hirschberg AL. Serum antimullerian hormone in response 
to dietary management and/or physical exercise in overweight/obese women with polycystic ovary 
syndrome: secondary analysis of a randomized controlled trial. Fertil Steril. 2013;100(4):1096-102.
108. Moran L, Gibson-Helm M, Teede H, Deeks A. Polycystic ovary syndrome: a biopsychosocial 
understanding in young women to improve knowledge and treatment options. J Psychosom Obstet 
Gynaecol. 2010;31(1):24-31.
109. Ackard DM, Croll JK, Kearney-Cooke A. Dieting frequency among college females: association with 
disordered eating, body image, and related psychological problems. J Psychosom Res. 2002;52(3):129-
36.
110. Devine CM, Bove CF, Olson CM. Continuity and change in women’s weight orientations and lifestyle 
practices through pregnancy and the postpartum period: the influence of life course trajectories and 
transitional events. Soc Sci Med. 2000;50(4):567-82.
111. Riboli E, Toniolo P, Kaaks R, Shore RE, Casagrande C, Pasternack BS. Reproducibility of a food frequency 
questionnaire used in the New York University Women’s Health Study: effect of self-selection by study 
subjects. Eur J Clin Nutr. 1997;51(7):437-42.
112. Willett WC. Nutritional Epidemiology 1998. 198 Madison Avenue, New York, New York 10016: Oxford 
University Press, Inc. 2nd.
113. Willett WC. Nutritional epidemiology issues in chronic disease at the turn of the century. Epidemiol Rev. 
2000;22(1):82-6.
114. Jarman M, Ogden J, Inskip H, Lawrence W, Baird J, Cooper C, et al. How do mothers manage their 
preschool children’s eating habits and does this change as children grow older? A longitudinal analysis. 
Appetite. 2015;95:466-74.
115. Katz I, Madjar N, Harari A. Parental support and adolescent motivation for dieting: the self-determination 
theory perspective. J Psychol. 2015;149(5):461-79.
116. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative 
marker for ovarian aging. Fertil Steril. 2002;77(2):357-62.
117. Eisner JR, Barnett MA, Dumesic DA, Abbott DH. Ovarian hyperandrogenism in adult female rhesus 
monkeys exposed to prenatal androgen excess. Fertil Steril. 2002;77(1):167-72.
118. Dumesic DA, Schramm RD, Peterson E, Paprocki AM, Zhou R, Abbott DH. Impaired developmental 
competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing 
gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87(3):1111-9.
119. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. 
J Endocrinol. 2002;174(1):1-5.
120. Sinclair KD, Watkins AJ. Parental diet, pregnancy outcomes and offspring health: metabolic 
determinants in developing oocytes and embryos. Reprod Fertil Dev. 2013;26(1):99-114.
121. Dupont C, Cordier AG, Junien C, Mandon-Pepin B, Levy R, Chavatte-Palmer P. Maternal environment 
and the reproductive function of the offspring. Theriogenology. 2012;78(7):1405-14.
122. Sloboda DM, Hickey M, Hart R. Reproduction in females: the role of the early life environment. Hum 
Reprod Update. 2011;17(2):210-27.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 144
144 Addendum
123. Leveille P, Tarrade A, Dupont C, Larcher T, Dahirel M, Poumerol E, et al. Maternal high-fat diet induces 
follicular atresia but does not affect fertility in adult rabbit offspring. J Dev Orig Health Dis. 2014;5(2):88-
97.
124. Sanchez N. A life course perspective on polycystic ovary syndrome. Int J Womens Health. 2014;6:115-
22.
125. Rodrigues AM, Martins LB, Franklin AM, Candido AL, Santos LC, Ferreira AV. Poor quality diet is associated 
with overweight status and obesity in patients with polycystic ovary syndrome. J Hum Nutr Diet. 2014.
126. Altieri P, Cavazza C, Pasqui F, Morselli AM, Gambineri A, Pasquali R. Dietary habits and their relationship 
with hormones and metabolism in overweight and obese women with polycystic ovary syndrome. Clin 
Endocrinol (Oxf ). 2013;78(1):52-9.
127. Douglas CC, Norris LE, Oster RA, Darnell BE, Azziz R, Gower BA. Difference in dietary intake between 
women with polycystic ovary syndrome and healthy controls. Fertil Steril. 2006;86(2):411-7.
128. Wright CE, Zborowski JV, Talbott EO, McHugh-Pemu K, Youk A. Dietary intake, physical activity, and 
obesity in women with polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2004;28(8):1026-32.
129. Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. The contribution of diet, 
physical activity and sedentary behaviour to body mass index in women with and without polycystic 
ovary syndrome. Hum Reprod. 2013;28(8):2276-83.
130. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol 
supplementation on oocyte’s quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci. 
2011;15(5):509-14.
131. Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C. Chronic inflammation and elevated homocysteine 
levels are associated with increased body mass index in women with polycystic ovary syndrome. 
Gynecol Endocrinol. 2007;23(9):505-10.
132. Nybacka A, Carlstrom K, Stahle A, Nyren S, Hellstrom PM, Hirschberg AL. Randomized comparison 
of the influence of dietary management and/or physical exercise on ovarian function and metabolic 
parameters in overweight women with polycystic ovary syndrome. Fertil Steril. 2011;96(6):1508-13.
133. Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. The effect of a hypocaloric 
diet with and without exercise training on body composition, cardiometabolic risk profile, and 
reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin 
Endocrinol Metab. 2008;93(9):3373-80.
134. Bahmani F, Karamali M, Shakeri H, Asemi Z. The effects of folate supplementation on inflammatory 
factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary 
syndrome: a randomized, double-blind, placebo-controlled clinical trial. Clin Endocrinol (Oxf ). 
2014;81(4):582-7.
135. Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, et al. The relationship of serum anti-Mullerian 
hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort 
study. Hum Reprod. 2013;28(4):1077-83.
136. Brown ZA, Louwers YV, Fong SL, Valkenburg O, Birnie E, de Jong FH, et al. The phenotype of polycystic 
ovary syndrome ameliorates with aging. Fertil Steril. 2011;96(5):1259-65.
137. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Mullerian hormone serum 
concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol 
Metab. 2004;89(1):318-23.
138. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Mullerian 
hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic 
anovulatory infertility. Hum Reprod. 2004;19(9):2036-42.
139. Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic 
ovary syndrome. J Clin Endocrinol Metab. 2013;98(6):E1088-96.
140. Barber TM, Franks S. Genetics of polycystic ovary syndrome. Front Horm Res. 2013;40:28-39.
141. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, et al. Genetics of polycystic ovary 
syndrome. Mol Cell Endocrinol. 1998;145(1-2):123-8.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 145
145References
142. Obermann-Borst SA, Vujkovic M, de Vries JH, Wildhagen MF, Looman CW, de Jonge R, et al. A maternal 
dietary pattern characterised by fish and seafood in association with the risk of congenital heart 
defects in the offspring. BJOG. 2011;118(10):1205-15.
143. Graff SK, Mario FM, Alves BC, Spritzer PM. Dietary glycemic index is associated with less favorable 
anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. 
Fertil Steril. 2013;100(4):1081-8.
144. Huijgen NA, Laven JS, Labee CT, Louwers YV, Willemsen SP, Steegers-Theunissen RP. Are Dieting and 
Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity? PLoS 
One. 2015;10(11):e0142772.
145. Steegers-Theunissen RP, Verheijden-Paulissen JJ, van Uitert EM, Wildhagen MF, Exalto N, Koning AH, et 
al. Cohort Profile: The Rotterdam Periconceptional Cohort (Predict Study). Int J Epidemiol. 2015.
146. Nederlands Voedingsstoffenbestand; The Dutch Food Composition Database (NEVO). Den Haag: 
Voedingscentrum, 2011.
147. Slimani N, Fahey M, Welch AA, Wirfalt E, Stripp C, Bergstrom E, et al. Diversity of dietary patterns 
observed in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public 
Health Nutr. 2002;5(6B):1311-28.
148. Wallace AM, Faye SA, Fleming R, Nelson SM. A multicentre evaluation of the new Beckman Coulter 
anti-Mullerian hormone immunoassay (AMH Gen II). Ann Clin Biochem. 2011;48(Pt 4):370-3.
149. Northstone K, Ness AR, Emmett PM, Rogers IS. Adjusting for energy intake in dietary pattern 
investigations using principal components analysis. Eur J Clin Nutr. 2008;62(7):931-8.
150. Goldberg GR, Black AE, Jebb SA, Cole TJ, Murgatroyd PR, Coward WA, et al. Critical evaluation of energy 
intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify 
under-recording. Eur J Clin Nutr. 1991;45(12):569-81.
151. Barr S, Hart K, Reeves S, Sharp K, Jeanes YM. Habitual dietary intake, eating pattern and physical activity 
of women with polycystic ovary syndrome. Eur J Clin Nutr. 2011;65(10):1126-32.
152. Moran LJ, Grieger JA, Mishra GD, Teede HJ. The Association of a Mediterranean-Style Diet Pattern with 
Polycystic Ovary Syndrome Status in a Community Cohort Study. Nutrients. 2015;7(10):8553-64.
153. Asemi Z, Karamali M, Esmaillzadeh A. Metabolic response to folate supplementation in overweight 
women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 
Mol Nutr Food Res. 2014;58(7):1465-73.
154. Schachter M, Raziel A, Strassburger D, Rotem C, Ron-El R, Friedler S. Prospective, randomized trial of 
metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary 
syndrome. Fertil Steril. 2007;88(1):227-30.
155. Kalgaonkar S, Almario RU, Gurusinghe D, Garamendi EM, Buchan W, Kim K, et al. Differential effects 
of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS. Eur J Clin Nutr. 
2011;65(3):386-93.
156. van der Steeg JW, Steures P, Eijkemans MJ, JD FH, Hompes PG, Kremer JA, et al. Role of semen analysis 
in subfertile couples. Fertil Steril. 2011;95(3):1013-9.
157. Tielemans MM, Jaspers Focks J, van Rossum LG, Eikendal T, Jansen JB, Laheij RJ, et al. Gastrointestinal 
symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional 
population based study in The Netherlands. PLoS One. 2013;8(7):e69876.
158. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett’s 
esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825-31.
159. Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of 
long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2000;14(6):651-68.
160. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin 
(vitamin B12). Ann Intern Med. 1994;120(3):211-5.
161. Wong WY, Thomas CM, Merkus JM, Zielhuis GA, Steegers-Theunissen RP. Male factor subfertility: 
possible causes and the impact of nutritional factors. Fertil Steril. 2000;73(3):435-42.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 146
146 Addendum
162. Ebisch IM, Pierik FH, de Jong FH, Thomas CM, Steegers-Theunissen RP. Does folic acid and zinc 
sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl. 
2006;29(2):339-45.
163. World Health Organization DoRHaR. WHO laboratory manual for the examination of human semen and 
sperm-cervical mucus interaction. - 4th ed. Cambridge: World Health Organization, 1999.
164. World Health Organization DoRHaR. WHO Laboratory Manual for the Examination and Processing of 
Human Semen. Geneva: World Health Organization, 2010.
165. Beijer C, Kooij van R, Repping S, Rhemrev JP, Breejen EME. Multidisciplinaire richtlijn Semenanalyse: 
Nederlandse Vereniging voor Obstetrie en Gynaecologie; 2011 [updated 2011; cited 2012 9 november]. 
Available from: http://nvog-documenten.nl/uploaded/docs/Multidisciplinaire%20richtlijn%20
Semenanalyse%20def.pdf.
166. Repping S, van Weert JM, Mol BW, de Vries JW, van der Veen F. Use of the total motile sperm count to 
predict total fertilization failure in in vitro fertilization. Fertil Steril. 2002;78(1):22-8.
167. Rhemrev JP, Lens JW, McDonnell J, Schoemaker J, Vermeiden JP. The postwash total progressively 
motile sperm cell count is a reliable predictor of total fertilization failure during in vitro fertilization 
treatment. Fertil Steril. 2001;76(5):884-91.
168. Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast JG, Eskes TK, et al. Low-dose folic acid 
supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr. 
1999;69(1):99-104.
169. Eisenberg ML, Li S, Behr B, Pera RR, Cullen MR. Relationship between semen production and medical 
comorbidity. Fertil Steril. 2015;103(1):66-71.
170. Sanchez-Pozo MC, Mendiola J, Serrano M, Mozas J, Bjorndahl L, Menkveld R, et al. Proposal of guidelines 
for the appraisal of SEMen QUAlity studies (SEMQUA). Hum Reprod. 2013;28(1):10-21.
171. Magnusdottir EV, Thorsteinsson T, Thorsteinsdottir S, Heimisdottir M, Olafsdottir K. Persistent 
organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod. 
2005;20(1):208-15.
172. Hayashi T, Miyata A, Yamada T. The impact of commonly prescribed drugs on male fertility. Hum Fertil 
(Camb). 2008;11(3):191-6.
173. Gupta A, Gupta S, Tiwary AK. Spermicidal efficacy of H2-receptor antagonists and potentiation with 2’, 
4’-dichlorobenzamil hydrochloride: role of intrasperm Ca2+. Contraception. 2003;68(1):61-4.
174. Van Thiel DH, Gavaler JS, Smith WI, Jr., Paul G. Hypothalamic-pituitary-gonadal dysfunction in men 
using cimetidine. N Engl J Med. 1979;300(18):1012-5.
175. Wang C, Wong KL, Lam KC, Lai CL. Ranitidine does not affect gonadal function in man. Br J Clin 
Pharmacol. 1983;16(4):430-2.
176. Huijgen NA, de Ridder MA, Verhamme KM, Dohle GR, Vanrolleghem AM, Sturkenboom MC, et al. Are 
proton-pump inhibitors harmful for the semen quality of men in couples who are planning pregnancy? 
Fertil Steril. 2016;106(7):1666-72 e2.
177. Eisenberg ML, Kim S, Chen Z, Sundaram R, Schisterman EF, Buck Louis GM. The relationship between 
male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod. 
2014;29(2):193-200.
178. Sermondade N, Faure C, Fezeu L, Shayeb AG, Bonde JP, Jensen TK, et al. BMI in relation to sperm count: 
an updated systematic review and collaborative meta-analysis. Hum Reprod Update. 2013;19(3):221-
31.
179. Hammiche F, Laven JS, Boxmeer JC, Dohle GR, Steegers EA, Steegers-Theunissen RP. Sperm quality 
decline among men below 60 years of age undergoing IVF or ICSI treatment. J Androl. 2011;32(1):70-6.
180. Hansen ML, Thulstrup AM, Bonde JP, Olsen J, Hakonsen LB, Ramlau-Hansen CH. Does last week’s alcohol 
intake affect semen quality or reproductive hormones? A cross-sectional study among healthy young 
Danish men. Reprod Toxicol. 2012;34(3):457-62.
181. Lopez Teijon M, Garcia F, Serra O, Moragas M, Rabanal A, Olivares R, et al. Semen quality in a population 
of volunteers from the province of Barcelona. Reprod Biomed Online. 2007;15(4):434-44.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 147
147References
182. Martini AC, Molina RI, Estofan D, Senestrari D, Fiol de Cuneo M, Ruiz RD. Effects of alcohol and cigarette 
consumption on human seminal quality. Fertil Steril. 2004;82(2):374-7.
183. Povey AC, Clyma JA, McNamee R, Moore HD, Baillie H, Pacey AA, et al. Modifiable and non-modifiable 
risk factors for poor semen quality: a case-referent study. Hum Reprod. 2012;27(9):2799-806.
184. Jensen TK, Swan S, Jorgensen N, Toppari J, Redmon B, Punab M, et al. Alcohol and male reproductive 
health: a cross-sectional study of 8344 healthy men from Europe and the USA. Hum Reprod. 
2014;29(8):1801-9.
185. Joo KJ, Kwon YW, Myung SC, Kim TH. The effects of smoking and alcohol intake on sperm quality: light 
and transmission electron microscopy findings. J Int Med Res. 2012;40(6):2327-35.
186. Kunzle R, Mueller MD, Hanggi W, Birkhauser MH, Drescher H, Bersinger NA. Semen quality of male 
smokers and nonsmokers in infertile couples. Fertil Steril. 2003;79(2):287-91.
187. Wallock LM, Tamura T, Mayr CA, Johnston KE, Ames BN, Jacob RA. Low seminal plasma folate 
concentrations are associated with low sperm density and count in male smokers and nonsmokers. 
Fertil Steril. 2001;75(2):252-9.
188. Young SS, Eskenazi B, Marchetti FM, Block G, Wyrobek AJ. The association of folate, zinc and antioxidant 
intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod. 2008;23(5):1014-22.
189. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the 
German prospective study and impact on the management of infertility. Hum Reprod. 2003;18(9):1959-
66.
190. Hamilton JA, Cissen M, Brandes M, Smeenk JM, de Bruin JP, Kremer JA, et al. Total motile sperm count: 
a better indicator for the severity of male factor infertility than the WHO sperm classification system. 
Hum Reprod. 2015;30(5):1110-21.
191. Fisch H. Older men are having children, but the reality of a male biological clock makes this trend 
worrisome. Geriatrics. 2009;64(1):14-7.
192. Rolland M, Le Moal J, Wagner V, Royere D, De Mouzon J. Decline in semen concentration and 
morphology in a sample of 26,609 men close to general population between 1989 and 2005 in France. 
Hum Reprod. 2013;28(2):462-70.
193. Medicatiegebruik mannen in fertiele leeftijd: Centraal Bureau voor de Statistiek; 2014 [updated 30 juni 
2014; cited 2015 23-04]. Available from: http://statline.cbs.nl/.
194. Howden CW, Hunt RH. The relationship between suppression of acidity and gastric ulcer healing rates. 
Aliment Pharmacol Ther. 1990;4(1):25-33.
195. Welage LS. Pharmacologic properties of proton pump inhibitors. Pharmacotherapy:The Journal of 
Human Pharmacology & Drug Therapy. 2003;23(10 Pt 2):74S-80S.
196. van der Lei J, Duisterhout JS, Westerhof HP, van der Does E, Cromme PV, Boon WM, et al. The introduction 
of computer-based patient records in The Netherlands. Ann Intern Med. 1993;119(10):1036-41.
197. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, et al. 
Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med. 
1999;38(4-5):339-44.
198. Adler ID, Schmid TE, Baumgartner A. Induction of aneuploidy in male mouse germ cells detected by the 
sperm-FISH assay: a review of the present data base. Mutat Res. 2002;504(1-2):173-82.
199. Sachs G, Scott D, Reuben M. Omeprazole and the gastric mucosa. Digestion. 1990;47 Suppl 1:35-8.
200. El-Garem Y, El-Sawy M, Mostafa T. Seminal Helicobacter pylori treatment improves sperm motility in 
infertile asthenozoospermic men. Urology. 2014;84(6):1347-50.
201. van Boxel OS, Hagenaars MP, Smout AJ, Siersema PD. Socio-demographic factors influence chronic 
proton pump inhibitor use by a large population in the Netherlands. Aliment Pharmacol Ther. 
2009;29(5):571-9.
202. van Kamp I, van Loon J, Droomers M, de Hollander A. Residential environment and health: a review of 
methodological and conceptual issues. Rev Environ Health. 2004;19(3-4):381-401.
203. Hvid-Jensen F, Nielsen RB, Pedersen L, Funch-Jensen P, Drewes AM, Larsen FB, et al. Lifestyle factors 
among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based 
setting. Clin Epidemiol. 2013;5:493-9.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 148
148 Addendum
204. Jensen TK, Gottschau M, Madsen JO, Andersson AM, Lassen TH, Skakkebaek NE, et al. Habitual alcohol 
consumption associated with reduced semen quality and changes in reproductive hormones; a cross-
sectional study among 1221 young Danish men. BMJ Open. 2014;4(9):e005462.
205. Ramlau-Hansen CH, Thulstrup AM, Aggerholm AS, Jensen MS, Toft G, Bonde JP. Is smoking a risk factor 
for decreased semen quality? A cross-sectional analysis. Hum Reprod. 2007;22(1):188-96.
206. Collins CE, Burrows TL, Rollo ME, Boggess MM, Watson JF, Guest M, et al. The comparative validity and 
reproducibility of a diet quality index for adults: the Australian Recommended Food Score. Nutrients. 
2015;7(2):785-98.
207. Pot GK, Richards M, Prynne CJ, Stephen AM. Development of the Eating Choices Index (ECI): a four-item 
index to measure healthiness of diet. Public Health Nutr. 2014;17(12):2660-6.
208. Verger EO, Mariotti F, Holmes BA, Paineau D, Huneau JF. Evaluation of a diet quality index based on the 
probability of adequate nutrient intake (PANDiet) using national French and US dietary surveys. PLoS 
One. 2012;7(8):e42155.
209. Brase GL, Richmond J. The White-Coat Effect: Physician attire and perceived authority, friendliness, and 
attractiveness. Journal of Applied Social Psychology. 2004;34(12):2469-81.
210. Chen L, Xu WM, Zhang D. Association of abdominal obesity, insulin resistance, and oxidative stress in 
adipose tissue in women with polycystic ovary syndrome. Fertil Steril. 2014;102(4):1167-74 e4.
211. Koning AM, Kuchenbecker WK, Groen H, Hoek A, Land JA, Khan KS, et al. Economic consequences of 
overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility 
care. Hum Reprod Update. 2010;16(3):246-54.
212. van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Burggraaff JM, et al. Obesity 
affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008;23(2):324-
8.
213. Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, et al. The effect of weight loss on 
anti-Mullerian hormone levels in overweight and obese women with polycystic ovary syndrome and 
reproductive impairment. Hum Reprod. 2009;24(8):1976-81.
214. Gezondheid, leefstijl, zorggebruik: Centraal Bureau voor de Statistiek; 2015 [updated 17 februari 2015; 
cited 2015]. Available from: http://statline.cbs.nl/.
215. Guidance for Industry; Reproductive and Developmental Toxicities - Integrating Study Results to Assess 
Concerns. Food and Drug Administration (FDA); Center for Drug Evaluation and Research (CDER), 2011.
216. Samplaski MK, Nangia AK. Adverse effects of common medications on male fertility. Nat Rev Urol. 
2015;12(7):401-13.
217. Hill AB. The Environment and Disease: Association or Causation? Proc R Soc Med. 1965;58:295-300.
218. Neugebauer R, Ng S. Differential recall as a source of bias in epidemiologic research. J Clin Epidemiol. 
1990;43(12):1337-41.
219. Kemeter P. Studies on psychosomatic implications of infertility--effects of emotional stress on 
fertilization and implantation in in-vitro fertilization. Hum Reprod. 1988;3(3):341-52.
220. Lawson CC, Johnson CY, Chavarro JE, Lividoti Hibert EN, Whelan EA, Rocheleau CM, et al. Work schedule 
and physically demanding work in relation to menstrual function: the Nurses’ Health Study 3. Scand J 
Work Environ Health. 2015;41(2):194-203.
221. Chiu YH, Afeiche MC, Gaskins AJ, Williams PL, Petrozza JC, Tanrikut C, et al. Fruit and vegetable intake 
and their pesticide residues in relation to semen quality among men from a fertility clinic. Hum Reprod. 
2015;30(6):1342-51.
222. Comhaire F, Decleer W. Quantifying the effectiveness and cost-efficiency of food supplementation with 
antioxidants for male infertility. Reprod Biomed Online. 2011;23(3):361-2.
223. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic 
heart disease. Lancet. 1989;2(8663):577-80.
224. Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S. Methyl donor supplementation prevents 
transgenerational amplification of obesity. Int J Obes (Lond). 2008;32(9):1373-9.
225. Kaati G, Bygren LO, Pembrey M, Sjostrom M. Transgenerational response to nutrition, early life 
circumstances and longevity. Eur J Hum Genet. 2007;15(7):784-90.
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 149
149Authors and affiliations
Authors and affiliations
Erasmus MC, University Medical Center, Rotterdam, the Netherlands 
Department of Obstetrics and Gynaecology
Prof.dr. R.P.M. Steegers-Theunissen
Prof.dr. J.S.E. Laven
Prof.dr. E.A.P. Steegers
Dr. Y.V. Louwers
Dr. A.G.M.G.J. Mulders
Dr. J.M. Twigt
Drs. M.R. van Dijk
Drs. M.E. van de Kamp
Drs. C.T. Labee
Drs. H.J. Goijen
Department of Biostatistics
Prof.dr. P.H.C. Eilers
Drs. S.P. Willemsen
Department of Medical Informatics
Prof.dr. M.C.J.M. Sturkenboom
Dr. M.A.J. de Ridder
Dr. K.M. Verhamme 
Drs. A. M. Vanrolleghem
Department of Urology, Andrology Unit
Dr. G.R. Dohle
Department of Clinical Chemistry
Prof.dr. J. Lindemans
Wageningen University, Wageningen, the Netherlands
Human Nutrition 
Dr. J.H.M. de Vries
509960-L-bw-huijgen
Processed on: 15-6-2017 PDF page: 150
150 Addendum
List of abbreviations
1-C One-Carbon 
AD Androstenedione 
ALA Alpha linolenic acid
AMH Anti-Müllerian Hormone
ATC Anatomical Therapeutic Chemical 
BMI Body Mass Index
DDD Defined Daily Dosage 
DHA Docosahexaenoic acid
DHEAS Dehydroepiandrosterone sulfate
EDTA Ethylenediamine tetraacetate 
EPA Eicosapentaenoic acid
FAI Free Androgen Index
FFQ Food Frequency Questionnaire 
FSH Follicle Stimulating Hormone
H2RA H2-receptor antagonist
HA Hyperandrogenism
HOMA-IR Homeostatic model assessment - insulin resistance.
HPG Hypothalamic-pituitary-gonadal
ICSI Intra cytoplasmatic sperm injection
IPCI Integrated Primary Care Information 
IQR Interquartile range
IVF/ICSI In-vitro fertilization
LH Luteinizing Hormone
MESA Micro chirurgic epididymal sperm aspiration
MUFA Monounsaturated fatty acids
OAT Oligoasthenoteratozoospermia
OD Ovulatory Dysfunction 
PCA Principal component factor analysis 
PCOM Polycystic Ovarian Morphology
PCOS Polycystic Ovary Syndrome
PDR Preconception Dietary Risk score
PESA Percutan epididymal sperm aspiration
PPI Proton-pump inhibitor
PQ Preconception Questionnaire 
PUFA Polyunsaturated fatty acids
RBC folate Red blood cell
RIA Radioimmunoassay 
SHBG Sex Hormone-Binding Globulin
SKML Dutch Foundation for Quality Assessment in Clinical Laboratories 
T Testosterone
tHcy Total Homocysteine
TMSC Total Motile Sperm Count
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